activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1651026	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651026	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651027	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651028	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651029	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651030	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651031	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651032	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651033	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1651034	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL5285	Homo sapiens	Kd		
	1652116	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	120.0	CHEMBL5285	Homo sapiens	Kd	uM	0.12
Not Active	1652117	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652118	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652119	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652120	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652121	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652122	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652123	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652124	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652125	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL5285	Homo sapiens	Kd		
Not Active	1652126	CHEMBL860654	Average Binding Constant for MAP3K5; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL5285	Homo sapiens	Kd		
	2147193	CHEMBL927937	Activity of human ASK1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	120.0	CHEMBL5285	Homo sapiens	Activity	%	120.0
	2393764	CHEMBL1004489	Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	<	Tm	degrees C	2.0	CHEMBL5285	Homo sapiens	Tm	degrees C	2.0
	2393765	CHEMBL1004489	Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	<	Tm	degrees C	2.0	CHEMBL5285	Homo sapiens	Tm	degrees C	2.0
	2393766	CHEMBL1004489	Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCC[C@@H](O)[C@@H](C)CC/C=C/2		CHEMBL454394	<	Tm	degrees C	2.0	CHEMBL5285	Homo sapiens	Tm	degrees C	2.0
	2393767	CHEMBL1004489	Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCCC(=O)[C@@H](C)CC/C=C/2		CHEMBL453389	<	Tm	degrees C	2.0	CHEMBL5285	Homo sapiens	Tm	degrees C	2.0
	2393768	CHEMBL1004489	Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc(O)c2c(c1)/C=C/CC[C@H](C)C(=O)CCC[C@H](C)OC2=O		CHEMBL510836	<	Tm	degrees C	2.0	CHEMBL5285	Homo sapiens	Tm	degrees C	2.0
	2393769	CHEMBL1004489	Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL454173	<	Tm	degrees C	2.0	CHEMBL5285	Homo sapiens	Tm	degrees C	2.0
	2393770	CHEMBL1004489	Binding affinity to human recombinant MAP3K5 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)[C@@H](C)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL453375	<	Tm	degrees C	2.0	CHEMBL5285	Homo sapiens	Tm	degrees C	2.0
	2463397	CHEMBL965354	Inhibition of ASK1 by fluorescence correlation spectroscopy	B	Cn1cc(/C=C2\C(=O)Nc3ccccc32)c2ccccc21		CHEMBL471375	>	IC50	nM	100000.0	CHEMBL5285	Homo sapiens	IC50	uM	100.0
	2463398	CHEMBL965356	Inhibition of ASK1 by luciferase assay	B	Cn1cc(/C=C2\C(=O)Nc3ccccc32)c2ccccc21		CHEMBL471375	=	IC50	nM	82700.0	CHEMBL5285	Homo sapiens	IC50	uM	82.7
	2463399	CHEMBL965354	Inhibition of ASK1 by fluorescence correlation spectroscopy	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	2463400	CHEMBL965354	Inhibition of ASK1 by fluorescence correlation spectroscopy	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	7000.0	CHEMBL5285	Homo sapiens	IC50	uM	7.0
	2463401	CHEMBL965356	Inhibition of ASK1 by luciferase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	37.0	CHEMBL5285	Homo sapiens	IC50	uM	0.037
	2463402	CHEMBL965356	Inhibition of ASK1 by luciferase assay	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	150.0	CHEMBL5285	Homo sapiens	IC50	uM	0.15
	2463403	CHEMBL965357	Binding affinity to ASK1	B	CO[C@@H]1[C@H](N(C)C(=O)COCCOCCNC(=O)c2ccc(-c3c4ccc(=[N+](C)C)cc-4oc4cc(N(C)C)ccc34)c(C(=O)O)c2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4.[Cl-]		CHEMBL478889	=	Kd	nM	8000.0	CHEMBL5285	Homo sapiens	Kd	uM	8.0
	2463404	CHEMBL965357	Binding affinity to ASK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	110.0	CHEMBL5285	Homo sapiens	Kd	nM	110.0
	2470252	CHEMBL987171	Inhibition of MAP3K5 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5285	Homo sapiens	INH	%	10.0
Not Evaluated	2476764	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2478603	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2478806	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2479661	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5285	Homo sapiens	Activity		
	2479864	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	15.6	CHEMBL5285	Homo sapiens	Activity	%	15.6
	2480661	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	1.4	CHEMBL5285	Homo sapiens	Activity	%	1.4
Not Evaluated	2480863	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2577282	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2577485	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2593690	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2593956	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2594159	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2594899	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2595102	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2596299	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2596502	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5285	Homo sapiens	Activity		
Not Evaluated	2597771	CHEMBL992623	Binding affinity to human MAP3K5 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5285	Homo sapiens	Activity		
	2701587	CHEMBL1061564	Inhibition of MEKK5 at 1 uM	B	C[C@@H]1CNc2c(sc3ccc4nc(-c5cccnc5)ccc4c23)C(=O)N1		CHEMBL560075	>	Inhibition	%	70.0	CHEMBL5285	Homo sapiens	INH	%	70.0
	2701588	CHEMBL1061564	Inhibition of MEKK5 at 1 uM	B	Cc1ccncc1-c1ccc2c(ccc3sc4c(c32)NC[C@@H](C)NC4=O)n1		CHEMBL549915	>	Inhibition	%	70.0	CHEMBL5285	Homo sapiens	INH	%	70.0
	2721552	CHEMBL1060960	Inhibition of ASK1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	2898100	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898101	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898102	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898103	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898104	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898105	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898106	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898107	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898108	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898109	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898110	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898111	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898112	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898113	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898114	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898115	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898116	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898117	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898118	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898119	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898120	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898121	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898122	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898123	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898124	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898125	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898126	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898127	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898128	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898129	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898130	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898131	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898132	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	110.0	CHEMBL5285	Homo sapiens	Kd	nM	110.0
	2898133	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898134	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898135	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898136	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	2898137	CHEMBL1060199	Binding constant for MAP3K5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
Not Active	2990115	CHEMBL1046149	Inhibition of ASK1 at 3 uM	B	Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1		CHEMBL585951		Activity			CHEMBL5285	Homo sapiens	Activity		
	3213955	CHEMBL1116703	Inhibition of MAP3K5 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O	Outside typical range	CHEMBL1077739	=	Inhibition	%	-24.0	CHEMBL5285	Homo sapiens	INH	%	-24.0
	3331830	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3333245	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3334650	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3336070	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3337454	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3337702	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3339033	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3339289	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3340598	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3342014	CHEMBL1168789	Inhibition of ASK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	3358457	CHEMBL1174071	Inhibition of ASK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL5285	Homo sapiens	INH	%	100.0
	3358899	CHEMBL1174071	Inhibition of ASK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	24.0	CHEMBL5285	Homo sapiens	INH	%	24.0
	3445031	CHEMBL1244727	Binding affinity to ASK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	70.0	CHEMBL5285	Homo sapiens	Kd	nM	70.0
	3448694	CHEMBL1244727	Binding affinity to ASK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	3449563	CHEMBL1244727	Binding affinity to ASK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	3449988	CHEMBL1244727	Binding affinity to ASK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	3450290	CHEMBL1244727	Binding affinity to ASK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	3450916	CHEMBL1244727	Binding affinity to ASK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	3451207	CHEMBL1244727	Binding affinity to ASK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	uM	10.0
	3561312	CHEMBL1286996	Inhibition of human ASK1 at 10 uM	B	Cc1c2c(=O)n(-c3ccccc3Cl)[nH]c2cc(=O)n1Cc1ccccn1		CHEMBL1276946	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	5120333	CHEMBL1648176	Inhibition of human ASK1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	102.0	CHEMBL5285	Homo sapiens	INH	%	102.0
	5138884	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138885	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Cc1c(C)n(C2CCCC2)c2nc[nH]c(=O)c12		CHEMBL1642658	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138886	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	NC(=O)c1ccc(-n2cnc3ccccc32)cc1		CHEMBL345730	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138887	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	CNc1nc(-c2cccnc2)cn2ccnc12		CHEMBL1642659	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138888	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Nc1nc(SCc2c(Cl)cccc2Cl)c2nc[nH]c2n1		CHEMBL1642660	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138889	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Nc1nc(OCc2ccccc2)c2nc[nH]c2n1		CHEMBL407874	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138890	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Nc1nc(Nc2cccc3ccccc23)c2nc[nH]c2n1		CHEMBL1642661	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138891	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Nc1nc(N)c2c(Cl)c(Br)ccc2n1		CHEMBL266638	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138892	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	CS(=O)(=O)c1ccc(C(=O)Nc2nc3ccccc3[nH]2)cc1[N+](=O)[O-]		CHEMBL1642654	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138893	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	CCNc1nc(N)c(C(C)=O)s1		CHEMBL1642662	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138894	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	CNc1nc(N)c(C(=O)c2ccc(F)cc2)s1		CHEMBL1642663	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138895	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Cc1c(C)n(CC(C)C)c2ncnc(N)c12		CHEMBL1642664	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138896	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Nc1nc(SCCCCC(O)O)c2nc[nH]c2n1		CHEMBL1642665	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138897	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	O=C(Nc1nc2ccccc2[nH]1)c1ccc2ncsc2c1		CHEMBL1642666	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138898	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	O=C(Nc1ccc(N2CCOCC2)cc1)c1n[nH]c2ccccc12		CHEMBL1642667	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138899	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	COc1cccc(C(=O)NN2CC(=O)C(c3nc4ccccc4c(=O)[nH]3)=C2N)c1		CHEMBL1642668	>	Inhibition	%	30.0	CHEMBL5285	Homo sapiens	INH	%	30.0
	5138900	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	CSc1nc(N)nc2[nH]cnc12		CHEMBL1172777	>	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	5138901	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	c1nc(N2CCCCC2)c2nc[nH]c2n1		CHEMBL264666	>	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	5138902	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	COc1ccc(OC)c(Nc2nc(N)nc3[nH]cnc23)c1		CHEMBL1642669	>	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	5138903	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1		CHEMBL269881	>	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	5138904	CHEMBL1648129	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide at 10 uM by mobility shift assay	B	CCCN(CCC)c1[nH]cnc2ncnc1-2		CHEMBL1410917	>	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	5138905	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL1642655	=	IC50	nM	14.0	CHEMBL5285	Homo sapiens	IC50	nM	14.0
	5138906	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	CC(C)(C)c1ccc(C(=O)Nc2cn3c(ccc4ccccc43)n2)cc1		CHEMBL1642656	=	IC50	nM	15.0	CHEMBL5285	Homo sapiens	IC50	nM	15.0
	5138907	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	CC(C)(C(=O)O)c1ccc(C(=O)Nc2cn3cc(-c4ccsc4)ccc3n2)cc1		CHEMBL1642657	=	IC50	nM	19.0	CHEMBL5285	Homo sapiens	IC50	nM	19.0
	5138908	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	CSc1nc(N)nc2[nH]cnc12		CHEMBL1172777	=	IC50	nM	13300.0	CHEMBL5285	Homo sapiens	IC50	uM	13.3
	5138909	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	CCCN(CCC)c1[nH]cnc2ncnc1-2		CHEMBL1410917	=	IC50	nM	25800.0	CHEMBL5285	Homo sapiens	IC50	uM	25.8
	5138910	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	Nc1nc(OCC2CCCCC2)c2nc[nH]c2n1		CHEMBL269881	=	IC50	nM	25100.0	CHEMBL5285	Homo sapiens	IC50	uM	25.1
	5138911	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	COc1ccc(OC)c(Nc2nc(N)nc3[nH]cnc23)c1		CHEMBL1642669	=	IC50	nM	18900.0	CHEMBL5285	Homo sapiens	IC50	uM	18.9
	5138912	CHEMBL1648128	Inhibition of ASK1 assessed as phosphorylated fluorescent peptide by mobility shift assay	B	c1nc(N2CCCCC2)c2nc[nH]c2n1		CHEMBL264666	=	IC50	nM	17000.0	CHEMBL5285	Homo sapiens	IC50	uM	17.0
	5293784	CHEMBL1696297	Inhibition of ASK1	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	5690.0	CHEMBL5285	Homo sapiens	IC50	uM	5.69
	5312991	CHEMBL1694382	Inhibition of recombinant human Ask1 kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	Cc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689369	=	Activity	%	92.0	CHEMBL5285	Homo sapiens	Activity	%	92.0
	5312999	CHEMBL1694382	Inhibition of recombinant human Ask1 kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	CCOc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689372	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	6169212	CHEMBL1769080	Inhibition of ASK1	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	>	IC50	nM	27542.0	CHEMBL5285	Homo sapiens	IC50	nM	27542.0
	6172474	CHEMBL1767754	Competitive inhibition of human ASK1 by Lineweaver-Burk plot analysis	B	CCOC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O		CHEMBL1345690	=	Ki	nM	500.0	CHEMBL5285	Homo sapiens	Ki	nM	500.0
	6172475	CHEMBL1767755	Inhibition of human ASK1 assessed as residual activity at 25 uM after 20 mins using MBP as a substrate for [gamma-33P]ATP incorporation by liquid scintillation counting	B	CCOC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O		CHEMBL1345690	=	Activity	%	12.5	CHEMBL5285	Homo sapiens	Activity	%	12.5
	6172483	CHEMBL1767806	Competitive inhibition of human ASK1	B	CCOC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O		CHEMBL1345690	=	IC50	nM	3000.0	CHEMBL5285	Homo sapiens	IC50	uM	3.0
	6172484	CHEMBL1767806	Competitive inhibition of human ASK1	B	CNc1c2c3c(cccc3n(C)c1=O)C(=O)c1ccccc1-2		CHEMBL1767077	=	IC50	nM	4700.0	CHEMBL5285	Homo sapiens	IC50	uM	4.7
	6172485	CHEMBL1767806	Competitive inhibition of human ASK1	B	CCNc1c2c3c(cccc3n(C)c1=O)C(=O)c1ccccc1-2		CHEMBL1767078	=	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	6172486	CHEMBL1767806	Competitive inhibition of human ASK1	B	CC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O		CHEMBL1529134	=	IC50	nM	15000.0	CHEMBL5285	Homo sapiens	IC50	uM	15.0
	6172487	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cn1c(=O)c(NCCO)c2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1767070	=	IC50	nM	25000.0	CHEMBL5285	Homo sapiens	IC50	uM	25.0
	6172488	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cn1c(=O)c(C(=O)c2ccccc2)c2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1767071	=	IC50	nM	35000.0	CHEMBL5285	Homo sapiens	IC50	uM	35.0
	6172489	CHEMBL1767806	Competitive inhibition of human ASK1	B	CC(=O)c1c2c3c(ccc(C)c3[nH]c1=O)C(=O)c1ccccc1-2		CHEMBL1767072	=	IC50	nM	35000.0	CHEMBL5285	Homo sapiens	IC50	uM	35.0
Not Active	6172490	CHEMBL1767806	Competitive inhibition of human ASK1	B	CC(=O)c1c2c3c(c(Cl)ccc3[nH]c1=O)C(=O)c1ccccc1-2		CHEMBL1767073		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Active	6172491	CHEMBL1767806	Competitive inhibition of human ASK1	B	CC(=O)c1c2c3c(c(O)ccc3[nH]c1=O)C(=O)c1ccccc1-2		CHEMBL1767074		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Active	6172492	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cn1c(=O)c(NC2CCCCC2)c2c3c(c(Br)ccc31)C(=O)c1ccccc1-2		CHEMBL1767075		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Active	6172493	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cn1c(=O)cc2c3c(c(NS(=O)(=O)c4ccccc4)ccc31)C(=O)c1ccccc1-2		CHEMBL1767076		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Active	6172494	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cn1c(=O)cc2c3c(c(NS(=O)(=O)c4ccc(F)cc4)ccc31)C(=O)c1ccccc1-2		CHEMBL1766957		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Active	6172495	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cc1ccc(S(=O)(=O)Nc2ccc3c4c(cc(=O)n3C)-c3ccccc3C(=O)c24)cc1[N+](=O)[O-]		CHEMBL1766958		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Active	6172496	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cc1ccccc1S(=O)(=O)Nc1ccc2c3c(cc(=O)n2C)-c2ccccc2C(=O)c13		CHEMBL1766959		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Active	6172497	CHEMBL1767806	Competitive inhibition of human ASK1	B	Cn1c(=O)cc2c3c(c(Sc4nc5ccccc5s4)ccc31)C(=O)c1ccccc1-2		CHEMBL1767069		IC50			CHEMBL5285	Homo sapiens	IC50		
	6180237	CHEMBL1772602	Inhibition of ASK1 assessed as residual activity of enzyme at 10 uM	B	Cc1cc(N/N=C/c2ccncc2)nc2ccccc12		CHEMBL1771411	=	Activity	%	94.0	CHEMBL5285	Homo sapiens	Activity	%	94.0
	6180238	CHEMBL1772603	Inhibition of ASK1 assessed as residual activity of enzyme at 25 uM	B	Cc1cc(N/N=C/c2ccncc2)nc2ccccc12		CHEMBL1771411	=	Activity	%	68.0	CHEMBL5285	Homo sapiens	Activity	%	68.0
	6325304	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	88.0	CHEMBL5285	Homo sapiens	INH	%	88.0
	6325333	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	10.0	CHEMBL5285	Homo sapiens	INH	%	10.0
	6325365	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	42.0	CHEMBL5285	Homo sapiens	INH	%	42.0
	6325397	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	31.0	CHEMBL5285	Homo sapiens	INH	%	31.0
	6325429	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	39.0	CHEMBL5285	Homo sapiens	INH	%	39.0
	6325458	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	80.0	CHEMBL5285	Homo sapiens	INH	%	80.0
	6325488	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	52.0	CHEMBL5285	Homo sapiens	INH	%	52.0
	6325516	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	17.0	CHEMBL5285	Homo sapiens	INH	%	17.0
	6325859	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	77.0	CHEMBL5285	Homo sapiens	INH	%	77.0
	6325889	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	1.0	CHEMBL5285	Homo sapiens	INH	%	1.0
	6325919	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	13.0	CHEMBL5285	Homo sapiens	INH	%	13.0
	6325948	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	3.0	CHEMBL5285	Homo sapiens	INH	%	3.0
	6325977	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	9.0	CHEMBL5285	Homo sapiens	INH	%	9.0
	6326006	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	6326035	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	8.0	CHEMBL5285	Homo sapiens	INH	%	8.0
	6326065	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	9.0	CHEMBL5285	Homo sapiens	INH	%	9.0
	6326093	CHEMBL1819983	Inhibition of ASK1 expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by IMAP assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	2.0	CHEMBL5285	Homo sapiens	INH	%	2.0
	6340929	CHEMBL1826953	Activity of ASK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	92.0	CHEMBL5285	Homo sapiens	Activity	%	92.0
	6385738	CHEMBL1838177	Inhibition of human MAP3K5 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	6385739	CHEMBL1838177	Inhibition of human MAP3K5 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	6385740	CHEMBL1838177	Inhibition of human MAP3K5 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	6385741	CHEMBL1838177	Inhibition of human MAP3K5 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	6385742	CHEMBL1838177	Inhibition of human MAP3K5 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	7567426	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7567914	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7568382	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7568814	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7569417	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7569889	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7570352	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7570779	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7570933	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7571390	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7571866	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7572329	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7572745	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7572914	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7573371	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7573847	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7574316	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7574724	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7574892	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7575353	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7575824	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7576289	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7576866	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7577325	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7577803	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7578236	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7578874	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7579248	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7579698	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7580199	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7580602	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7581232	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7581617	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7582062	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7582091	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7582555	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7582955	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7583578	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7583975	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7584449	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7584911	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7585315	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7586320	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7586791	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7587245	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7587427	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7587846	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7588299	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7588770	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7589221	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7589392	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7589816	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	70.0	CHEMBL5285	Homo sapiens	Kd	nM	70.0
	7590283	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7590757	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7591208	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7591365	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7591787	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7592259	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7592732	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7593332	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7593767	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7594239	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7594722	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7595300	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7595744	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7596218	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7596247	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7596694	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7597272	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7597725	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7598226	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5285	Homo sapiens	Kd	nM	10000.0
	7598668	CHEMBL1908725	Binding constant for ASK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	110.0	CHEMBL5285	Homo sapiens	Kd	nM	110.0
	7922709	CHEMBL1919204	Inhibition of human recombinant ASK at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	8.0	CHEMBL5285	Homo sapiens	INH	%	8.0
	7939623	CHEMBL1921401	Inhibition of human ASK1	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	7956234	CHEMBL1924897	Inhibition of N-terminus flag-tagged ASK1 expressed in baculovirus infected insect cells using [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	nM	10000.0
	7959675	CHEMBL1932328	Inhibition of ASK1	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL5285	Homo sapiens	IC50	uM	30.0
	7959676	CHEMBL1932328	Inhibition of ASK1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL5285	Homo sapiens	IC50	uM	30.0
	7969692	CHEMBL1930871	Inhibition of ASK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	99.0	CHEMBL5285	Homo sapiens	Activity	%	99.0
	8004300	CHEMBL1943317	Inhibition of human MAP3K5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	8004301	CHEMBL1943317	Inhibition of human MAP3K5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	8004302	CHEMBL1943317	Inhibition of human MAP3K5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	8004303	CHEMBL1943317	Inhibition of human MAP3K5 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	8046165	CHEMBL1960379	Inhibition of ASK1	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	10839391	CHEMBL2014957	Inhibition of MAP3K5 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	17.0	CHEMBL5285	Homo sapiens	INH	%	17.0
	10839599	CHEMBL2015922	Inhibition of ASK1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	78.0	CHEMBL5285	Homo sapiens	Activity	%	78.0
	10839690	CHEMBL2015830	Inhibition of ASK1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	97.0	CHEMBL5285	Homo sapiens	Activity	%	97.0
	10921344	CHEMBL2046172	Inhibition of ASK1 at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	99.0	CHEMBL5285	Homo sapiens	INH	%	99.0
	10921345	CHEMBL2046169	Inhibition of ASK1 at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	72.0	CHEMBL5285	Homo sapiens	INH	%	72.0
	10925140	CHEMBL2046101	Inhibition of human ASK1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	105.0	CHEMBL5285	Homo sapiens	Activity	%	105.0
	10925141	CHEMBL2046101	Inhibition of human ASK1 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	102.0	CHEMBL5285	Homo sapiens	Activity	%	102.0
	10949925	CHEMBL2049457	Inhibition of N-terminus FLAG-tagged ASK1 expressed in baculovirus expression system using [gamma-33P]-ATP measured after 60 mins by scintillation counting	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	nM	10000.0
	12036430	CHEMBL2150265	Inhibition of N-terminal FLAG-tagged ASK1 expressed in baculovirus after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	nM	10000.0
	12170843	CHEMBL2212710	Inhibition of ASK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	12172144	CHEMBL2209222	Inhibition of ASK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	92.0	CHEMBL5285	Homo sapiens	Activity	%	92.0
	12173735	CHEMBL2212072	Inhibition of ASK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	12183860	CHEMBL2211528	Inhibition of MAP3K5	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	pIC50		5.0
	12194125	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(O)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL2205636	=	IC50	nM	70.0	CHEMBL5285	Homo sapiens	IC50	nM	70.0
	12194126	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(CO)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL2205635	=	IC50	nM	32.0	CHEMBL5285	Homo sapiens	IC50	nM	32.0
	12194127	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL1642655	=	IC50	nM	14.0	CHEMBL5285	Homo sapiens	IC50	nM	14.0
	12194128	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4cccc4)ccc3n2)cc1		CHEMBL2205634	=	IC50	nM	30.0	CHEMBL5285	Homo sapiens	IC50	nM	30.0
	12194129	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-c4cccnc4)ccc3n2)cc1		CHEMBL2205633	=	IC50	nM	21.0	CHEMBL5285	Homo sapiens	IC50	nM	21.0
	12194130	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-c4ccccc4)ccc3n2)cc1		CHEMBL2205632	=	IC50	nM	82.0	CHEMBL5285	Homo sapiens	IC50	nM	82.0
	12194131	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CNCc1ccc2nc(NC(=O)c3ccc(C(C)(C)C)cc3)cn2c1		CHEMBL2205631	=	IC50	nM	870.0	CHEMBL5285	Homo sapiens	IC50	nM	870.0
	12194132	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(CO)ccc3n2)cc1		CHEMBL2205630	=	IC50	nM	129.0	CHEMBL5285	Homo sapiens	IC50	nM	129.0
	12194133	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(Br)ccc3n2)cc1		CHEMBL2205629	=	IC50	nM	21.0	CHEMBL5285	Homo sapiens	IC50	nM	21.0
	12194134	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(Cl)ccc3n2)cc1		CHEMBL2205628	=	IC50	nM	16.0	CHEMBL5285	Homo sapiens	IC50	nM	16.0
	12194135	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(F)ccc3n2)cc1		CHEMBL2205627	=	IC50	nM	34.0	CHEMBL5285	Homo sapiens	IC50	nM	34.0
	12194136	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	Cc1ccc2nc(NC(=O)c3ccc(C(C)(C)C)cc3)cn2c1		CHEMBL2205626	=	IC50	nM	22.0	CHEMBL5285	Homo sapiens	IC50	nM	22.0
	12194137	CHEMBL2214716	Competitive inhibition of human recombinant N-terminal FLAG-tagged ASK1 expressed in baculovirus infected Sf2 cells after 60 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	Cc1ccc2nc(NC(=O)c3ccc(C(C)(C)C)cc3)sc2c1		CHEMBL2205625	=	IC50	nM	260.0	CHEMBL5285	Homo sapiens	IC50	nM	260.0
	12241132	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	108.0	CHEMBL5285	Homo sapiens	Residual Activity	%	108.0
	12241133	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	111.0	CHEMBL5285	Homo sapiens	Residual Activity	%	111.0
	12241134	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12241135	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	109.0	CHEMBL5285	Homo sapiens	Residual Activity	%	109.0
	12241136	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	103.0	CHEMBL5285	Homo sapiens	Residual Activity	%	103.0
	12241137	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12241138	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	29.0	CHEMBL5285	Homo sapiens	Residual Activity	%	29.0
	12241139	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	103.0	CHEMBL5285	Homo sapiens	Residual Activity	%	103.0
	12241140	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL5285	Homo sapiens	Residual Activity	%	109.0
	12241141	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	113.0	CHEMBL5285	Homo sapiens	Residual Activity	%	113.0
	12241142	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12241143	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	113.0	CHEMBL5285	Homo sapiens	Residual Activity	%	113.0
	12241144	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	108.0	CHEMBL5285	Homo sapiens	Residual Activity	%	108.0
	12241145	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	111.0	CHEMBL5285	Homo sapiens	Residual Activity	%	111.0
	12241146	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	94.0	CHEMBL5285	Homo sapiens	Residual Activity	%	94.0
	12241147	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12241148	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	106.0	CHEMBL5285	Homo sapiens	Residual Activity	%	106.0
	12241149	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	117.0	CHEMBL5285	Homo sapiens	Residual Activity	%	117.0
	12241150	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	114.0	CHEMBL5285	Homo sapiens	Residual Activity	%	114.0
	12241151	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	81.0	CHEMBL5285	Homo sapiens	Residual Activity	%	81.0
	12241152	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	111.0	CHEMBL5285	Homo sapiens	Residual Activity	%	111.0
	12241153	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	110.0	CHEMBL5285	Homo sapiens	Residual Activity	%	110.0
	12241154	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	109.0	CHEMBL5285	Homo sapiens	Residual Activity	%	109.0
	12241155	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12241156	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	117.0	CHEMBL5285	Homo sapiens	Residual Activity	%	117.0
	12241157	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	115.0	CHEMBL5285	Homo sapiens	Residual Activity	%	115.0
	12241158	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	101.0	CHEMBL5285	Homo sapiens	Residual Activity	%	101.0
	12241159	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	77.0	CHEMBL5285	Homo sapiens	Residual Activity	%	77.0
	12241160	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	79.0	CHEMBL5285	Homo sapiens	Residual Activity	%	79.0
	12241161	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	82.0	CHEMBL5285	Homo sapiens	Residual Activity	%	82.0
	12241162	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12241163	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12241164	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	99.0	CHEMBL5285	Homo sapiens	Residual Activity	%	99.0
	12241165	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12241166	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12241167	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	87.0	CHEMBL5285	Homo sapiens	Residual Activity	%	87.0
	12241168	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	74.0	CHEMBL5285	Homo sapiens	Residual Activity	%	74.0
	12241169	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12241170	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	83.0	CHEMBL5285	Homo sapiens	Residual Activity	%	83.0
	12243769	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	83.0	CHEMBL5285	Homo sapiens	Residual Activity	%	83.0
	12243770	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243771	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243772	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	17.0	CHEMBL5285	Homo sapiens	Residual Activity	%	17.0
	12243773	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	61.0	CHEMBL5285	Homo sapiens	Residual Activity	%	61.0
	12243774	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243775	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	93.0	CHEMBL5285	Homo sapiens	Residual Activity	%	93.0
	12243776	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12243777	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	82.0	CHEMBL5285	Homo sapiens	Residual Activity	%	82.0
	12243778	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL5285	Homo sapiens	Residual Activity	%	107.0
	12243779	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	109.0	CHEMBL5285	Homo sapiens	Residual Activity	%	109.0
	12243780	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12243781	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243782	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	26.0	CHEMBL5285	Homo sapiens	Residual Activity	%	26.0
	12243783	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12243784	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12243785	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	82.0	CHEMBL5285	Homo sapiens	Residual Activity	%	82.0
	12243786	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	103.0	CHEMBL5285	Homo sapiens	Residual Activity	%	103.0
	12243787	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	106.0	CHEMBL5285	Homo sapiens	Residual Activity	%	106.0
	12243788	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12243789	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12243790	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	93.0	CHEMBL5285	Homo sapiens	Residual Activity	%	93.0
	12243791	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243792	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	81.0	CHEMBL5285	Homo sapiens	Residual Activity	%	81.0
	12243793	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12243794	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243795	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243796	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243797	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243798	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	78.0	CHEMBL5285	Homo sapiens	Residual Activity	%	78.0
	12243799	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	84.0	CHEMBL5285	Homo sapiens	Residual Activity	%	84.0
	12243800	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	78.0	CHEMBL5285	Homo sapiens	Residual Activity	%	78.0
	12243801	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	89.0	CHEMBL5285	Homo sapiens	Residual Activity	%	89.0
	12243802	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243803	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243804	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12243805	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	81.0	CHEMBL5285	Homo sapiens	Residual Activity	%	81.0
	12243806	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12243807	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	60.0	CHEMBL5285	Homo sapiens	Residual Activity	%	60.0
	12243808	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	83.0	CHEMBL5285	Homo sapiens	Residual Activity	%	83.0
	12243809	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL5285	Homo sapiens	Residual Activity	%	-1.0
	12243810	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	115.0	CHEMBL5285	Homo sapiens	Residual Activity	%	115.0
	12243811	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243812	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243813	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	101.0	CHEMBL5285	Homo sapiens	Residual Activity	%	101.0
	12243814	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243815	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	99.0	CHEMBL5285	Homo sapiens	Residual Activity	%	99.0
	12243816	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	101.0	CHEMBL5285	Homo sapiens	Residual Activity	%	101.0
	12243817	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	138.0	CHEMBL5285	Homo sapiens	Residual Activity	%	138.0
	12243818	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243819	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	52.0	CHEMBL5285	Homo sapiens	Residual Activity	%	52.0
	12243820	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243821	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243822	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	94.0	CHEMBL5285	Homo sapiens	Residual Activity	%	94.0
	12243823	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	99.0	CHEMBL5285	Homo sapiens	Residual Activity	%	99.0
	12243824	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243825	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12243826	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	103.0	CHEMBL5285	Homo sapiens	Residual Activity	%	103.0
	12243827	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	111.0	CHEMBL5285	Homo sapiens	Residual Activity	%	111.0
	12243828	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	110.0	CHEMBL5285	Homo sapiens	Residual Activity	%	110.0
	12243829	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	111.0	CHEMBL5285	Homo sapiens	Residual Activity	%	111.0
	12243830	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	99.0	CHEMBL5285	Homo sapiens	Residual Activity	%	99.0
	12243831	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL5285	Homo sapiens	Residual Activity	%	0.0
	12243832	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	119.0	CHEMBL5285	Homo sapiens	Residual Activity	%	119.0
	12243833	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243834	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	106.0	CHEMBL5285	Homo sapiens	Residual Activity	%	106.0
	12243835	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	113.0	CHEMBL5285	Homo sapiens	Residual Activity	%	113.0
	12243836	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	107.0	CHEMBL5285	Homo sapiens	Residual Activity	%	107.0
	12243837	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL5285	Homo sapiens	Residual Activity	%	89.0
	12243838	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12243839	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	84.0	CHEMBL5285	Homo sapiens	Residual Activity	%	84.0
	12243840	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243841	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243842	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12243843	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243844	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12243845	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	81.0	CHEMBL5285	Homo sapiens	Residual Activity	%	81.0
	12243846	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	48.0	CHEMBL5285	Homo sapiens	Residual Activity	%	48.0
	12243847	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	94.0	CHEMBL5285	Homo sapiens	Residual Activity	%	94.0
	12243848	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243849	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243850	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	93.0	CHEMBL5285	Homo sapiens	Residual Activity	%	93.0
	12243851	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12243852	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243853	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12243854	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	68.0	CHEMBL5285	Homo sapiens	Residual Activity	%	68.0
	12243855	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	89.0	CHEMBL5285	Homo sapiens	Residual Activity	%	89.0
	12243856	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243857	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243858	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	103.0	CHEMBL5285	Homo sapiens	Residual Activity	%	103.0
	12243859	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL5285	Homo sapiens	Residual Activity	%	1.0
	12243860	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12243861	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243862	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	36.0	CHEMBL5285	Homo sapiens	Residual Activity	%	36.0
	12243863	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL5285	Homo sapiens	Residual Activity	%	89.0
	12243864	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243865	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	112.0	CHEMBL5285	Homo sapiens	Residual Activity	%	112.0
	12243866	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	107.0	CHEMBL5285	Homo sapiens	Residual Activity	%	107.0
	12243867	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12243868	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12243869	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	71.0	CHEMBL5285	Homo sapiens	Residual Activity	%	71.0
	12243870	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	106.0	CHEMBL5285	Homo sapiens	Residual Activity	%	106.0
	12243871	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243872	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243873	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	93.0	CHEMBL5285	Homo sapiens	Residual Activity	%	93.0
	12243874	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12243875	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12243876	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243877	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	78.0	CHEMBL5285	Homo sapiens	Residual Activity	%	78.0
	12243878	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	83.0	CHEMBL5285	Homo sapiens	Residual Activity	%	83.0
	12243879	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	99.0	CHEMBL5285	Homo sapiens	Residual Activity	%	99.0
	12243880	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243881	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12243882	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243883	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	78.0	CHEMBL5285	Homo sapiens	Residual Activity	%	78.0
	12243884	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243885	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	87.0	CHEMBL5285	Homo sapiens	Residual Activity	%	87.0
	12243886	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243887	CHEMBL2219383	Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12243888	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	109.0	CHEMBL5285	Homo sapiens	Residual Activity	%	109.0
	12243889	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12243890	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12243891	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12243892	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	112.0	CHEMBL5285	Homo sapiens	Residual Activity	%	112.0
	12243893	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	101.0	CHEMBL5285	Homo sapiens	Residual Activity	%	101.0
	12243894	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	7.0	CHEMBL5285	Homo sapiens	Residual Activity	%	7.0
	12243895	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	106.0	CHEMBL5285	Homo sapiens	Residual Activity	%	106.0
	12243896	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	112.0	CHEMBL5285	Homo sapiens	Residual Activity	%	112.0
	12243897	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	107.0	CHEMBL5285	Homo sapiens	Residual Activity	%	107.0
	12243898	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	94.0	CHEMBL5285	Homo sapiens	Residual Activity	%	94.0
	12243899	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	110.0	CHEMBL5285	Homo sapiens	Residual Activity	%	110.0
	12243900	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	108.0	CHEMBL5285	Homo sapiens	Residual Activity	%	108.0
	12243901	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243902	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	78.0	CHEMBL5285	Homo sapiens	Residual Activity	%	78.0
	12243903	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243904	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243905	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	107.0	CHEMBL5285	Homo sapiens	Residual Activity	%	107.0
	12243906	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	109.0	CHEMBL5285	Homo sapiens	Residual Activity	%	109.0
	12243907	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	35.0	CHEMBL5285	Homo sapiens	Residual Activity	%	35.0
	12243908	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	111.0	CHEMBL5285	Homo sapiens	Residual Activity	%	111.0
	12243909	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243910	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243911	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243912	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	125.0	CHEMBL5285	Homo sapiens	Residual Activity	%	125.0
	12243913	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	115.0	CHEMBL5285	Homo sapiens	Residual Activity	%	115.0
	12243914	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12243915	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	82.0	CHEMBL5285	Homo sapiens	Residual Activity	%	82.0
	12243916	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	67.0	CHEMBL5285	Homo sapiens	Residual Activity	%	67.0
	12243917	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	76.0	CHEMBL5285	Homo sapiens	Residual Activity	%	76.0
	12243918	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12243919	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12243920	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243921	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL5285	Homo sapiens	Residual Activity	%	94.0
	12243922	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243923	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243924	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	87.0	CHEMBL5285	Homo sapiens	Residual Activity	%	87.0
	12243925	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243926	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243927	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	81.0	CHEMBL5285	Homo sapiens	Residual Activity	%	81.0
	12243928	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	114.0	CHEMBL5285	Homo sapiens	Residual Activity	%	114.0
	12243929	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12243930	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	16.0	CHEMBL5285	Homo sapiens	Residual Activity	%	16.0
	12243931	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	20.0	CHEMBL5285	Homo sapiens	Residual Activity	%	20.0
	12243932	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	77.0	CHEMBL5285	Homo sapiens	Residual Activity	%	77.0
	12243933	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	77.0	CHEMBL5285	Homo sapiens	Residual Activity	%	77.0
	12243934	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243935	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	56.0	CHEMBL5285	Homo sapiens	Residual Activity	%	56.0
	12243936	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	143.0	CHEMBL5285	Homo sapiens	Residual Activity	%	143.0
	12243937	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	103.0	CHEMBL5285	Homo sapiens	Residual Activity	%	103.0
	12243938	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243939	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12243940	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	7.0	CHEMBL5285	Homo sapiens	Residual Activity	%	7.0
	12243941	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	87.0	CHEMBL5285	Homo sapiens	Residual Activity	%	87.0
	12243942	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	97.0	CHEMBL5285	Homo sapiens	Residual Activity	%	97.0
	12243943	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	88.0	CHEMBL5285	Homo sapiens	Residual Activity	%	88.0
	12243944	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243945	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	116.0	CHEMBL5285	Homo sapiens	Residual Activity	%	116.0
	12243946	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243947	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL5285	Homo sapiens	Residual Activity	%	97.0
	12243948	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	87.0	CHEMBL5285	Homo sapiens	Residual Activity	%	87.0
	12243949	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	75.0	CHEMBL5285	Homo sapiens	Residual Activity	%	75.0
	12243950	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	93.0	CHEMBL5285	Homo sapiens	Residual Activity	%	93.0
	12243951	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12243952	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12243953	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	99.0	CHEMBL5285	Homo sapiens	Residual Activity	%	99.0
	12243954	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	99.0	CHEMBL5285	Homo sapiens	Residual Activity	%	99.0
	12243955	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	78.0	CHEMBL5285	Homo sapiens	Residual Activity	%	78.0
	12243956	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12243957	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	73.0	CHEMBL5285	Homo sapiens	Residual Activity	%	73.0
	12243958	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	83.0	CHEMBL5285	Homo sapiens	Residual Activity	%	83.0
	12243959	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243960	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	108.0	CHEMBL5285	Homo sapiens	Residual Activity	%	108.0
	12243961	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243962	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	93.0	CHEMBL5285	Homo sapiens	Residual Activity	%	93.0
	12243963	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12243964	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	97.0	CHEMBL5285	Homo sapiens	Residual Activity	%	97.0
	12243965	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	43.0	CHEMBL5285	Homo sapiens	Residual Activity	%	43.0
	12243966	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	77.0	CHEMBL5285	Homo sapiens	Residual Activity	%	77.0
	12243967	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL5285	Homo sapiens	Residual Activity	%	-1.0
	12243968	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12243969	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	46.0	CHEMBL5285	Homo sapiens	Residual Activity	%	46.0
	12243970	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	86.0	CHEMBL5285	Homo sapiens	Residual Activity	%	86.0
	12243971	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243972	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243973	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12243974	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	86.0	CHEMBL5285	Homo sapiens	Residual Activity	%	86.0
	12243975	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12243976	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12243977	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	7.0	CHEMBL5285	Homo sapiens	Residual Activity	%	7.0
	12243978	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL5285	Homo sapiens	Residual Activity	%	97.0
	12243979	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243980	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243981	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	56.0	CHEMBL5285	Homo sapiens	Residual Activity	%	56.0
	12243982	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	119.0	CHEMBL5285	Homo sapiens	Residual Activity	%	119.0
	12243983	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12243984	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12243985	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	115.0	CHEMBL5285	Homo sapiens	Residual Activity	%	115.0
	12243986	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	116.0	CHEMBL5285	Homo sapiens	Residual Activity	%	116.0
	12243987	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12243988	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12243989	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL5285	Homo sapiens	Residual Activity	%	0.0
	12243990	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	112.0	CHEMBL5285	Homo sapiens	Residual Activity	%	112.0
	12243991	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	60.0	CHEMBL5285	Homo sapiens	Residual Activity	%	60.0
	12243992	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12243993	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243994	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	102.0	CHEMBL5285	Homo sapiens	Residual Activity	%	102.0
	12243995	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12243996	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12243997	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	82.0	CHEMBL5285	Homo sapiens	Residual Activity	%	82.0
	12243998	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	100.0	CHEMBL5285	Homo sapiens	Residual Activity	%	100.0
	12243999	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12244000	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	77.0	CHEMBL5285	Homo sapiens	Residual Activity	%	77.0
	12244001	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	70.0	CHEMBL5285	Homo sapiens	Residual Activity	%	70.0
	12244002	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	61.0	CHEMBL5285	Homo sapiens	Residual Activity	%	61.0
	12244003	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL5285	Homo sapiens	Residual Activity	%	92.0
	12244004	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	8.0	CHEMBL5285	Homo sapiens	Residual Activity	%	8.0
	12244005	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12244006	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	76.0	CHEMBL5285	Homo sapiens	Residual Activity	%	76.0
	12244007	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	83.0	CHEMBL5285	Homo sapiens	Residual Activity	%	83.0
	12246601	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	83.0	CHEMBL5285	Homo sapiens	Residual Activity	%	83.0
	12246602	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	89.0	CHEMBL5285	Homo sapiens	Residual Activity	%	89.0
	12246603	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	86.0	CHEMBL5285	Homo sapiens	Residual Activity	%	86.0
	12246604	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	86.0	CHEMBL5285	Homo sapiens	Residual Activity	%	86.0
	12246605	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	29.0	CHEMBL5285	Homo sapiens	Residual Activity	%	29.0
	12246606	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	94.0	CHEMBL5285	Homo sapiens	Residual Activity	%	94.0
	12246607	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12246608	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	105.0	CHEMBL5285	Homo sapiens	Residual Activity	%	105.0
	12246609	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	98.0	CHEMBL5285	Homo sapiens	Residual Activity	%	98.0
	12246610	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL5285	Homo sapiens	Residual Activity	%	-1.0
	12246611	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	85.0	CHEMBL5285	Homo sapiens	Residual Activity	%	85.0
	12246612	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	84.0	CHEMBL5285	Homo sapiens	Residual Activity	%	84.0
	12246613	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	5.0	CHEMBL5285	Homo sapiens	Residual Activity	%	5.0
	12246614	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12246615	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	95.0	CHEMBL5285	Homo sapiens	Residual Activity	%	95.0
	12246616	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	104.0	CHEMBL5285	Homo sapiens	Residual Activity	%	104.0
	12246617	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	75.0	CHEMBL5285	Homo sapiens	Residual Activity	%	75.0
	12246618	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	24.0	CHEMBL5285	Homo sapiens	Residual Activity	%	24.0
	12246619	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	86.0	CHEMBL5285	Homo sapiens	Residual Activity	%	86.0
	12246620	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	29.0	CHEMBL5285	Homo sapiens	Residual Activity	%	29.0
	12246621	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	103.0	CHEMBL5285	Homo sapiens	Residual Activity	%	103.0
	12246622	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	89.0	CHEMBL5285	Homo sapiens	Residual Activity	%	89.0
	12246623	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	72.0	CHEMBL5285	Homo sapiens	Residual Activity	%	72.0
	12246624	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	84.0	CHEMBL5285	Homo sapiens	Residual Activity	%	84.0
	12246625	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL5285	Homo sapiens	Residual Activity	%	96.0
	12246626	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12246627	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	94.0	CHEMBL5285	Homo sapiens	Residual Activity	%	94.0
	12246628	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	79.0	CHEMBL5285	Homo sapiens	Residual Activity	%	79.0
	12246629	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	90.0	CHEMBL5285	Homo sapiens	Residual Activity	%	90.0
	12246630	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12246631	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	41.0	CHEMBL5285	Homo sapiens	Residual Activity	%	41.0
	12246632	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	91.0	CHEMBL5285	Homo sapiens	Residual Activity	%	91.0
	12246633	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	86.0	CHEMBL5285	Homo sapiens	Residual Activity	%	86.0
	12246634	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	78.0	CHEMBL5285	Homo sapiens	Residual Activity	%	78.0
	12246635	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12246636	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12246637	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	80.0	CHEMBL5285	Homo sapiens	Residual Activity	%	80.0
	12246638	CHEMBL2218943	Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	65.0	CHEMBL5285	Homo sapiens	Residual Activity	%	65.0
	12673099	CHEMBL2345635	Inhibition of recombinant ASK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	81.0	CHEMBL5285	Homo sapiens	Activity	%	81.0
	12673100	CHEMBL2345635	Inhibition of recombinant ASK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	12693258	CHEMBL2343943	Inhibition of ASK1 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	nM	10000.0
	12728080	CHEMBL2351295	Inhibition of N-terminal FLAG-tagged full length FAK (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to ATP addition measured after 60 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	nM	10000.0
	12728082	CHEMBL2351297	Inhibition of N-terminal FLAG-tagged ASK1 (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-33P]ATP addition measured after 60 mins by scintillation counting analysis	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	nM	10000.0
	12730933	CHEMBL2350106	Inhibition of ASK1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	75.0	CHEMBL5285	Homo sapiens	Activity	%	75.0
	12731160	CHEMBL2352236	Inhibition of human ASK1 using MBP as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349212	=	Activity	%	2.5	CHEMBL5285	Homo sapiens	Activity	%	2.5
	12732099	CHEMBL2352236	Inhibition of human ASK1 using MBP as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349206	=	Activity	%	3.0	CHEMBL5285	Homo sapiens	Activity	%	3.0
	12732100	CHEMBL2352236	Inhibition of human ASK1 using MBP as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349205	=	Activity	%	3.0	CHEMBL5285	Homo sapiens	Activity	%	3.0
	12732101	CHEMBL2352236	Inhibition of human ASK1 using MBP as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2346710	=	Activity	%	3.0	CHEMBL5285	Homo sapiens	Activity	%	3.0
	12732102	CHEMBL2352236	Inhibition of human ASK1 using MBP as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348833	=	Activity	%	3.5	CHEMBL5285	Homo sapiens	Activity	%	3.5
	12732103	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C1NC(=S)S/C1=C\c1cccnc1		CHEMBL274480	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732104	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C1NC(=S)S/C1=C\c1cccc(Br)c1		CHEMBL2348829	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732105	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	COC(=O)c1ccc(/C=C2\SC(=S)N(c3ccc(O)c(C(=O)O)c3)C2=O)cc1		CHEMBL2348828	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732106	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C/c2ccncc2)SC1=S		CHEMBL2348827	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732107	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)c1ccc(N2C(=O)/C(=C/c3cccnc3)SC2=S)cc1		CHEMBL2348826	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732108	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C1/C(=C/c2ccco2)SC(=S)N1c1cccnc1		CHEMBL1609550	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732109	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCCCN1C(=O)/C(=C/c2ccc(-c3cccc(C(F)(F)F)c3)o2)SC1=S		CHEMBL2349219	=	IC50	nM	500.0	CHEMBL5285	Homo sapiens	IC50	uM	0.5
	12732110	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CN1C(=O)/C(=C/c2ccncc2)SC1=S		CHEMBL2348825	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732111	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCCC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)SC1=S		CHEMBL2349218	=	IC50	nM	1800.0	CHEMBL5285	Homo sapiens	IC50	uM	1.8
	12732112	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)SC1=S		CHEMBL2349217	=	IC50	nM	650.0	CHEMBL5285	Homo sapiens	IC50	uM	0.65
	12732113	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C1NC(=S)S/C1=C\c1ccc(-c2ccccc2[N+](=O)[O-])o1		CHEMBL1916996	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732114	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCc1ccc(-c2ccc(/C=C3\SC(=S)N(C(CC(=O)O)C(=O)O)C3=O)o2)cc1		CHEMBL2349216	=	IC50	nM	1800.0	CHEMBL5285	Homo sapiens	IC50	uM	1.8
	12732115	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCOC(=O)c1ccc(-c2ccc(/C=C3\SC(=S)N(C(CC(=O)O)C(C)=O)C3=O)o2)cc1		CHEMBL2349215	=	IC50	nM	800.0	CHEMBL5285	Homo sapiens	IC50	uM	0.8
	12732116	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	COc1ccc(-c2ccc(/C=C3\SC(=S)N(CC(C)=O)C3=O)o2)cc1		CHEMBL2349214	=	IC50	nM	2500.0	CHEMBL5285	Homo sapiens	IC50	uM	2.5
	12732117	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	COC(=O)CCCN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349221	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732118	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349213	=	IC50	nM	3000.0	CHEMBL5285	Homo sapiens	IC50	uM	3.0
	12732119	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349212	=	IC50	nM	300.0	CHEMBL5285	Homo sapiens	IC50	uM	0.3
	12732120	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349211	=	IC50	nM	3000.0	CHEMBL5285	Homo sapiens	IC50	uM	3.0
	12732121	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C1/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC(=S)N1c1cccc(O)c1		CHEMBL2349210	=	IC50	nM	2000.0	CHEMBL5285	Homo sapiens	IC50	uM	2.0
	12732122	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CN1C(=O)/C(=C/c2ccco2)SC1=S		CHEMBL2348824	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732123	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349209	=	IC50	nM	2800.0	CHEMBL5285	Homo sapiens	IC50	uM	2.8
	12732124	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCCC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349208	=	IC50	nM	500.0	CHEMBL5285	Homo sapiens	IC50	uM	0.5
	12732125	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349207	=	IC50	nM	500.0	CHEMBL5285	Homo sapiens	IC50	uM	0.5
	12732126	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349206	=	IC50	nM	200.0	CHEMBL5285	Homo sapiens	IC50	uM	0.2
	12732127	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	COC(=O)CCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349220	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732128	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349205	=	IC50	nM	200.0	CHEMBL5285	Homo sapiens	IC50	uM	0.2
	12732129	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C1/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC(=S)N1c1ccc(F)cc1		CHEMBL2349204	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732130	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CSCCC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2349203	=	IC50	nM	750.0	CHEMBL5285	Homo sapiens	IC50	uM	0.75
	12732131	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCCC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2349202	=	IC50	nM	3900.0	CHEMBL5285	Homo sapiens	IC50	uM	3.9
	12732132	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3c(Cl)cccc3Cl)o2)SC1=S		CHEMBL2349201	=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	12732133	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3c(Cl)cccc3Cl)o2)SC1=S		CHEMBL2348839	=	IC50	nM	500.0	CHEMBL5285	Homo sapiens	IC50	uM	0.5
	12732134	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2346710	=	IC50	nM	650.0	CHEMBL5285	Homo sapiens	IC50	uM	0.65
	12732135	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3cc(Cl)ccc3Cl)o2)SC1=S		CHEMBL2348838	=	IC50	nM	500.0	CHEMBL5285	Homo sapiens	IC50	uM	0.5
	12732136	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3cc(Cl)ccc3Cl)o2)SC1=S		CHEMBL2348837	=	IC50	nM	350.0	CHEMBL5285	Homo sapiens	IC50	uM	0.35
	12732137	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CCC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3cccc(Cl)c3)o2)SC1=S		CHEMBL2348836	=	IC50	nM	750.0	CHEMBL5285	Homo sapiens	IC50	uM	0.75
	12732138	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3cccc(Cl)c3)o2)SC1=S		CHEMBL1688850	=	IC50	nM	350.0	CHEMBL5285	Homo sapiens	IC50	uM	0.35
	12732139	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3cccc(Cl)c3)o2)SC1=S		CHEMBL2348835	=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	12732140	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCCCN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348834	=	IC50	nM	500.0	CHEMBL5285	Homo sapiens	IC50	uM	0.5
	12732141	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348833	=	IC50	nM	300.0	CHEMBL5285	Homo sapiens	IC50	uM	0.3
	12732142	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348832	=	IC50	nM	750.0	CHEMBL5285	Homo sapiens	IC50	uM	0.75
	12732143	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348831	=	IC50	nM	1250.0	CHEMBL5285	Homo sapiens	IC50	uM	1.25
	12732144	CHEMBL2352238	Inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C1/C(=C/c2ccc(Cl)cc2Cl)SC(=S)N1Nc1ccccc1		CHEMBL2348830	>	IC50	nM	33000.0	CHEMBL5285	Homo sapiens	IC50	uM	33.0
	12732145	CHEMBL2352237	Competitive inhibition of human ASK1 using MBP as substrate incubated for 10 mins prior to ATP addition measured after 20 mins by Lineweaver-Burk plot analysis	B	CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2346710	=	Ki	nM	340.0	CHEMBL5285	Homo sapiens	Ki	nM	340.0
	13375805	CHEMBL2404316	Inhibition of ASK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	13.0	CHEMBL5285	Homo sapiens	INH	%	13.0
	13439720	CHEMBL2428034	Competitive binding affinity to MAP3K5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	13445553	CHEMBL2428034	Competitive binding affinity to MAP3K5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	13451540	CHEMBL2428034	Competitive binding affinity to MAP3K5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	13503642	CHEMBL2447754	Inhibition of ASK1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)ccc1O		CHEMBL2442531	=	Activity	%	126.0	CHEMBL5285	Homo sapiens	Activity	%	126.0
	13503643	CHEMBL2447754	Inhibition of ASK1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)cc(Cl)c1O		CHEMBL2442530	=	Activity	%	124.0	CHEMBL5285	Homo sapiens	Activity	%	124.0
	13503644	CHEMBL2447754	Inhibition of ASK1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(C)c3o2)ccc1O		CHEMBL2442529	=	Activity	%	116.0	CHEMBL5285	Homo sapiens	Activity	%	116.0
	13503645	CHEMBL2447754	Inhibition of ASK1 (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(Cl)c3o2)ccc1O		CHEMBL2442424	=	Activity	%	126.0	CHEMBL5285	Homo sapiens	Activity	%	126.0
Not Active	13503648	CHEMBL2447755	Inhibition of ASK1 (unknown origin) at 10 uM	B	COc1cc(-c2cc(=O)c3cc(C)cc(C)c3o2)ccc1O		CHEMBL2442389		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
	13872206	CHEMBL3102393	Inhibition of human ASK1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	136.0	CHEMBL5285	Homo sapiens	Activity	%	136.0
	14553658	CHEMBL3223950	Inhibition of ASK1 (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	97.8	CHEMBL5285	Homo sapiens	Activity	%	97.8
	14582541	CHEMBL3242542	Inhibition of human MAP3K5 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	96.0	CHEMBL5285	Homo sapiens	Activity	%	96.0
Not Active	15062606	CHEMBL3367930	Inhibition of human MAP3K5 by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
	15072577	CHEMBL3388685	Inhibition of ASK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	97.0	CHEMBL5285	Homo sapiens	Activity	%	97.0
	15109385	CHEMBL3373395	Inhibition of ASK1 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	14.0	CHEMBL5285	Homo sapiens	Activity	%	14.0
	15118489	CHEMBL3375026	Inhibition of ASK1 (unknown origin)	B	Cc1cc2c(-c3ccc(S(=O)(=O)NCCN)s3)ccnc2[nH]1		CHEMBL3330172	=	IC50	nM	251.0	CHEMBL5285	Homo sapiens	IC50	uM	0.251
	15118490	CHEMBL3375026	Inhibition of ASK1 (unknown origin)	B	N#Cc1c[nH]c2c(C(N)=O)ccc(OC3CCNCC3)c12		CHEMBL3330171	=	IC50	nM	251.0	CHEMBL5285	Homo sapiens	IC50	uM	0.251
	15118491	CHEMBL3375026	Inhibition of ASK1 (unknown origin)	B	O=C(Nc1nc2cc(C(F)(F)F)cc(NC3CC3)n2n1)c1cccnc1		CHEMBL3330170	=	IC50	nM	93.0	CHEMBL5285	Homo sapiens	IC50	uM	0.093
	15118492	CHEMBL3375026	Inhibition of ASK1 (unknown origin)	B	NCCNS(=O)(=O)c1ccc(-c2c[nH]c3ncccc23)s1		CHEMBL3330169	=	IC50	nM	50.0	CHEMBL5285	Homo sapiens	IC50	uM	0.05
	15118493	CHEMBL3375026	Inhibition of ASK1 (unknown origin)	B	NC[C@H](Oc1cnc(-c2ccoc2)c(-c2c[nH]c3ncccc23)c1)c1ccccc1		CHEMBL3330168	=	IC50	nM	7.9	CHEMBL5285	Homo sapiens	IC50	uM	0.0079
	15118494	CHEMBL3375026	Inhibition of ASK1 (unknown origin)	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-c4cn[nH]c4)ccc3n2)cc1		CHEMBL3330167	=	IC50	nM	6.3	CHEMBL5285	Homo sapiens	IC50	uM	0.0063
	15181098	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CC(C)CCOc1cccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)c1		CHEMBL3402508	=	Activity	%	13.97	CHEMBL5285	Homo sapiens	Activity	%	13.97
	15181099	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)cc1		CHEMBL3402507	=	Activity	%	18.07	CHEMBL5285	Homo sapiens	Activity	%	18.07
	15181100	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402506	=	Activity	%	13.16	CHEMBL5285	Homo sapiens	Activity	%	13.16
	15181101	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402505	=	Activity	%	15.75	CHEMBL5285	Homo sapiens	Activity	%	15.75
	15181102	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402503	=	Activity	%	19.8	CHEMBL5285	Homo sapiens	Activity	%	19.8
	15181103	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1OCC		CHEMBL3402502	=	Activity	%	19.72	CHEMBL5285	Homo sapiens	Activity	%	19.72
	15181104	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CC(C)(C)c1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402501	=	Activity	%	12.26	CHEMBL5285	Homo sapiens	Activity	%	12.26
	15181105	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402500	=	Activity	%	43.0	CHEMBL5285	Homo sapiens	Activity	%	43.0
	15181106	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccc(C)cc4)C3c3ccc(C(C)(C)C)cc3)sc2c1		CHEMBL3402493	=	Activity	%	23.47	CHEMBL5285	Homo sapiens	Activity	%	23.47
	15181107	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccccc4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3402491	=	Activity	%	16.2	CHEMBL5285	Homo sapiens	Activity	%	16.2
	15181108	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(Cl)c1)c1cccs1		CHEMBL3402489	=	Activity	%	27.56	CHEMBL5285	Homo sapiens	Activity	%	27.56
	15181109	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4cccs4)C3c3ccc(C)cc3)sc2c1		CHEMBL3400173	=	Activity	%	27.02	CHEMBL5285	Homo sapiens	Activity	%	27.02
	15181110	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(F)cc4s3)C2c2ccc(C(C)(C)C)cc2)o1		CHEMBL3402485	=	Activity	%	32.61	CHEMBL5285	Homo sapiens	Activity	%	32.61
	15181111	CHEMBL3405545	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) assessed as residual enzyme activity at 10 uM using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	COc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3400828	=	Activity	%	39.11	CHEMBL5285	Homo sapiens	Activity	%	39.11
	15181112	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CC(C)CCOc1cccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)c1		CHEMBL3402508	=	IC50	nM	520.0	CHEMBL5285	Homo sapiens	IC50	uM	0.52
	15181113	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)cc1		CHEMBL3402507	=	IC50	nM	750.0	CHEMBL5285	Homo sapiens	IC50	uM	0.75
	15181114	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402506	=	IC50	nM	5200.0	CHEMBL5285	Homo sapiens	IC50	uM	5.2
	15181115	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402505	=	IC50	nM	5200.0	CHEMBL5285	Homo sapiens	IC50	uM	5.2
	15181116	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402504	=	IC50	nM	5000.0	CHEMBL5285	Homo sapiens	IC50	uM	5.0
	15181117	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402503	=	IC50	nM	4600.0	CHEMBL5285	Homo sapiens	IC50	uM	4.6
	15181118	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1OCC		CHEMBL3402502	=	IC50	nM	3600.0	CHEMBL5285	Homo sapiens	IC50	uM	3.6
	15181119	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CC(C)(C)c1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402501	=	IC50	nM	2500.0	CHEMBL5285	Homo sapiens	IC50	uM	2.5
	15181120	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402500	=	IC50	nM	2000.0	CHEMBL5285	Homo sapiens	IC50	uM	2.0
	15181121	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	COc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(F)cc4s3)C2c2cccc(F)c2)cc1		CHEMBL3402499	=	IC50	nM	17000.0	CHEMBL5285	Homo sapiens	IC50	uM	17.0
	15181122	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1cc(C)c2nc(N3C(=O)C(O)=C(C(=O)c4ccc(Cl)cc4)C3c3ccc(C(C)C)cc3)sc2c1		CHEMBL3402498	=	IC50	nM	6300.0	CHEMBL5285	Homo sapiens	IC50	uM	6.3
	15181123	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(C)cc4s3)C2c2ccc(F)cc2)cc1		CHEMBL3402497	=	IC50	nM	5500.0	CHEMBL5285	Homo sapiens	IC50	uM	5.5
	15181124	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccc(F)cc4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3402496	=	IC50	nM	2900.0	CHEMBL5285	Homo sapiens	IC50	uM	2.9
	15181125	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(F)cc4s3)C2c2ccc(C(C)(C)C)cc2)cc1		CHEMBL3402495	=	IC50	nM	7600.0	CHEMBL5285	Homo sapiens	IC50	uM	7.6
	15181126	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(C)cc4s3)C2c2ccc(C(C)(C)C)cc2)cc1		CHEMBL3402494	=	IC50	nM	4400.0	CHEMBL5285	Homo sapiens	IC50	uM	4.4
	15181127	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccc(C)cc4)C3c3ccc(C(C)(C)C)cc3)sc2c1		CHEMBL3402493	=	IC50	nM	2000.0	CHEMBL5285	Homo sapiens	IC50	uM	2.0
	15181128	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccccc4)C3c3ccc(C(C)(C)C)cc3)sc2c1		CHEMBL3402492	=	IC50	nM	5000.0	CHEMBL5285	Homo sapiens	IC50	uM	5.0
	15181129	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccccc4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3402491	=	IC50	nM	4200.0	CHEMBL5285	Homo sapiens	IC50	uM	4.2
	15181130	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc(C2C(C(=O)c3cccs3)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402490	=	IC50	nM	9100.0	CHEMBL5285	Homo sapiens	IC50	uM	9.1
	15181131	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(Cl)c1)c1cccs1		CHEMBL3402489	=	IC50	nM	4500.0	CHEMBL5285	Homo sapiens	IC50	uM	4.5
	15181132	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4cccs4)C3c3ccc(C)cc3)sc2c1		CHEMBL3400173	=	IC50	nM	4400.0	CHEMBL5285	Homo sapiens	IC50	uM	4.4
	15181133	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	COc1ccc(C2C(C(=O)c3ccc(C)o3)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1OC		CHEMBL3402488	=	IC50	nM	38000.0	CHEMBL5285	Homo sapiens	IC50	uM	38.0
	15181134	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	COc1ccccc1C1C(C(=O)c2ccc(C)o2)=C(O)C(=O)N1c1nc2c(C)cc(C)cc2s1		CHEMBL3402487	=	IC50	nM	35500.0	CHEMBL5285	Homo sapiens	IC50	uM	35.5
	15181135	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1cc(C)c2nc(N3C(=O)C(O)=C(C(=O)c4ccc(C)o4)C3c3ccc(C(C)C)cc3)sc2c1		CHEMBL3402486	=	IC50	nM	2000.0	CHEMBL5285	Homo sapiens	IC50	uM	2.0
	15181136	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(F)cc4s3)C2c2ccc(C(C)(C)C)cc2)o1		CHEMBL3402485	=	IC50	nM	1550.0	CHEMBL5285	Homo sapiens	IC50	uM	1.55
	15181137	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1cc(C)c2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccccc3)sc2c1		CHEMBL3402484	=	IC50	nM	63000.0	CHEMBL5285	Homo sapiens	IC50	uM	63.0
	15181138	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(F)c1)c1ccco1		CHEMBL3402483	=	IC50	nM	42600.0	CHEMBL5285	Homo sapiens	IC50	uM	42.6
	15181139	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3cccc(Br)c3)sc2c1		CHEMBL3402482	=	IC50	nM	31000.0	CHEMBL5285	Homo sapiens	IC50	uM	31.0
	15181140	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3402481	=	IC50	nM	30200.0	CHEMBL5285	Homo sapiens	IC50	uM	30.2
	15181141	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(Br)c1)c1ccco1		CHEMBL3400832	=	IC50	nM	29500.0	CHEMBL5285	Homo sapiens	IC50	uM	29.5
	15181142	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(Cl)c1)c1ccco1		CHEMBL3400831	=	IC50	nM	28200.0	CHEMBL5285	Homo sapiens	IC50	uM	28.2
	15181143	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1ccc(Br)cc1)c1ccco1		CHEMBL3400830	=	IC50	nM	28200.0	CHEMBL5285	Homo sapiens	IC50	uM	28.2
	15181144	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	Cc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccc(Br)cc3)sc2c1		CHEMBL3400829	=	IC50	nM	28200.0	CHEMBL5285	Homo sapiens	IC50	uM	28.2
	15181145	CHEMBL3405544	Inhibition of recombinant ASK1 catalytic subunit (unknown origin) using MBP substrate and gamma-labeled 32P ATP incubated for 20 mins by liquid scintillation counting method	B	COc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3400828	=	IC50	nM	4200.0	CHEMBL5285	Homo sapiens	IC50	uM	4.2
	15186242	CHEMBL3405650	Inhibition of ASK1 (unknown origin) assessed as residual activity at 33 uM relative to control	B	Oc1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL3401781	=	Activity	%	58.0	CHEMBL5285	Homo sapiens	Activity	%	58.0
	15186243	CHEMBL3405650	Inhibition of ASK1 (unknown origin) assessed as residual activity at 33 uM relative to control	B	Oc1cccc(Nc2ncnc3sc(-c4ccccc4)cc23)c1		CHEMBL3401782	=	Activity	%	93.8	CHEMBL5285	Homo sapiens	Activity	%	93.8
	15258355	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	6.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	6.3
	15258415	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15258475	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15258535	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	0.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.9
	15258595	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	0.5	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.5
	15258655	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	1.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.0
	15258715	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.6
	15258775	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.7
	15258835	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	2.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.4
	15258895	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	2.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.6
	15258955	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.0
	15259015	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	3.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	3.6
	15259075	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	1.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.8
	15259135	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	5.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.6
	15259195	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	16.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	16.8
	15259255	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	1.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.0
	15259315	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	0.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.7
	15259375	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15259435	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.6
	15259495	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15259555	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15259615	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15259675	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15259735	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	-0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.6
	15259795	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15259855	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15259915	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259975	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	-0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.1
	15260035	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	-0.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.7
	15260095	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.6
	15260155	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	4.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	4.0
	15260215	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	1.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.6
	15260275	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	0.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.9
	15260335	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	1.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.4
	15260395	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	1.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.0
	15260455	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.2
	15260515	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	1.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.2
	15260575	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15260635	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	1.5	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.5
	15260695	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	2.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.4
	15260755	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	2.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.2
	15260815	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	4.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	4.7
	15260875	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15260935	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15260995	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	-0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261055	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	1.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.3
	15261115	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15261198	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	-0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261258	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	1.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.9
	15261318	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15261378	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.6
	15261433	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	4.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	4.6
	15261493	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15261553	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	5.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.7
	15261613	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261686	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	1.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.4
	15261746	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.9
	15261806	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	1.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.1
	15261866	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.6
	15261922	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15261982	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15262042	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15262102	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	5.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.9
	15262175	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.8
	15262235	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15262295	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	0.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.9
	15262355	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	-0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262415	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	-0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262475	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15262535	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	1.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.7
	15262595	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15262655	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	2.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.8
	15262715	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.6
	15262775	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	-0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.6
	15262835	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	0.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.8
	15262895	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15262955	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	3.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	3.9
	15263015	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.8
	15263075	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	0.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.9
	15263135	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15263195	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	-0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.2
	15263255	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	-0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.2
	15263315	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15263375	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	-0.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.7
	15263411	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	-1.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-1.0
	15263471	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	1.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.1
	15263526	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	8.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	8.8
	15263586	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	-0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263646	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	5.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.8
	15263706	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15263780	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	1.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.8
	15263840	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	-1.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-1.4
	15263900	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	1.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.1
	15263960	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	0.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.7
	15264014	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	2.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.1
	15264074	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-2.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-2.6
	15264134	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.5	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.5
	15264194	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15264267	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	5.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.0
	15264327	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.6
	15264387	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	3.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	3.1
	15264447	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	10.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	10.4
	15264503	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	5.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.7
	15264563	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	12.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	12.7
	15264623	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264683	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15264755	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	2.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.6
	15264815	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15264875	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	4.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	4.9
	15264935	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15264991	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15265051	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15265111	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	-0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265171	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15265244	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15265304	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.1
	15265364	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	1.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.0
	15265424	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	2.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.0
	15265480	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	-0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265540	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	-0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265600	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	-0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265660	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	-0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265732	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	1.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.2
	15265792	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	1.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.0
	15265852	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	1.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.2
	15265912	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265969	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	1.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.2
	15266029	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	-0.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.6
	15266089	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	-0.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266149	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	5.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.7
	15266209	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	3.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	3.8
	15266221	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	1.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.6
	15266281	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-1.1	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-1.1
	15266341	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	0.8	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.8
	15266401	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	5.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.2
	15266516	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	-0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.2
	15266576	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	0.9	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.9
	15266636	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15266696	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15266709	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	3.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	3.4
	15266769	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.0
	15266829	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	5.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	5.4
	15266889	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	-0.7	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	-0.7
	15266949	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	2.6	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	2.6
	15267004	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15267064	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	0.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.0
	15267124	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.0
	15267184	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	16.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	16.3
	15267257	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	1.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.4
	15267317	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	1.0	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	1.0
	15267377	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15267437	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15267492	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15267552	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.4	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.4
	15267612	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.2	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.2
	15267672	CHEMBL3430814	Delta TM value showing the stabilisation of ASK1 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.3	CHEMBL5285	Homo sapiens	Thermal melting change	degrees C	0.3
	15756107	CHEMBL3631727	Inhibition of ASK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	9.88	CHEMBL5285	Homo sapiens	INH	%	9.88
	15757702	CHEMBL3631727	Inhibition of ASK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	19.76	CHEMBL5285	Homo sapiens	INH	%	19.76
	15757992	CHEMBL3631727	Inhibition of ASK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	19.71	CHEMBL5285	Homo sapiens	INH	%	19.71
	16425260	CHEMBL3751124	Inhibition of ASK1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-2.1	CHEMBL5285	Homo sapiens	INH	%	-2.1
	16431732	CHEMBL3748624	Inhibition of human ASK1 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
Active	16436854	CHEMBL3757486	Activation of ASK1 in human HuH7 cells assessed as Ser83 phosphorylation after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436855	CHEMBL3757486	Activation of ASK1 in human HuH7 cells assessed as Ser83 phosphorylation after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436856	CHEMBL3757485	Activation of ASK1 in human Mahlavu cells assessed as Ser83 phosphorylation after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436857	CHEMBL3757485	Activation of ASK1 in human Mahlavu cells assessed as Ser83 phosphorylation after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436858	CHEMBL3757484	Activation of ASK1 in human Mahlavu cells assessed as Ser966 phosphorylation after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436859	CHEMBL3757484	Activation of ASK1 in human Mahlavu cells assessed as Ser966 phosphorylation after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436860	CHEMBL3757483	Activation of ASK1 in human HuH7 cells assessed as Ser966 phosphorylation after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436861	CHEMBL3757483	Activation of ASK1 in human HuH7 cells assessed as Ser966 phosphorylation after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436862	CHEMBL3757481	Activation of ASK1 in human Mahlavu cells assessed as SAPK/JNK phosphorylation after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436863	CHEMBL3757481	Activation of ASK1 in human Mahlavu cells assessed as SAPK/JNK phosphorylation after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436864	CHEMBL3757480	Activation of ASK1 in human HuH7 cells assessed as SAPK/JNK phosphorylation after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	16436865	CHEMBL3757480	Activation of ASK1 in human HuH7 cells assessed as SAPK/JNK phosphorylation after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Activity			CHEMBL5285	Homo sapiens	Activity		
	16450761	CHEMBL3762147	Inhibition of ASK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	4.2	CHEMBL5285	Homo sapiens	INH	%	4.2
	16495335	CHEMBL3776648	Inhibition of N-terminal His6-tagged recombinant human ASK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	4.0	CHEMBL5285	Homo sapiens	Activity	%	4.0
	16508104	CHEMBL3776648	Inhibition of N-terminal His6-tagged recombinant human ASK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-17.0	CHEMBL5285	Homo sapiens	Activity	%	-17.0
	16509081	CHEMBL3776648	Inhibition of N-terminal His6-tagged recombinant human ASK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-11.0	CHEMBL5285	Homo sapiens	Activity	%	-11.0
	16509811	CHEMBL3783037	Inhibition of N-terminal GST/C-terminal His6-tagged recombinant human ASK1 (649 to 946 amino acids) expressed in Escherichia coli assessed as residual activity at 10 uM	B	Cc1ccc2nc(C3=C(N)N(c4cccc(O)c4)CC3=O)[nH]c2c1		CHEMBL3781980	=	Activity	%	91.6	CHEMBL5285	Homo sapiens	Activity	%	91.6
	16509812	CHEMBL3783037	Inhibition of N-terminal GST/C-terminal His6-tagged recombinant human ASK1 (649 to 946 amino acids) expressed in Escherichia coli assessed as residual activity at 10 uM	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1cccc(O)c1		CHEMBL3781511	=	Activity	%	95.7	CHEMBL5285	Homo sapiens	Activity	%	95.7
	16556385	CHEMBL3796366	Inhibition of active N-Terminal GST and C-terminal His6-tagged recombinant human ASK1 (649 to 946 amino acids) assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1sc2ncnc(Nc3cccc(C(=O)O)c3)c2c1-c1ccccc1		CHEMBL3792965	=	Activity	%	112.0	CHEMBL5285	Homo sapiens	Activity	%	112.0
	16556386	CHEMBL3796366	Inhibition of active N-Terminal GST and C-terminal His6-tagged recombinant human ASK1 (649 to 946 amino acids) assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	O=C(O)c1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL1719248	=	Activity	%	122.0	CHEMBL5285	Homo sapiens	Activity	%	122.0
	16556387	CHEMBL3796366	Inhibition of active N-Terminal GST and C-terminal His6-tagged recombinant human ASK1 (649 to 946 amino acids) assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1ccc(-c2csc3ncnc(Nc4cccc(C(=O)O)c4)c23)cc1		CHEMBL3401764	=	Activity	%	122.0	CHEMBL5285	Homo sapiens	Activity	%	122.0
	16565474	CHEMBL3804244	Inhibition of N-terminal FLAG-tagged ASK1 (unknown origin) expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	nM	1000.0
	16580646	CHEMBL3802870	Inhibition of N-terminal FLAG-tagged ASK1 (unknown origin) expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	Inhibition	%	59.0	CHEMBL5285	Homo sapiens	INH	%	59.0
	16580647	CHEMBL3802870	Inhibition of N-terminal FLAG-tagged ASK1 (unknown origin) expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	Inhibition	%	-6.0	CHEMBL5285	Homo sapiens	INH	%	-6.0
	16611906	CHEMBL3816637	Inhibition of human ASK1 (670 to 950 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-4.0	CHEMBL5285	Homo sapiens	Activity	%	-4.0
	16613771	CHEMBL3817207	Inhibition of human ASK1 at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	7.0	CHEMBL5285	Homo sapiens	INH	%	7.0
	16654228	CHEMBL3829762	Inhibition of human ASK1 (670 to 950 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	96.0	CHEMBL5285	Homo sapiens	Activity	%	96.0
	16857934	CHEMBL3879747	Inhibition of human ASK1 expressed in HEK293 cells assessed as inhibition of H2O2-induced JNK phosphorylation preincubated for 30 mins followed by H2O2 addition measured after 30 mins by ELISA	B	CC(C)Oc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3[C@H](C)CO)n1)C2		CHEMBL3954836	=	EC50	nM	6.31	CHEMBL5285	Homo sapiens	pEC50		8.2
	16857935	CHEMBL3879747	Inhibition of human ASK1 expressed in HEK293 cells assessed as inhibition of H2O2-induced JNK phosphorylation preincubated for 30 mins followed by H2O2 addition measured after 30 mins by ELISA	B	COCCOc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3[C@H](C)CO)n1)C2		CHEMBL3975466	=	EC50	nM	12.59	CHEMBL5285	Homo sapiens	pEC50		7.9
	16857936	CHEMBL3879747	Inhibition of human ASK1 expressed in HEK293 cells assessed as inhibition of H2O2-induced JNK phosphorylation preincubated for 30 mins followed by H2O2 addition measured after 30 mins by ELISA	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccc(OC[C@@H]4CN(C)CCO4)cc3C2=O)n1		CHEMBL3946139	=	EC50	nM	6.31	CHEMBL5285	Homo sapiens	pEC50		8.2
	16857937	CHEMBL3879747	Inhibition of human ASK1 expressed in HEK293 cells assessed as inhibition of H2O2-induced JNK phosphorylation preincubated for 30 mins followed by H2O2 addition measured after 30 mins by ELISA	B	COCCOc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3C(C)C)n1)C2		CHEMBL3966978	=	EC50	nM	15.85	CHEMBL5285	Homo sapiens	pEC50		7.8
	16857938	CHEMBL3879747	Inhibition of human ASK1 expressed in HEK293 cells assessed as inhibition of H2O2-induced JNK phosphorylation preincubated for 30 mins followed by H2O2 addition measured after 30 mins by ELISA	B	CC(C)Oc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3C(C)C)n1)C2		CHEMBL3937245	=	EC50	nM	31.62	CHEMBL5285	Homo sapiens	pEC50		7.5
	16857939	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(C)Oc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3[C@H](C)CO)n1)C2		CHEMBL3954836	=	IC50	nM	5.012	CHEMBL5285	Homo sapiens	pIC50		8.3
	16857940	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	COCCOc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3[C@H](C)CO)n1)C2		CHEMBL3975466	=	IC50	nM	7.943	CHEMBL5285	Homo sapiens	pIC50		8.1
	16857941	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccc(OC[C@@H]4CN(C)CCO4)cc3C2=O)n1		CHEMBL3946139	=	IC50	nM	6.31	CHEMBL5285	Homo sapiens	pIC50		8.2
	16857942	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	COCCOc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3C(C)C)n1)C2		CHEMBL3966978	=	IC50	nM	7.943	CHEMBL5285	Homo sapiens	pIC50		8.1
	16857943	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(C)Oc1ccc2c(c1)C(=O)N(c1cccc(-c3nncn3C(C)C)n1)C2		CHEMBL3937245	=	IC50	nM	15.85	CHEMBL5285	Homo sapiens	pIC50		7.8
	16857944	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	O=C1c2ccccc2CN1c1cccc(-c2nncn2CC2CCO2)n1		CHEMBL3955870	=	IC50	nM	794.33	CHEMBL5285	Homo sapiens	pIC50		6.1
	16857945	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(CC#N)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3928256	=	IC50	nM	19.95	CHEMBL5285	Homo sapiens	pIC50		7.7
	16857946	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(CF)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3925645	=	IC50	nM	12.59	CHEMBL5285	Homo sapiens	pIC50		7.9
	16857947	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(CCO)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3953259	=	IC50	nM	39.81	CHEMBL5285	Homo sapiens	pIC50		7.4
	16857948	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	C[C@@H](CO)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3934521	=	IC50	nM	31.62	CHEMBL5285	Homo sapiens	pIC50		7.5
	16857949	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	C[C@H](CO)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3962015	=	IC50	nM	10.0	CHEMBL5285	Homo sapiens	pIC50		8.0
	16857950	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC[C@H](C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3943495	=	IC50	nM	19.95	CHEMBL5285	Homo sapiens	pIC50		7.7
	16857951	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC[C@@H](C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3890544	=	IC50	nM	50.12	CHEMBL5285	Homo sapiens	pIC50		7.3
	16857952	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3952214	=	IC50	nM	12.59	CHEMBL5285	Homo sapiens	pIC50		7.9
	16857953	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	Cc1cc(F)c(C(=O)Nc2ccccn2)cc1-n1cnc(C2CC2)c1		CHEMBL3981026	=	IC50	nM	6309.57	CHEMBL5285	Homo sapiens	pIC50		5.2
	16857954	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccccc2)n1		CHEMBL3960900	=	IC50	nM	398.11	CHEMBL5285	Homo sapiens	pIC50		6.4
	16857955	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c(F)c1		CHEMBL3891901	=	IC50	nM	50.12	CHEMBL5285	Homo sapiens	pIC50		7.3
	16857956	CHEMBL3879746	Inhibition of recombinant human N-terminal GST-tagged ASK1 catalytic domain (654 to 971 residues) expressed in baculovirus infected sf21 cells using STK3 as substrate after 60 mins by HTRF assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	5.012	CHEMBL5285	Homo sapiens	pIC50		8.3
259307	17641835	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CC(C)(O)c1ccc(C(=O)Nc2cc3c(ccn3CC3CC3)cn2)cc1		CHEMBL3644035	=	IC50	nM	81.0	CHEMBL5285	Homo sapiens	IC50	nM	81.0
259308	17641836	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CC(C)(O)c1ccc(C(=O)Nc2cc3c(cn2)c(Br)cn3CC2CC2)cc1		CHEMBL3644036	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
259309	17641837	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CCn1cc(Br)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644037	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
259310	17641838	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CCn1cc(C)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644038	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
259311	17641839	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CCn1ccc2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3894807	=	IC50	nM	55.0	CHEMBL5285	Homo sapiens	IC50	nM	55.0
259312	17641840	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CCn1cc(Cl)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3955000	=	IC50	nM	6.0	CHEMBL5285	Homo sapiens	IC50	nM	6.0
259313	17641841	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	Cn1cc(Br)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644041	=	IC50	nM	5.0	CHEMBL5285	Homo sapiens	IC50	nM	5.0
259314	17641842	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	Cn1cc(Br)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3916273	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
259315	17641843	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	C[C@](O)(CO)c1ccc(C(=O)Nc2cc3c(ccn3C3CC3)cn2)cc1		CHEMBL3644043	=	IC50	nM	69.0	CHEMBL5285	Homo sapiens	IC50	nM	69.0
259316	17641844	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CCn1cc(C)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3910870	=	IC50	nM	14.0	CHEMBL5285	Homo sapiens	IC50	nM	14.0
259317	17641845	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	Cc1cn(C)c2cc(NC(=O)c3ccc(C(C)(C)O)cc3)ncc12		CHEMBL3644045	=	IC50	nM	19.0	CHEMBL5285	Homo sapiens	IC50	nM	19.0
259318	17641846	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CCn1cc(Br)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3937743	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
259319	17641847	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	C[C@](O)(CO)c1ccc(C(=O)Nc2cc3c(cn2)c(Br)cn3C2CC2)cc1		CHEMBL3644048	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
259320	17641848	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	C[C@](O)(CO)c1ccc(C(=O)Nc2cc3c(cn2)c(Cl)cn3C2CC2)cc1		CHEMBL3644049	=	IC50	nM	4.0	CHEMBL5285	Homo sapiens	IC50	nM	4.0
259321	17641849	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	Cn1cc(Cl)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644050	=	IC50	nM	11.0	CHEMBL5285	Homo sapiens	IC50	nM	11.0
259322	17641850	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	Cn1c(Cl)c(Cl)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644051	=	IC50	nM	60.0	CHEMBL5285	Homo sapiens	IC50	nM	60.0
259323	17641851	CHEMBL3705518	Scintillation Assay: The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM DTT) including 30 ng of active ASK1 protein and 1 μg of myelin basic protein (Wako), and incubated at room temperature for 5 min. To start the reaction, 10 μL of ATP solution (2.5 μM ATP, 0.1 μCi [γ-32P]ATP) was added to wells. After incubating at room temperature for 30 min, the reaction was terminated by adding 50 μL of 20% TCA solution. The reaction solution was incubated at 4° C. for 30 min and an acid-insoluble fraction was transferred onto a GF/C filter (Packard) with Cell Harvester (Packard), and washed with 250 mM phosphoric acid. After drying at 45° C. for 60 min., 40 μL of Microscint 0 (Packard) was added and the radioactivity was measured with TopCount (Packard).	B	CCn1cc(Cl)c2cnc(NC(=O)c3ccc([C@](C)(O)CO)cc3)cc21		CHEMBL3963789	=	IC50	nM	9.0	CHEMBL5285	Homo sapiens	IC50	nM	9.0
259324	17641852	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CC(C)(O)c1ccc(C(=O)Nc2cc3c(ccn3CC3CC3)cn2)cc1		CHEMBL3644035	=	IC50	nM	237.0	CHEMBL5285	Homo sapiens	IC50	nM	237.0
259325	17641853	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CC(C)(O)c1ccc(C(=O)Nc2cc3c(cn2)c(Br)cn3CC2CC2)cc1		CHEMBL3644036	=	IC50	nM	62.0	CHEMBL5285	Homo sapiens	IC50	nM	62.0
259326	17641854	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1cc(Br)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644037	=	IC50	nM	8.0	CHEMBL5285	Homo sapiens	IC50	nM	8.0
259327	17641855	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1cc(C)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644038	=	IC50	nM	20.0	CHEMBL5285	Homo sapiens	IC50	nM	20.0
259328	17641856	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1ccc2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3894807	=	IC50	nM	64.0	CHEMBL5285	Homo sapiens	IC50	nM	64.0
259329	17641857	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1cc(Cl)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3955000	=	IC50	nM	16.0	CHEMBL5285	Homo sapiens	IC50	nM	16.0
259330	17641858	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cn1cc(Br)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644041	=	IC50	nM	10.0	CHEMBL5285	Homo sapiens	IC50	nM	10.0
259331	17641859	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cn1cc(Br)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3916273	=	IC50	nM	20.0	CHEMBL5285	Homo sapiens	IC50	nM	20.0
259332	17641860	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	C[C@](O)(CO)c1ccc(C(=O)Nc2cc3c(ccn3C3CC3)cn2)cc1		CHEMBL3644043	=	IC50	nM	214.0	CHEMBL5285	Homo sapiens	IC50	nM	214.0
259333	17641861	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1cc(C)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3910870	=	IC50	nM	17.0	CHEMBL5285	Homo sapiens	IC50	nM	17.0
259334	17641862	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cc1cn(C)c2cc(NC(=O)c3ccc(C(C)(C)O)cc3)ncc12		CHEMBL3644045	=	IC50	nM	29.0	CHEMBL5285	Homo sapiens	IC50	nM	29.0
259335	17641863	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1cc(Br)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3937743	=	IC50	nM	10.0	CHEMBL5285	Homo sapiens	IC50	nM	10.0
259336	17641864	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CC(C)(O)c1ccc(C(=O)Nc2cc3c(ccn3CS(C)(=O)=O)cn2)cc1		CHEMBL3644047	=	IC50	nM	12446.0	CHEMBL5285	Homo sapiens	IC50	nM	12446.0
259337	17641865	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	C[C@](O)(CO)c1ccc(C(=O)Nc2cc3c(cn2)c(Br)cn3C2CC2)cc1		CHEMBL3644048	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
259338	17641866	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	C[C@](O)(CO)c1ccc(C(=O)Nc2cc3c(cn2)c(Cl)cn3C2CC2)cc1		CHEMBL3644049	=	IC50	nM	6.0	CHEMBL5285	Homo sapiens	IC50	nM	6.0
259339	17641867	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cn1cc(Cl)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644050	=	IC50	nM	18.0	CHEMBL5285	Homo sapiens	IC50	nM	18.0
259340	17641868	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cn1c(Cl)c(Cl)c2cnc(NC(=O)c3ccc(C(C)(C)O)cc3)cc21		CHEMBL3644051	=	IC50	nM	146.0	CHEMBL5285	Homo sapiens	IC50	nM	146.0
259341	17641869	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1cc(Cl)c2cnc(NC(=O)c3ccc([C@](C)(O)CO)cc3)cc21		CHEMBL3963789	=	IC50	nM	12.0	CHEMBL5285	Homo sapiens	IC50	nM	12.0
259342	17641870	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1ccc2cnc(NC(=O)c3ccc([C@@](C)(O)CO)c(C)c3)cc21		CHEMBL3890514	=	IC50	nM	528.0	CHEMBL5285	Homo sapiens	IC50	nM	528.0
259343	17641871	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CC(C)(CO)c1ccc(C(=O)Nc2cc3c(cn2)c(Cl)cn3C2CC2)cc1		CHEMBL3644053	=	IC50	nM	16.0	CHEMBL5285	Homo sapiens	IC50	nM	16.0
259344	17641872	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cn1cc(Cl)c2cnc(NC(=O)c3ccc([C@](C)(O)CO)cc3)cc21		CHEMBL3927617	=	IC50	nM	38.0	CHEMBL5285	Homo sapiens	IC50	nM	38.0
259345	17641873	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cn1cc(Cl)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3966379	=	IC50	nM	19.0	CHEMBL5285	Homo sapiens	IC50	nM	19.0
259346	17641874	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	Cn1c(Cl)c(Cl)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)cc3)cc21		CHEMBL3936587	=	IC50	nM	122.0	CHEMBL5285	Homo sapiens	IC50	nM	122.0
259347	17641875	CHEMBL3705948	Homogeneous Time-Resolved Fluorescence Assay: The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM ASK1, 1 uM CisBio STK S3-biotion peptide, 100 uM ATP, and 1%-2% DMSO in kinase assay buffer of 50 mM HEPES, pH 7.3, 10 mM NaCl, 10 mM MgCl2, 0.01% Brij35, 0.2 mM EDTA, and 1 mM DTT. Reaction product is determined quantitatively by HTRF after the addition of detection reagent SA-XL665 and STK-antibody-cryptate.The assay reaction may be initiated as follows: 2 ul of the mixture of 3 uM CisBio STK S3-biotion peptide and 300 uM ATP with 2 ul of test compound (2 fold serial dilutions for 11 data points for each inhibitor) containing 3%-6% DMSO are added to each well of the plate, followed by the addition of 2 uL of 75 nM ASK1 to initiate the reaction (final enzyme concentration was 25 nM for ASK1). The reaction mixture may then be incubated at room temperature for 1 hour, and quenched and developed.	B	CCn1cc(Cl)c2cnc(NC(=O)c3ccc([C@@](C)(O)CO)c(C)c3)cc21		CHEMBL3974873	=	IC50	nM	41.0	CHEMBL5285	Homo sapiens	IC50	nM	41.0
305298	17686165	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCOCC2)cn1		CHEMBL3683259	=	IC50	nM	1.44	CHEMBL5285	Homo sapiens	IC50	nM	1.44
305299	17686166	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	CC1(O)CN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)C1		CHEMBL3683260	=	IC50	nM	1.58	CHEMBL5285	Homo sapiens	IC50	nM	1.58
305300	17686167	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCOCC3)cn2)cs1)C(F)(F)F		CHEMBL3683261	=	IC50	nM	2.62	CHEMBL5285	Homo sapiens	IC50	nM	2.62
305301	17686168	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CC(C)(O)C3)cn2)cs1)C(F)(F)F		CHEMBL3683262	=	IC50	nM	1.69	CHEMBL5285	Homo sapiens	IC50	nM	1.69
305302	17686169	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N(C)C)cn2)cs1)C(F)(F)F		CHEMBL3683263	=	IC50	nM	1.88	CHEMBL5285	Homo sapiens	IC50	nM	1.88
305303	17686170	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCC2)cn1		CHEMBL3683264	=	IC50	nM	2.4	CHEMBL5285	Homo sapiens	IC50	nM	2.4
305304	17686171	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC3)cn2)cs1)C(F)(F)F		CHEMBL3683265	=	IC50	nM	1.7	CHEMBL5285	Homo sapiens	IC50	nM	1.7
305305	17686172	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCCC3)cn2)cs1)C(F)(F)F		CHEMBL3683266	=	IC50	nM	2.2	CHEMBL5285	Homo sapiens	IC50	nM	2.2
305306	17686173	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCCC2)cn1		CHEMBL3683267	=	IC50	nM	1.9	CHEMBL5285	Homo sapiens	IC50	nM	1.9
305307	17686174	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCC(O)C2)cn1		CHEMBL3683268	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
305308	17686175	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC(O)C3)cn2)cs1)C(F)(F)F		CHEMBL3683269	=	IC50	nM	2.2	CHEMBL5285	Homo sapiens	IC50	nM	2.2
305309	17686176	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	O=C(Nc1csc(-c2nncn2C2CC2)n1)c1cc(-n2cnc(C3CC3)c2)c(N2CCCCC2)cn1		CHEMBL3639821	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
305310	17686177	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCCCC3)cn2)cs1)C(F)(F)F		CHEMBL3683270	=	IC50	nM	0.7	CHEMBL5285	Homo sapiens	IC50	nM	0.7
305311	17686178	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCC(C)(O)CC3)cn2)cs1)C(F)(F)F		CHEMBL3687971	=	IC50	nM	1.8	CHEMBL5285	Homo sapiens	IC50	nM	1.8
305312	17686179	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	CC1(O)CCN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)CC1		CHEMBL3687972	=	IC50	nM	2.5	CHEMBL5285	Homo sapiens	IC50	nM	2.5
305313	17686180	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	C[C@H](n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCN(C)CC3)cn2)cs1)C(F)(F)F		CHEMBL3687973	=	IC50	nM	2.1	CHEMBL5285	Homo sapiens	IC50	nM	2.1
305314	17686181	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	CN1CCN(c2cnc(C(=O)Nc3csc(-c4nncn4C4CC4)n3)cc2-n2cnc(C3CC3)c2)CC1		CHEMBL3687974	=	IC50	nM	3.1	CHEMBL5285	Homo sapiens	IC50	nM	3.1
305315	17686182	CHEMBL3705386	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay measures the phosphorylation level of a biotinylated peptide substrate by the ASK1 kinase using HTRF detection (6.1). This is a competitive, time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay, based on HTRF KinEASE-STK manual from Cisbio (6.1). Test compound, 1 uM STK3 peptide substrate, 4 nM of ASK1 kinase are incubated with 10 mM MOP buffer, pH. 7.0 containing 10 mM Mg-acetate, 0.025% NP-40, 1 mM DTT, 0.05% BSA and 1.5% glycerol for 30 minutes then 100 uM ATP is added to start the kinase reaction and incubated for 3 hr. Peptide antibody labeled with 1x Eu3+ Cryptate buffer containing 10 mM EDTA and 125 nM Streptavidin XL665 are added to stop the reaction and phosphorylated peptide substrate is detected using Envision 2103 Multilabeled reader from PerkinElmer. The fluorescence is measured at 615 nm (Cryptate) and 665 nm (XL665) and a ratio of 665 nm/615 nm is calculated for each well.	B	CN[C@@H]1CC2OC([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL3683258	=	IC50	nM	6.3	CHEMBL5285	Homo sapiens	IC50	nM	6.3
Inactive	17912794	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912795	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912796	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912797	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912798	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912799	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912800	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912801	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912802	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912803	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912804	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912805	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912806	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912807	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912808	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912809	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912810	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912811	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912812	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912813	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912814	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912815	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912816	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912817	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	50536.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	50536.0
Inactive	17912818	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912819	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912820	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912821	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912822	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912823	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912824	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912825	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912826	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912827	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912828	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912829	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912830	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912831	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912832	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912833	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912834	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912835	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912836	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912837	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912838	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912839	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912840	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912841	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912842	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912843	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912844	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912845	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912846	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912847	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912848	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912849	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912850	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912851	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912852	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912853	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912854	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912855	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912856	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912857	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912858	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	878.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	878.0
Inactive	17912859	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912860	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912861	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912862	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912863	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912864	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912865	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912866	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912867	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912868	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912869	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912870	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912871	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912872	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912873	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912874	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912875	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912876	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912877	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912878	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912879	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912880	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912881	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912882	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	182.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	182.0
Inactive	17912883	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912884	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912885	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912886	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912887	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912888	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	285.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	285.0
Inactive	17912889	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912890	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912891	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912892	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912893	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912894	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912895	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912896	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912897	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912898	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912899	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912900	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912901	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912902	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912903	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912904	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912905	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912906	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912907	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912908	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912909	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912910	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912911	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912912	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912913	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912914	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912915	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	631.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	631.0
Inactive	17912916	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912917	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912918	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912919	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912920	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912921	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912922	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912923	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912924	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912925	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	2792.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	2792.0
Inactive	17912926	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912927	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912928	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912929	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912930	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912931	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912932	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912933	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912934	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912935	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912936	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912937	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912938	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912939	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912940	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1273.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	1273.0
Inactive	17912941	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912942	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912943	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912944	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912945	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912946	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912947	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912948	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912949	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Active	17912950	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	23168.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	23168.0
Inactive	17912951	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912952	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912953	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912954	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912955	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912956	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912957	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912958	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912959	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912960	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912961	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912962	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912963	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912964	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912965	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912966	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912967	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912968	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912969	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912970	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912971	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912972	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912973	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912974	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912975	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912976	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912977	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912978	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912979	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912980	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912981	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912982	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912983	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912984	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912985	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912986	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912987	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912988	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912989	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912990	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912991	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912992	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912993	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912994	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912995	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912996	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912997	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912998	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17912999	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913000	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913001	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913002	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913003	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913004	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913005	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913006	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913007	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913008	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913009	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913010	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913011	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913012	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913013	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913014	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913015	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913016	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913017	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913018	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913019	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913020	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913021	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913022	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913023	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913024	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913025	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913026	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913027	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913028	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913029	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913030	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913031	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913032	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913033	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913034	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913035	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913036	CHEMBL3991762	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5285	Homo sapiens	Kd apparent	nM	30000.0
	18048935	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	5.0	CHEMBL5285	Homo sapiens	IC50	nM	5.0
	18048944	CHEMBL4011129	Inhibition of ASK1 (unknown origin) assessed as reduction in JNK phosphorylation by cell based assay	B	COCCOc1ccnc(NC(=O)c2csc(-c3nncn3C(C)C)n2)c1		CHEMBL4064613	=	EC50	nM	140.0	CHEMBL5285	Homo sapiens	EC50	nM	140.0
	18048945	CHEMBL4011129	Inhibition of ASK1 (unknown origin) assessed as reduction in JNK phosphorylation by cell based assay	B	COCCNc1ccnc(NC(=O)c2csc(-c3nncn3C(C)C)n2)c1		CHEMBL4086119	=	EC50	nM	99.0	CHEMBL5285	Homo sapiens	EC50	nM	99.0
	18048946	CHEMBL4011129	Inhibition of ASK1 (unknown origin) assessed as reduction in JNK phosphorylation by cell based assay	B	COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4073198	=	EC50	nM	60.0	CHEMBL5285	Homo sapiens	EC50	nM	60.0
	18048947	CHEMBL4011129	Inhibition of ASK1 (unknown origin) assessed as reduction in JNK phosphorylation by cell based assay	B	COCCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4093878	=	EC50	nM	65.0	CHEMBL5285	Homo sapiens	EC50	nM	65.0
	18048948	CHEMBL4011129	Inhibition of ASK1 (unknown origin) assessed as reduction in JNK phosphorylation by cell based assay	B	CC(C)n1cnnc1-c1nc(C(=O)Nc2cnn(C3COC3)c2)cs1		CHEMBL4081134	=	EC50	nM	130.0	CHEMBL5285	Homo sapiens	EC50	nM	130.0
	18048949	CHEMBL4011129	Inhibition of ASK1 (unknown origin) assessed as reduction in JNK phosphorylation by cell based assay	B	CCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4084596	=	EC50	nM	600.0	CHEMBL5285	Homo sapiens	EC50	nM	600.0
	18048950	CHEMBL4011132	Inhibition of ASK1 (unknown origin) at 500 uM using biotin-MBP as substrate after 20 mins by TR-FRET assay relative to control	B	CCn1cnc(NC(=O)c2cscn2)c1		CHEMBL4062930	=	Inhibition	%	75.0	CHEMBL5285	Homo sapiens	INH	%	75.0
	18048951	CHEMBL4011132	Inhibition of ASK1 (unknown origin) at 500 uM using biotin-MBP as substrate after 20 mins by TR-FRET assay relative to control	B	CCn1cnc(NC(=O)C2CCC2)c1		CHEMBL4074305	<	Inhibition	%	10.0	CHEMBL5285	Homo sapiens	INH	%	10.0
	18048952	CHEMBL4011132	Inhibition of ASK1 (unknown origin) at 500 uM using biotin-MBP as substrate after 20 mins by TR-FRET assay relative to control	B	CCn1cnc(NC(=O)c2ccccc2)c1		CHEMBL4101050	=	Inhibition	%	40.0	CHEMBL5285	Homo sapiens	INH	%	40.0
	18048953	CHEMBL4011132	Inhibition of ASK1 (unknown origin) at 500 uM using biotin-MBP as substrate after 20 mins by TR-FRET assay relative to control	B	CCn1cnc(NC(=O)c2ccco2)c1		CHEMBL4100085	=	Inhibition	%	35.0	CHEMBL5285	Homo sapiens	INH	%	35.0
	18048954	CHEMBL4011132	Inhibition of ASK1 (unknown origin) at 500 uM using biotin-MBP as substrate after 20 mins by TR-FRET assay relative to control	B	CCn1cnc(NC(=O)c2ccoc2)c1		CHEMBL4082079	=	Inhibition	%	51.0	CHEMBL5285	Homo sapiens	INH	%	51.0
	18048955	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4073198	=	IC50	nM	60.0	CHEMBL5285	Homo sapiens	IC50	nM	60.0
	18048956	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	CC(C)n1cnnc1-c1nc(C(=O)Nc2ccccn2)cs1		CHEMBL4105386	=	IC50	nM	400.0	CHEMBL5285	Homo sapiens	IC50	nM	400.0
	18048957	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	CCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4084596	=	IC50	nM	600.0	CHEMBL5285	Homo sapiens	IC50	nM	600.0
	18048958	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	CCn1cnc(NC(=O)c2cscn2)c1		CHEMBL4062930	=	IC50	nM	100000.0	CHEMBL5285	Homo sapiens	IC50	uM	100.0
	18048959	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	CCn1cnc(NC(=O)c2ccoc2)c1	Outside typical range	CHEMBL4082079	=	IC50	nM	500000.0	CHEMBL5285	Homo sapiens	IC50	uM	500.0
	18048960	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c(F)c1		CHEMBL3891901	=	IC50	nM	55.0	CHEMBL5285	Homo sapiens	IC50	nM	55.0
	18048961	CHEMBL4011131	Inhibition of ASK1 (unknown origin) using biotin-MBP as substrate after 20 mins by TR-FRET assay	B	Cc1cc(F)c(C(=O)Nc2ccccn2)cc1-n1cnc(C2CC2)c1		CHEMBL3981026	=	IC50	nM	6000.0	CHEMBL5285	Homo sapiens	IC50	uM	6.0
Active	18057523	CHEMBL4012568	Binding affinity to MAP3K5 in human INA-6 cells after 3 hrs by nanoLC-MS/MS method	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCNCCOc1ccc(C(C(=O)NCc2ccccc2)N(C(=O)CCc2ccccc2)C2CC2)cc1		CHEMBL4092773		Activity			CHEMBL5285	Homo sapiens	Activity		
Active	18057524	CHEMBL4012568	Binding affinity to MAP3K5 in human INA-6 cells after 3 hrs by nanoLC-MS/MS method	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCNCCOc1ccc(C(C(=O)NCc2ccccc2)N(C(=O)CCc2ccc(O)cc2)C2CC2)cc1		CHEMBL4100500		Activity			CHEMBL5285	Homo sapiens	Activity		
	18113956	CHEMBL4024899	Inhibition of recombinant human ASK1 using STK3 peptide as substrate incubated for 30 mins followed by ATP addition measured for 3 hrs by TR-FRET assay	B	CC(n1cnnc1-c1nc(NC(=O)c2cc(-n3cnc(C4CC4)c3)c(N3CCCCC3)cn2)cs1)C(F)(F)F		CHEMBL4083562	=	IC50	nM	0.7	CHEMBL5285	Homo sapiens	IC50	nM	0.7
	18114478	CHEMBL4025016	Inhibition of wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	18134452	CHEMBL4029522	Inhibition of ASK1 (unknown origin) at 1 uM using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	18134483	CHEMBL4029522	Inhibition of ASK1 (unknown origin) at 1 uM using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469	=	Inhibition	%	60.0	CHEMBL5285	Homo sapiens	INH	%	60.0
	18153075	CHEMBL4034387	Inhibition of MAP3K5 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	10.3	CHEMBL5285	Homo sapiens	INH	%	10.3
	18153078	CHEMBL4034381	Inhibition of MAP3K5 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	3.7	CHEMBL5285	Homo sapiens	INH	%	3.7
	18203406	CHEMBL4043827	Inhibition of wild-type human partial length ASK1 (E648 to S964 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	18211580	CHEMBL4045747	Inhibition of MAP3K5 conserved Lys2 (DIKGDNVLINTYSGVLK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	25.3	CHEMBL5285	Homo sapiens	INH	%	25.3
	18211684	CHEMBL4045741	Inhibition of MAP3K5 conserved Lys1 (IAIKEIPER) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-3.3	CHEMBL5285	Homo sapiens	INH	%	-3.3
	18211886	CHEMBL4045982	Inhibition of MAP3K5 conserved Lys1 (IAIKEIPER) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-0.5	CHEMBL5285	Homo sapiens	INH	%	-0.5
	18211892	CHEMBL4045988	Inhibition of MAP3K5 conserved Lys2 (DIKGDNVLINTYSGVLK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	11.0	CHEMBL5285	Homo sapiens	INH	%	11.0
	18218025	CHEMBL4047092	Inhibition of ASK1 (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2c(N=Cc3ccc4ccccc4c3)c(C#N)c3n2CCC3)cc1		CHEMBL4079032	=	Inhibition	%	19.0	CHEMBL5285	Homo sapiens	INH	%	19.0
	18218026	CHEMBL4047092	Inhibition of ASK1 (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	5.0	CHEMBL5285	Homo sapiens	INH	%	5.0
	18232081	CHEMBL4050421	Inhibition of human ASK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	118.0	CHEMBL5285	Homo sapiens	Activity	%	118.0
	18253859	CHEMBL4055214	Inhibition of wild-type human partial length MAP3K5 (E648 to S964 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	18253860	CHEMBL4055214	Inhibition of wild-type human partial length MAP3K5 (E648 to S964 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	18275061	CHEMBL4118399	Inhibition of MAP3K5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKGDNVLINTYSGVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	25.5	CHEMBL5285	Homo sapiens	INH	%	25.5
	18275062	CHEMBL4118399	Inhibition of MAP3K5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKGDNVLINTYSGVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	10.0	CHEMBL5285	Homo sapiens	INH	%	10.0
	18275063	CHEMBL4118399	Inhibition of MAP3K5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKGDNVLINTYSGVLK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-11.7	CHEMBL5285	Homo sapiens	INH	%	-11.7
	18282049	CHEMBL4120004	Inhibition of recombinant full length GST-tagged human ASK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	-5.3	CHEMBL5285	Homo sapiens	INH	%	-5.3
	18282368	CHEMBL4120004	Inhibition of recombinant full length GST-tagged human ASK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	3.1	CHEMBL5285	Homo sapiens	INH	%	3.1
	18440082	CHEMBL4156906	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	80.0	CHEMBL5285	Homo sapiens	Activity	%	80.0
	18449869	CHEMBL4178103	Inhibition of human ASK1 (670 to 950 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	106.0	CHEMBL5285	Homo sapiens	Activity	%	106.0
	18463717	CHEMBL4181133	Inhibition of recombinant human N-Terminal GST-tagged and C-terminal His6-tagged ASK1 ( 649 to 946 residues) expressed in Escherichia coli cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	4.0	CHEMBL5285	Homo sapiens	INH	%	4.0
	18479902	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CN(C)c1cccc(Nc2nccc(NCCOc3ccccc3)n2)c1		CHEMBL4205988	=	IC50	nM	2000.0	CHEMBL5285	Homo sapiens	IC50	uM	2.0
	18479903	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	c1ccc(Nc2ncnc3[nH]cnc23)cc1		CHEMBL359730	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479904	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Fc1ccc(Nc2[nH]cnc3ncnc2-3)cc1		CHEMBL361227	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479905	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Clc1cccc(Nc2ncnc3[nH]cnc23)c1		CHEMBL4204805	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479906	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(=O)Nc1cccc(Nc2ncnc3[nH]cnc23)c1		CHEMBL3431228	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479907	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CN(C)c1cccc(Nc2ncnc3[nH]cnc23)c1		CHEMBL4208205	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479908	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	c1ccc(Nc2ncc3ccccc3n2)cc1		CHEMBL1644356	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479909	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Clc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4214456	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479910	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Fc1ccc(Nc2ncc3ccccc3n2)cc1		CHEMBL4211446	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479911	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(=O)Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4211961	=	IC50	nM	900.0	CHEMBL5285	Homo sapiens	IC50	uM	0.9
	18479912	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4212924	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479913	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Brc1ccc2nc(Nc3ccccc3)ncc2c1		CHEMBL4208553	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479914	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Fc1ccc(Nc2ncc3cc(Br)ccc3n2)cc1		CHEMBL4203678	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479915	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(=O)Nc1cccc(Nc2ncc3cc(Br)ccc3n2)c1		CHEMBL4213056	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479916	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Nc1cccc(Nc2ncc3cc(Br)ccc3n2)c1		CHEMBL4202621	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479917	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(C)(C)C(=O)N(c1ccccc1)c1cccc(Nc2ncc3cc(Br)ccc3n2)c1		CHEMBL4214280	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479918	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Nc1cccc(-c2ccc3nc(Nc4ccccc4)ncc3c2)c1		CHEMBL4214507	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479919	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	c1ccc(Nc2ncc3cc(-c4cn[nH]c4)ccc3n2)cc1		CHEMBL4213241	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479920	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Cn1cc(-c2ccc3nc(Nc4ccccc4)ncc3c2)cn1		CHEMBL4213931	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479921	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(=O)Nc1cccc(Nc2ncc3cc(-c4cccc(N)c4)ccc3n2)c1		CHEMBL4208855	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479922	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(=O)Nc1cccc(Nc2ncc3cc(-c4cn[nH]c4)ccc3n2)c1		CHEMBL4215414	=	IC50	nM	200.0	CHEMBL5285	Homo sapiens	IC50	uM	0.2
	18479923	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(=O)Nc1cccc(Nc2ncc3cc(-c4cnn(C)c4)ccc3n2)c1		CHEMBL4205418	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479924	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Nc1cccc(Nc2ncc3cc(-c4cccc(N)c4)ccc3n2)c1		CHEMBL4215465	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479925	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Nc1cccc(Nc2ncc3cc(-c4cn[nH]c4)ccc3n2)c1		CHEMBL4217652	=	IC50	nM	600.0	CHEMBL5285	Homo sapiens	IC50	uM	0.6
	18479926	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Cn1cc(-c2ccc3nc(Nc4cccc(N)c4)ncc3c2)cn1		CHEMBL4205944	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479927	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	CC(C)(C)C(=O)N(c1ccccc1)c1cccc(Nc2ncc3cc(-c4cn[nH]c4)ccc3n2)c1		CHEMBL4214195	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479928	CHEMBL4184745	Inhibition of stress-activated full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system using MKK6 as substrate pretreated for 10 mins followed by substrate addition by Alphascreen assay	B	Cn1cc(-c2ccc3nc(Nc4cccc(N(C(=O)C(C)(C)C)c5ccccc5)c4)ncc3c2)cn1		CHEMBL4202507	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	18479929	CHEMBL4184746	ATP-competitive inhibition of full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system assessed as Km for substrate at 2 uM using MKK6 as substrate by Lineweaver-burk plot analysis (Rvb = 6.08 +/- 0.4093 10'-6 M)	B	CC(=O)Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4211961	=	Km	nM	9297.0	CHEMBL5285	Homo sapiens	Km	10'-6M	9.297
	18479930	CHEMBL4184747	ATP-competitive inhibition of full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system assessed as Km for substrate at 1 uM using MKK6 as substrate by Lineweaver-burk plot analysis (Rvb = 6.08 +/- 0.4093 10'-6 M)	B	CC(=O)Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4211961	=	Km	nM	7790.0	CHEMBL5285	Homo sapiens	Km	10'-6M	7.79
	18479931	CHEMBL4184748	ATP-competitive inhibition of full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system assessed as Km for substrate at 0.5 uM using MKK6 as substrate by Lineweaver-burk plot analysis (Rvb = 6.08 +/- 0.4093 10'-6 M)	B	CC(=O)Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4211961	=	Km	nM	7010.0	CHEMBL5285	Homo sapiens	Km	10'-6M	7.01
	18479932	CHEMBL4184749	ATP-competitive inhibition of full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system assessed as Vmax for substrate at 2 uM using MKK6 as substrate by Lineweaver-burk plot analysis (Rvb = 1.624 +/- 0.9307 10'-7 min/cpm)	B	CC(=O)Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4211961	=	Vmax	10'-7cpm/min	1.159	CHEMBL5285	Homo sapiens	Vmax	10'-7cpm/min	1.159
	18479933	CHEMBL4184750	ATP-competitive inhibition of full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system assessed as Vmax for substrate at 1 uM using MKK6 as substrate by Lineweaver-burk plot analysis (Rvb = 1.624 +/- 0.9307 10'-7 min/cpm)	B	CC(=O)Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4211961	=	Vmax	10'-7cpm/min	1.083	CHEMBL5285	Homo sapiens	Vmax	10'-7cpm/min	1.083
	18479934	CHEMBL4184751	ATP-competitive inhibition of full length recombinant human N-terminal GST-tagged ASK1 expressed in baculovirus expression system assessed as Vmax for substrate at 0.5 uM using MKK6 as substrate by Lineweaver-burk plot analysis (Rvb = 1.624 +/- 0.9307 10'-7 min/cpm)	B	CC(=O)Nc1cccc(Nc2ncc3ccccc3n2)c1		CHEMBL4211961	=	Vmax	10'-8cpm/min	7.368	CHEMBL5285	Homo sapiens	Vmax	10'-8cpm/min	7.368
	18479963	CHEMBL4184761	Inhibition of ASK1 (unknown origin)	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	6.0	CHEMBL5285	Homo sapiens	IC50	nM	6.0
	18484522	CHEMBL4185685	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL5285	Homo sapiens	Activity	%	99.0
	18485099	CHEMBL4185685	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	18507896	CHEMBL4190870	Inhibition of recombinant human ASK1 (649 to 946 residues) at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-7.0	CHEMBL5285	Homo sapiens	INH	%	-7.0
	18655635	CHEMBL4230585	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	18702463	CHEMBL4255144	Selectivity ratio of IC50 for inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells to IC50 for inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Ratio IC50		94.0	CHEMBL5285	Homo sapiens	Ratio IC50		94.0
	18702464	CHEMBL4255144	Selectivity ratio of IC50 for inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells to IC50 for inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Ratio IC50		28.0	CHEMBL5285	Homo sapiens	Ratio IC50		28.0
	18702465	CHEMBL4255144	Selectivity ratio of IC50 for inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells to IC50 for inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Ratio IC50		840.0	CHEMBL5285	Homo sapiens	Ratio IC50		840.0
	18702466	CHEMBL4255144	Selectivity ratio of IC50 for inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells to IC50 for inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Ratio IC50		70.0	CHEMBL5285	Homo sapiens	Ratio IC50		70.0
	18702467	CHEMBL4255144	Selectivity ratio of IC50 for inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells to IC50 for inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Ratio IC50		18.0	CHEMBL5285	Homo sapiens	Ratio IC50		18.0
	18702510	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	IC50	nM	736.0	CHEMBL5285	Homo sapiens	IC50	nM	736.0
	18702512	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	IC50	nM	1.5	CHEMBL5285	Homo sapiens	IC50	nM	1.5
	18702513	CHEMBL4255144	Selectivity ratio of IC50 for inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells to IC50 for inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Ratio IC50		490.0	CHEMBL5285	Homo sapiens	Ratio IC50		490.0
	18702517	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	CCS(=O)(=O)Nc1cccc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c1		CHEMBL4286123	=	IC50	nM	73.0	CHEMBL5285	Homo sapiens	IC50	nM	73.0
	18702519	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cccc(C(N)=O)c2)n1		CHEMBL4293924	=	IC50	nM	580.0	CHEMBL5285	Homo sapiens	IC50	nM	580.0
	18702521	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cccc(-c3ncc[nH]3)c2)n1		CHEMBL4286022	=	IC50	nM	170.0	CHEMBL5285	Homo sapiens	IC50	nM	170.0
	18702523	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	CCS(=O)(=O)Nc1ccc(OC)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c1		CHEMBL4290518	=	IC50	nM	0.32	CHEMBL5285	Homo sapiens	IC50	nM	0.32
	18702525	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	CCS(=O)(=O)Nc1ccc(OC)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c1		CHEMBL4290518	=	IC50	nM	41.0	CHEMBL5285	Homo sapiens	IC50	nM	41.0
	18702527	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	IC50	nM	1.0	CHEMBL5285	Homo sapiens	IC50	nM	1.0
	18702529	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	IC50	nM	94.0	CHEMBL5285	Homo sapiens	IC50	nM	94.0
	18702570	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	IC50	nM	5.0	CHEMBL5285	Homo sapiens	IC50	nM	5.0
Active	18702572	CHEMBL4255096	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in autophosphorylation at Thr-838 residue at 10 uM after 30 mins by Western blot analysis	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
	18702573	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	IC50	nM	140.0	CHEMBL5285	Homo sapiens	IC50	nM	140.0
	18702619	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	CNC(=O)c1ccc(OC)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c1		CHEMBL4279174	=	IC50	nM	2.4	CHEMBL5285	Homo sapiens	IC50	nM	2.4
	18702621	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	CNC(=O)c1ccc(OC)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c1		CHEMBL4279174	=	IC50	nM	272.0	CHEMBL5285	Homo sapiens	IC50	nM	272.0
	18702623	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	IC50	nM	0.1	CHEMBL5285	Homo sapiens	IC50	nM	0.1
	18702625	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	IC50	nM	84.0	CHEMBL5285	Homo sapiens	IC50	nM	84.0
	18702667	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	IC50	nM	0.42	CHEMBL5285	Homo sapiens	IC50	nM	0.42
	18702669	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	IC50	nM	28.0	CHEMBL5285	Homo sapiens	IC50	nM	28.0
	18702710	CHEMBL4255094	Inhibition of recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system using STK3 peptide substrate preincubated for 15 mins followed by substrate addition measured after 90 mins in presence of 1 mM ATP by HTRF assay	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	IC50	nM	4.0	CHEMBL5285	Homo sapiens	IC50	nM	4.0
	18702712	CHEMBL4255097	Inhibition of recombinant full length human ASK1 expressed in HEK293/AP1-Luc cells assessed as reduction in p38 phosphorylation after 18 hrs by HTRF assay	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	IC50	nM	73.0	CHEMBL5285	Homo sapiens	IC50	nM	73.0
	18706605	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284524	=	IC50	nM	740.0	CHEMBL5285	Homo sapiens	IC50	uM	0.74
	18706606	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	O=C1NCc2c1c1c3cc(O)ccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4294912	=	IC50	nM	3000.0	CHEMBL5285	Homo sapiens	IC50	uM	3.0
	18706607	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	COC1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284275	>	IC50	nM	50000.0	CHEMBL5285	Homo sapiens	IC50	uM	50.0
	18706608	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6cc(O)ccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4279758	>	IC50	nM	50000.0	CHEMBL5285	Homo sapiens	IC50	uM	50.0
	18706609	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4287662	=	IC50	nM	6400.0	CHEMBL5285	Homo sapiens	IC50	uM	6.4
	18706610	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1O		CHEMBL4288105	=	IC50	nM	1100.0	CHEMBL5285	Homo sapiens	IC50	uM	1.1
	18706611	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	CC(=O)N[C@H]1C[C@H]2O[C@@](C)([C@@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4277459	=	IC50	nM	770.0	CHEMBL5285	Homo sapiens	IC50	uM	0.77
	18706612	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4291517	=	IC50	nM	4100.0	CHEMBL5285	Homo sapiens	IC50	uM	4.1
	18706613	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	C[C@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4280872	>	IC50	nM	50000.0	CHEMBL5285	Homo sapiens	IC50	uM	50.0
	18706614	CHEMBL4256097	Inhibition of ASK1 (unknown origin) by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.69	CHEMBL5285	Homo sapiens	IC50	uM	0.00069
	18751729	CHEMBL4264174	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	77.0	CHEMBL5285	Homo sapiens	Activity	%	77.0
	18857845	CHEMBL4307691	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	96.0	CHEMBL5285	Homo sapiens	Activity	%	96.0
	18892754	CHEMBL4314650	Inhibition of recombinant human ASK1 (649 to 946 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	102.0	CHEMBL5285	Homo sapiens	Activity	%	102.0
	18895023	CHEMBL4315505	Inhibition of recombinant human N-terminal GST-tagged ASK1 (649 to 946 residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	Activity	%	26.0	CHEMBL5285	Homo sapiens	Activity	%	26.0
	18895042	CHEMBL4315505	Inhibition of recombinant human N-terminal GST-tagged ASK1 (649 to 946 residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	Activity	%	-14.0	CHEMBL5285	Homo sapiens	Activity	%	-14.0
	18895061	CHEMBL4315505	Inhibition of recombinant human N-terminal GST-tagged ASK1 (649 to 946 residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	Activity	%	-3.0	CHEMBL5285	Homo sapiens	Activity	%	-3.0
	18895080	CHEMBL4315505	Inhibition of recombinant human N-terminal GST-tagged ASK1 (649 to 946 residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	5.0	CHEMBL5285	Homo sapiens	Activity	%	5.0
Active	18904536	CHEMBL4317162	Inhibition of ASK1 Ser-966 phosphorylation in human HuH7 cells at 1 uM after 24 to 72 hrs by Western blot analysis	B	COc1ccc2c3c(c4cc(OC)c(OC)cc4c2c1)CN1CCCC[C@@H]1C3		CHEMBL1958071		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
Active	18904537	CHEMBL4317162	Inhibition of ASK1 Ser-966 phosphorylation in human HuH7 cells at 1 uM after 24 to 72 hrs by Western blot analysis	B	COc1ccc2c3c(c4cc(OC)c(OC)cc4c2c1)CN1CCCCC1C3O		CHEMBL4446479		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
Active	18904538	CHEMBL4317163	Inhibition of ASK1 Ser-966 phosphorylation in human Mahlavu cells at 1 uM after 24 to 72 hrs by Western blot analysis	B	COc1ccc2c3c(c4cc(OC)c(OC)cc4c2c1)CN1CCCC[C@@H]1C3		CHEMBL1958071		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
Active	18904539	CHEMBL4317163	Inhibition of ASK1 Ser-966 phosphorylation in human Mahlavu cells at 1 uM after 24 to 72 hrs by Western blot analysis	B	COc1ccc2c3c(c4cc(OC)c(OC)cc4c2c1)CN1CCCCC1C3O		CHEMBL4446479		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
	18919413	CHEMBL4322772	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MAP3K5 (unknown origin) (654 to 971 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	136.0	CHEMBL5285	Homo sapiens	Kd	nM	136.0
	18919601	CHEMBL4322772	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MAP3K5 (unknown origin) (654 to 971 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	248.0	CHEMBL5285	Homo sapiens	Kd	nM	248.0
	18924235	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1cc2nncc(Oc3ccc(NC(=O)c4cn(C(C)C)c5ccccc5c4=O)cc3)c2cc1OC		CHEMBL4466569	=	IC50	nM	18.0	CHEMBL5285	Homo sapiens	IC50	nM	18.0
	18924236	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c5ccccc5c4=O)cc3)c2cc1OC		CHEMBL4449840	=	IC50	nM	9.0	CHEMBL5285	Homo sapiens	IC50	nM	9.0
	18924237	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C(Nc1nc2cc(C(F)(F)F)cc(NC3CC3)n2n1)c1cccnc1		CHEMBL3330170	=	IC50	nM	131.0	CHEMBL5285	Homo sapiens	IC50	nM	131.0
	18924238	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	5.9	CHEMBL5285	Homo sapiens	IC50	nM	5.9
	18924239	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccccc2F)n1		CHEMBL4451125	=	IC50	nM	76.0	CHEMBL5285	Homo sapiens	IC50	nM	76.0
	18924240	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCOc2ccccc21		CHEMBL4470285	=	IC50	nM	161.0	CHEMBL5285	Homo sapiens	IC50	nM	161.0
	18924241	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccccc21		CHEMBL4561768	=	IC50	nM	11.0	CHEMBL5285	Homo sapiens	IC50	nM	11.0
	18924242	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCCCOc2ccccc21		CHEMBL4447729	=	IC50	nM	20.0	CHEMBL5285	Homo sapiens	IC50	nM	20.0
	18924243	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1ccccc1C(=O)Nc1cccc(-c2nncn2C)n1		CHEMBL4521694	=	IC50	nM	92.0	CHEMBL5285	Homo sapiens	IC50	nM	92.0
	18924244	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@H]1CCCOc2ccccc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4514925	=	IC50	nM	4.0	CHEMBL5285	Homo sapiens	IC50	nM	4.0
	18924245	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@@H]1CCCOc2ccccc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4537756	=	IC50	nM	350.0	CHEMBL5285	Homo sapiens	IC50	nM	350.0
	18924246	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@@H]1CCOc2ccccc2C(=O)Nc2cccc(n2)-c2nncn2C1		CHEMBL4462230	=	IC50	nM	14.0	CHEMBL5285	Homo sapiens	IC50	nM	14.0
	18924247	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@@H]1CCn2cnnc2-c2cccc(n2)NC(=O)c2ccccc2OC1		CHEMBL4442116	=	IC50	nM	13.0	CHEMBL5285	Homo sapiens	IC50	nM	13.0
	18924248	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@H]1CCCn2cnnc2-c2cccc(n2)NC(=O)c2ccccc2O1		CHEMBL4565615	=	IC50	nM	165.0	CHEMBL5285	Homo sapiens	IC50	nM	165.0
	18924249	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(F)cc21		CHEMBL4469413	=	IC50	nM	17.0	CHEMBL5285	Homo sapiens	IC50	nM	17.0
	18924250	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2cc(F)ccc21		CHEMBL4590290	=	IC50	nM	8.0	CHEMBL5285	Homo sapiens	IC50	nM	8.0
	18924251	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@H]1CCCOc2cc(F)ccc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4562269	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
	18924252	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@@H]1CCOc2cc(F)ccc2C(=O)Nc2cccc(n2)-c2nncn2C1		CHEMBL4542440	=	IC50	nM	8.0	CHEMBL5285	Homo sapiens	IC50	nM	8.0
	18924253	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(Br)cc21		CHEMBL4590759	=	IC50	nM	31.0	CHEMBL5285	Homo sapiens	IC50	nM	31.0
	18924254	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(N3CCOCC3)cc21		CHEMBL4548492	=	IC50	nM	8.0	CHEMBL5285	Homo sapiens	IC50	nM	8.0
	18924255	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(N3CC4(COC4)C3)cc21		CHEMBL4544934	=	IC50	nM	28.0	CHEMBL5285	Homo sapiens	IC50	nM	28.0
	18924256	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	CS(=O)(=O)c1ccc2c(c1)C(=O)Nc1cccc(n1)-c1nncn1CCCCO2		CHEMBL4473364	=	IC50	nM	8.0	CHEMBL5285	Homo sapiens	IC50	nM	8.0
	18924257	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	Cc1cn(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)cn1		CHEMBL4569388	=	IC50	nM	4.0	CHEMBL5285	Homo sapiens	IC50	nM	4.0
	18924258	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	Cn1cc(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)cn1		CHEMBL4475667	=	IC50	nM	5.0	CHEMBL5285	Homo sapiens	IC50	nM	5.0
	18924259	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	CN(C)CCn1cc(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)cn1		CHEMBL4456722	=	IC50	nM	6.0	CHEMBL5285	Homo sapiens	IC50	nM	6.0
	18924260	CHEMBL4324209	Inhibition of human ASK1 using myelin basic protein substrate pre-incubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@@H]1CCOc2cc(F)c(-c3cnn(CCN(C)C)c3)cc2C(=O)Nc2cccc(n2)-c2nncn2C1		CHEMBL4591648	=	IC50	nM	8.0	CHEMBL5285	Homo sapiens	IC50	nM	8.0
	18924261	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	COc1cc2nncc(Oc3ccc(NC(=O)c4cn(C(C)C)c5ccccc5c4=O)cc3)c2cc1OC		CHEMBL4466569	=	IC50	nM	869.0	CHEMBL5285	Homo sapiens	IC50	nM	869.0
	18924262	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c5ccccc5c4=O)cc3)c2cc1OC		CHEMBL4449840	=	IC50	nM	277.0	CHEMBL5285	Homo sapiens	IC50	nM	277.0
	18924263	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C(Nc1nc2cc(C(F)(F)F)cc(NC3CC3)n2n1)c1cccnc1		CHEMBL3330170	=	IC50	nM	13.0	CHEMBL5285	Homo sapiens	IC50	nM	13.0
	18924264	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	20.0	CHEMBL5285	Homo sapiens	IC50	nM	20.0
	18924265	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccccc2F)n1		CHEMBL4451125	=	IC50	nM	8164.0	CHEMBL5285	Homo sapiens	IC50	nM	8164.0
	18924266	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	COc1ccccc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4551282	=	IC50	nM	299.0	CHEMBL5285	Homo sapiens	IC50	nM	299.0
	18924267	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C1Nc2cccc(n2)-c2nncn2CCCOc2ccccc21		CHEMBL4470285	=	IC50	nM	6065.0	CHEMBL5285	Homo sapiens	IC50	nM	6065.0
	18924268	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccccc21		CHEMBL4561768	=	IC50	nM	1210.0	CHEMBL5285	Homo sapiens	IC50	nM	1210.0
	18924269	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C1Nc2cccc(n2)-c2nncn2CCCCCOc2ccccc21		CHEMBL4447729	=	IC50	nM	1776.0	CHEMBL5285	Homo sapiens	IC50	nM	1776.0
	18924270	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	COc1ccccc1C(=O)Nc1cccc(-c2nncn2C)n1		CHEMBL4521694	=	IC50	nM	3735.0	CHEMBL5285	Homo sapiens	IC50	nM	3735.0
	18924271	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@H]1CCCOc2ccccc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4514925	=	IC50	nM	73.0	CHEMBL5285	Homo sapiens	IC50	nM	73.0
	18924272	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@@H]1CCCOc2ccccc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4537756	=	IC50	nM	5152.0	CHEMBL5285	Homo sapiens	IC50	nM	5152.0
	18924273	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@@H]1CCOc2ccccc2C(=O)Nc2cccc(n2)-c2nncn2C1		CHEMBL4462230	=	IC50	nM	232.0	CHEMBL5285	Homo sapiens	IC50	nM	232.0
	18924274	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@@H]1CCn2cnnc2-c2cccc(n2)NC(=O)c2ccccc2OC1		CHEMBL4442116	=	IC50	nM	351.0	CHEMBL5285	Homo sapiens	IC50	nM	351.0
	18924275	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@H]1CCCn2cnnc2-c2cccc(n2)NC(=O)c2ccccc2O1		CHEMBL4565615	=	IC50	nM	969.0	CHEMBL5285	Homo sapiens	IC50	nM	969.0
	18924276	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(F)cc21		CHEMBL4469413	=	IC50	nM	658.0	CHEMBL5285	Homo sapiens	IC50	nM	658.0
	18924277	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2cc(F)ccc21		CHEMBL4590290	=	IC50	nM	867.0	CHEMBL5285	Homo sapiens	IC50	nM	867.0
	18924278	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@H]1CCCOc2cc(F)ccc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4562269	=	IC50	nM	43.0	CHEMBL5285	Homo sapiens	IC50	nM	43.0
	18924279	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@@H]1CCOc2cc(F)ccc2C(=O)Nc2cccc(n2)-c2nncn2C1		CHEMBL4542440	=	IC50	nM	95.0	CHEMBL5285	Homo sapiens	IC50	nM	95.0
	18924280	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(N3CCOCC3)cc21		CHEMBL4548492	=	IC50	nM	107.0	CHEMBL5285	Homo sapiens	IC50	nM	107.0
	18924281	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(N3CC4(COC4)C3)cc21		CHEMBL4544934	=	IC50	nM	253.0	CHEMBL5285	Homo sapiens	IC50	nM	253.0
	18924282	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	CS(=O)(=O)c1ccc2c(c1)C(=O)Nc1cccc(n1)-c1nncn1CCCCO2		CHEMBL4473364	=	IC50	nM	1437.0	CHEMBL5285	Homo sapiens	IC50	nM	1437.0
	18924283	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	Cc1cn(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)cn1		CHEMBL4569388	=	IC50	nM	28.0	CHEMBL5285	Homo sapiens	IC50	nM	28.0
	18924284	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	Cn1cc(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)cn1		CHEMBL4475667	=	IC50	nM	25.0	CHEMBL5285	Homo sapiens	IC50	nM	25.0
	18924285	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	CN(C)CCn1cc(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)cn1		CHEMBL4456722	=	IC50	nM	148.0	CHEMBL5285	Homo sapiens	IC50	nM	148.0
	18924286	CHEMBL4324210	Inhibition of V5 tagged human ASK1 expressed in HEK-293T cells assessed as reduction in T838 autophosphorylation incubated for 1 hr	B	C[C@@H]1CCOc2cc(F)c(-c3cnn(CCN(C)C)c3)cc2C(=O)Nc2cccc(n2)-c2nncn2C1		CHEMBL4591648	=	IC50	nM	37.0	CHEMBL5285	Homo sapiens	IC50	nM	37.0
	18937715	CHEMBL4327587	Inhibition of human ASK1 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	87.64	CHEMBL5285	Homo sapiens	Activity	%	87.64
	18937716	CHEMBL4327587	Inhibition of human ASK1 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	89.42	CHEMBL5285	Homo sapiens	Activity	%	89.42
	18938428	CHEMBL4327948	Inhibition of human ASK1 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5285	Homo sapiens	Activity	%	65.0
	18938800	CHEMBL4328312	Inhibition of human ASK1 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	19.9	CHEMBL5285	Homo sapiens	IC50	10'-8M	1.99
	18958680	CHEMBL4333283	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	18964072	CHEMBL4334970	Inhibition of recombinant human ASK1 (649 to 946 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	101.0	CHEMBL5285	Homo sapiens	Activity	%	101.0
	18964073	CHEMBL4334970	Inhibition of recombinant human ASK1 (649 to 946 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	102.0	CHEMBL5285	Homo sapiens	Activity	%	102.0
	18971788	CHEMBL4336798	Inhibition of recombinant human ASK1 (649 to 946 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	58.0	CHEMBL5285	Homo sapiens	Activity	%	58.0
Not Active	19039894	CHEMBL4351747	Inhibition of recombinant human ASK1 (649 to 946 residues) at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
Active	19041013	CHEMBL4352274	Inhibition of human ASK1 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
	19059462	CHEMBL4357763	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	19090035	CHEMBL4365609	Inhibition of wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	60.0	CHEMBL5285	Homo sapiens	Activity	%	60.0
	19091816	CHEMBL4366290	Inhibition of human ASK1 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-8.49	CHEMBL5285	Homo sapiens	INH	%	-8.49
	19144617	CHEMBL4377633	Inhibition of recombinant human ASK1 (649 to 946 residues) at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-7.0	CHEMBL5285	Homo sapiens	INH	%	-7.0
	19146824	CHEMBL4378968	Inhibition of recombinant human ASK1 (649 to 946 residues) at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	13.0	CHEMBL5285	Homo sapiens	INH	%	13.0
	19147748	CHEMBL4379144	Inhibition of human recombinant ASK1 (649 to 946 residues) using myelin as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	19159290	CHEMBL4382394	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	19172374	CHEMBL4385144	Inhibition of ASK1 (unknown origin)	B	CS(=O)(=O)Nc1cc(-c2ccncc2)cnc1Cl		CHEMBL4474208	<	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	pIC50		5.0
	19172800	CHEMBL4385322	Inhibition of recombinant V5-tagged ASK1 (unknown origin) expressed in HEK293 cells assessed as reduction in ASK1 autophosphorylation at T838 residue after 1 hr by MSD assay	B	O=C1Nc2cccc(n2)-c2nncn2CCCCCOc2ccccc21		CHEMBL4447729	=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	19172801	CHEMBL4385322	Inhibition of recombinant V5-tagged ASK1 (unknown origin) expressed in HEK293 cells assessed as reduction in ASK1 autophosphorylation at T838 residue after 1 hr by MSD assay	B	O=C1Nc2cccc(n2)-c2nncn2C/C=C/COc2c(Br)cccc21		CHEMBL4457403	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	19172802	CHEMBL4385322	Inhibition of recombinant V5-tagged ASK1 (unknown origin) expressed in HEK293 cells assessed as reduction in ASK1 autophosphorylation at T838 residue after 1 hr by MSD assay	B	C[C@@H]1CCn2cnnc2-c2cccc(n2)NC(=O)c2ccccc2OC1		CHEMBL4442116	<=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	19172803	CHEMBL4385322	Inhibition of recombinant V5-tagged ASK1 (unknown origin) expressed in HEK293 cells assessed as reduction in ASK1 autophosphorylation at T838 residue after 1 hr by MSD assay	B	Cc1ncn(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)c1C		CHEMBL4536051	<=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	19172804	CHEMBL4385322	Inhibition of recombinant V5-tagged ASK1 (unknown origin) expressed in HEK293 cells assessed as reduction in ASK1 autophosphorylation at T838 residue after 1 hr by MSD assay	B	Cc1ccc2c(c1)C(=O)Nc1cccc(n1)-c1nncn1CCCCO2		CHEMBL4455414	<=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	19172805	CHEMBL4385322	Inhibition of recombinant V5-tagged ASK1 (unknown origin) expressed in HEK293 cells assessed as reduction in ASK1 autophosphorylation at T838 residue after 1 hr by MSD assay	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(N3CCOCC3)cc21		CHEMBL4548492	<=	IC50	nM	1000.0	CHEMBL5285	Homo sapiens	IC50	uM	1.0
	19172806	CHEMBL4385321	Inhibition of human ASK1 using MBP as substrate measured in presence of [gamma-33P]-ATP	B	O=C1Nc2cccc(n2)-c2nncn2CCCCCOc2ccccc21		CHEMBL4447729	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172807	CHEMBL4385321	Inhibition of human ASK1 using MBP as substrate measured in presence of [gamma-33P]-ATP	B	C[C@@H]1CCn2cnnc2-c2cccc(n2)NC(=O)c2ccccc2OC1		CHEMBL4442116	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172808	CHEMBL4385321	Inhibition of human ASK1 using MBP as substrate measured in presence of [gamma-33P]-ATP	B	Cc1ncn(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)c1C		CHEMBL4536051	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172809	CHEMBL4385321	Inhibition of human ASK1 using MBP as substrate measured in presence of [gamma-33P]-ATP	B	Cc1ccc2c(c1)C(=O)Nc1cccc(n1)-c1nncn1CCCCO2		CHEMBL4455414	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172810	CHEMBL4385321	Inhibition of human ASK1 using MBP as substrate measured in presence of [gamma-33P]-ATP	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(N3CCOCC3)cc21		CHEMBL4548492	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172811	CHEMBL4385320	Inhibition of full-length human GST-tagged ASK1 expressed in baculovirus expression system using biotinylated STK Substrate 3 preincubated for 10 mins followed by ATP addition and measured after 5 hrs by TR-FRET assay	B	O=C1Nc2cccc(n2)-c2nncn2CCCCCOc2ccccc21		CHEMBL4447729	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172812	CHEMBL4385320	Inhibition of full-length human GST-tagged ASK1 expressed in baculovirus expression system using biotinylated STK Substrate 3 preincubated for 10 mins followed by ATP addition and measured after 5 hrs by TR-FRET assay	B	O=C1Nc2cccc(n2)-c2nncn2C/C=C/COc2c(Br)cccc21		CHEMBL4457403	=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172813	CHEMBL4385320	Inhibition of full-length human GST-tagged ASK1 expressed in baculovirus expression system using biotinylated STK Substrate 3 preincubated for 10 mins followed by ATP addition and measured after 5 hrs by TR-FRET assay	B	C[C@@H]1CCn2cnnc2-c2cccc(n2)NC(=O)c2ccccc2OC1		CHEMBL4442116	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172814	CHEMBL4385320	Inhibition of full-length human GST-tagged ASK1 expressed in baculovirus expression system using biotinylated STK Substrate 3 preincubated for 10 mins followed by ATP addition and measured after 5 hrs by TR-FRET assay	B	Cc1ncn(-c2ccc3c(c2)C(=O)Nc2cccc(n2)-c2nncn2CCCCO3)c1C		CHEMBL4536051	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172815	CHEMBL4385320	Inhibition of full-length human GST-tagged ASK1 expressed in baculovirus expression system using biotinylated STK Substrate 3 preincubated for 10 mins followed by ATP addition and measured after 5 hrs by TR-FRET assay	B	Cc1ccc2c(c1)C(=O)Nc1cccc(n1)-c1nncn1CCCCO2		CHEMBL4455414	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19172816	CHEMBL4385320	Inhibition of full-length human GST-tagged ASK1 expressed in baculovirus expression system using biotinylated STK Substrate 3 preincubated for 10 mins followed by ATP addition and measured after 5 hrs by TR-FRET assay	B	O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(N3CCOCC3)cc21		CHEMBL4548492	<=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	uM	0.1
	19180960	CHEMBL4387170	Inhibition of tracer 236 binding to recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	4.3	CHEMBL5285	Homo sapiens	INH	%	4.3
	19181186	CHEMBL4387170	Inhibition of tracer 236 binding to recombinant full length human GST-tagged ASK1 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	7.0	CHEMBL5285	Homo sapiens	INH	%	7.0
	19191235	CHEMBL4389590	Inhibition of wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	97.0	CHEMBL5285	Homo sapiens	INH	%	97.0
	19191717	CHEMBL4389113	Inhibition of wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5285	Homo sapiens	INH	%	100.0
	19200006	CHEMBL4391216	Binding affinity to wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	80.0	CHEMBL5285	Homo sapiens	Activity	%	80.0
	19230857	CHEMBL4397164	Inhibition of N-terminal FLAG-tagged ASK1 (unknown origin) expressed in baculovirus expression system at 100 nM using myelin basic protein as substrate preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 60 mins by topcount scintillation counting method relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	-1.0	CHEMBL5285	Homo sapiens	INH	%	-1.0
	19242706	CHEMBL4400041	Inhibition of recombinant human ASK1 (649 to 946 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	72.0	CHEMBL5285	Homo sapiens	Activity	%	72.0
	19266313	CHEMBL4405263	Inhibition of wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	19275932	CHEMBL4407935	Inhibition of recombinant human ASK1 (649 to 946 residues) at 1 uM using myelin ba as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	19411464	CHEMBL4427701	Inhibition of MAP3K5 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL5285	Homo sapiens	IC50	uM	5.0
	19411520	CHEMBL4427645	Inhibition of MAP3K5 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL5285	Homo sapiens	INH	%	16.0
	19474389	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	O=C(NCC1COc2ccccc2O1)c1ccc(NC(=O)c2ccco2)cc1		CHEMBL1448756	=	Delta Tm	degrees C	1.2	CHEMBL5285	Homo sapiens	deltaTm	degrees C	1.2
	19474390	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	Cc1ccc(C(=O)CSc2nnc(-c3ccncc3)[nH]2)c(C)c1		CHEMBL4567815	=	Delta Tm	degrees C	0.4	CHEMBL5285	Homo sapiens	deltaTm	degrees C	0.4
	19474391	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	c1cc2[nH]c3c(c2c2nonc12)CCCC3		CHEMBL1700355	=	Delta Tm	degrees C	0.0	CHEMBL5285	Homo sapiens	deltaTm	degrees C	0.0
	19474392	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	Cc1ccc(NCCCC(=O)N/N=C/c2cc(Br)cc(Br)c2O)cc1		CHEMBL4554066	=	Delta Tm	degrees C	1.2	CHEMBL5285	Homo sapiens	deltaTm	degrees C	1.2
	19474393	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	O=C(O)c1cc(-c2ccc(-c3ccccc3[N+](=O)[O-])o2)nc2ccc3ccccc3c12		CHEMBL4553877	=	Delta Tm	degrees C	1.7	CHEMBL5285	Homo sapiens	deltaTm	degrees C	1.7
	19474394	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	CS(=O)(=O)c1ccc2nc(NC(=O)CCCOc3ccc(Cl)cc3)sc2c1		CHEMBL4586284	=	Delta Tm	degrees C	1.2	CHEMBL5285	Homo sapiens	deltaTm	degrees C	1.2
	19474395	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	CCOCCCn1c(=S)[nH]c2cc(C(=O)NCC3COc4ccccc4O3)ccc2c1=O		CHEMBL3715362	=	Delta Tm	degrees C	2.1	CHEMBL5285	Homo sapiens	deltaTm	degrees C	2.1
	19474396	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	CCC(=O)Nc1nc(C)c(-c2csc(Nc3cc(OC)ccc3OC)n2)s1		CHEMBL4537058	=	Delta Tm	degrees C	2.7	CHEMBL5285	Homo sapiens	deltaTm	degrees C	2.7
	19474397	CHEMBL4479299	Binding affinity to ASK1 (unknown origin) assessed as change in melting temperature at 1 uM by SYPRO orange dye-based DSF analysis	B	O=C(NCC1COc2ccccc2O1)c1ccc2c(c1)C(=O)N(CC1=CC=CC1)C(=S)C2		CHEMBL4550547	=	Delta Tm	degrees C	1.1	CHEMBL5285	Homo sapiens	deltaTm	degrees C	1.1
	19474674	CHEMBL4479363	Inhibition of ASK1 (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	pIC50		5.0
	20608780	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	5.5	CHEMBL5285	Homo sapiens	IC50	nM	5.5
	20608781	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccccc2)n1		CHEMBL3960900	=	IC50	nM	607.0	CHEMBL5285	Homo sapiens	IC50	nM	607.0
	20608782	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccn(C)n2)n1		CHEMBL4647622	=	IC50	nM	29.0	CHEMBL5285	Homo sapiens	IC50	nM	29.0
	20608783	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cnn(C)c2)n1		CHEMBL4640860	=	IC50	nM	108.0	CHEMBL5285	Homo sapiens	IC50	nM	108.0
	20608784	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4643577	=	IC50	nM	3.9	CHEMBL5285	Homo sapiens	IC50	nM	3.9
	20608785	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	C[C@H]1CCCOc2nn(C)cc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4646085	=	IC50	nM	6.8	CHEMBL5285	Homo sapiens	IC50	nM	6.8
	20608786	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)c1		CHEMBL4632465	=	IC50	nM	6164.0	CHEMBL5285	Homo sapiens	IC50	nM	6164.0
	20608787	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2cncn2C(C)C)n1		CHEMBL4641666	=	IC50	nM	2.4	CHEMBL5285	Homo sapiens	IC50	nM	2.4
	20608788	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	20.0	CHEMBL5285	Homo sapiens	IC50	nM	20.0
	20608789	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccccc2)n1		CHEMBL3960900	>	IC50	nM	20000.0	CHEMBL5285	Homo sapiens	IC50	nM	20000.0
	20608790	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccn(C)n2)n1		CHEMBL4647622	>	IC50	nM	20000.0	CHEMBL5285	Homo sapiens	IC50	nM	20000.0
	20608791	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cnn(C)c2)n1		CHEMBL4640860	=	IC50	nM	6797.0	CHEMBL5285	Homo sapiens	IC50	nM	6797.0
	20608792	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4643577	=	IC50	nM	90.0	CHEMBL5285	Homo sapiens	IC50	nM	90.0
	20608793	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	C[C@H]1CCCOc2nn(C)cc2C(=O)Nc2cccc(n2)-c2nncn21		CHEMBL4646085	=	IC50	nM	32.0	CHEMBL5285	Homo sapiens	IC50	nM	32.0
	20608794	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)c1		CHEMBL4632465	>	IC50	nM	20000.0	CHEMBL5285	Homo sapiens	IC50	nM	20000.0
	20608795	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2cncn2C(C)C)n1		CHEMBL4641666	=	IC50	nM	93.0	CHEMBL5285	Homo sapiens	IC50	nM	93.0
	20608848	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	CCn1cc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c(OC)n1		CHEMBL4640063	=	IC50	nM	4.1	CHEMBL5285	Homo sapiens	IC50	nM	4.1
	20608849	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(CC2CC2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4647065	=	IC50	nM	6.9	CHEMBL5285	Homo sapiens	IC50	nM	6.9
	20608850	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COCCn1cc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c(OC)n1		CHEMBL4641264	=	IC50	nM	7.3	CHEMBL5285	Homo sapiens	IC50	nM	7.3
	20608851	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(-c2ccccn2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4642504	=	IC50	nM	17.0	CHEMBL5285	Homo sapiens	IC50	nM	17.0
	20608852	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(-c2ccncc2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4636506	=	IC50	nM	134.0	CHEMBL5285	Homo sapiens	IC50	nM	134.0
	20608853	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(-c2cccnc2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4633993	=	IC50	nM	5.3	CHEMBL5285	Homo sapiens	IC50	nM	5.3
	20608854	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(-c2cncc(C3CC3)c2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4642251	=	IC50	nM	5.6	CHEMBL5285	Homo sapiens	IC50	nM	5.6
	20608855	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(-c2cncc(N(C)C)c2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4634900	=	IC50	nM	1.9	CHEMBL5285	Homo sapiens	IC50	nM	1.9
	20608856	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(-c2cncnc2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4638598	=	IC50	nM	16.0	CHEMBL5285	Homo sapiens	IC50	nM	16.0
	20608857	CHEMBL4605628	Inhibition of human ASK1 using myelin basic protein substrate preincubated for 20 mins before [33P]-ATP addition and measured after 2 hrs by filter-binding method	B	COc1nn(-c2cnccn2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4632672	=	IC50	nM	21.0	CHEMBL5285	Homo sapiens	IC50	nM	21.0
	20608858	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	CCn1cc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c(OC)n1		CHEMBL4640063	=	IC50	nM	22.0	CHEMBL5285	Homo sapiens	IC50	nM	22.0
	20608859	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(CC2CC2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4647065	=	IC50	nM	12.0	CHEMBL5285	Homo sapiens	IC50	nM	12.0
	20608860	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COCCn1cc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c(OC)n1		CHEMBL4641264	=	IC50	nM	35.0	CHEMBL5285	Homo sapiens	IC50	nM	35.0
	20608861	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(-c2ccccn2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4642504	=	IC50	nM	299.0	CHEMBL5285	Homo sapiens	IC50	nM	299.0
	20608862	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(-c2ccncc2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4636506	=	IC50	nM	1710.0	CHEMBL5285	Homo sapiens	IC50	nM	1710.0
	20608863	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(-c2cccnc2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4633993	=	IC50	nM	11.0	CHEMBL5285	Homo sapiens	IC50	nM	11.0
	20608864	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(-c2cncc(C3CC3)c2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4642251	=	IC50	nM	28.0	CHEMBL5285	Homo sapiens	IC50	nM	28.0
	20608865	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(-c2cncc(N(C)C)c2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4634900	=	IC50	nM	21.0	CHEMBL5285	Homo sapiens	IC50	nM	21.0
	20608866	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(-c2cncnc2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4638598	=	IC50	nM	74.0	CHEMBL5285	Homo sapiens	IC50	nM	74.0
	20608867	CHEMBL4605627	Inhibition of V5 tagged human ASK1 expressed in HEK293T cells assessed as reduction in T848 autophosphorylation incubated for 1 hr by MSD assay	B	COc1nn(-c2cnccn2)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4632672	=	IC50	nM	138.0	CHEMBL5285	Homo sapiens	IC50	nM	138.0
	22391728	CHEMBL4666982	Inhibition of tracer 236 binding to recombinant human GST-tagged full length ASK1 expressed in baculovirus expression system at 0.1 uM incubated for 60 mins by Lanthascreen assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	4.0	CHEMBL5285	Homo sapiens	INH	%	4.0
	22391729	CHEMBL4666982	Inhibition of tracer 236 binding to recombinant human GST-tagged full length ASK1 expressed in baculovirus expression system at 0.1 uM incubated for 60 mins by Lanthascreen assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	2.0	CHEMBL5285	Homo sapiens	INH	%	2.0
	22391730	CHEMBL4666982	Inhibition of tracer 236 binding to recombinant human GST-tagged full length ASK1 expressed in baculovirus expression system at 0.1 uM incubated for 60 mins by Lanthascreen assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	-2.0	CHEMBL5285	Homo sapiens	INH	%	-2.0
	22391933	CHEMBL4667084	Inhibition of tracer 236 binding to recombinant human GST-tagged full length ASK1 expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.5	CHEMBL5285	Homo sapiens	INH	%	0.5
	22423825	CHEMBL4674488	Inhibition of human ASK1 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	103.83	CHEMBL5285	Homo sapiens	Activity	%	103.83
	22423826	CHEMBL4674488	Inhibition of human ASK1 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	83.63	CHEMBL5285	Homo sapiens	Activity	%	83.63
	22479110	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	24.4	CHEMBL5285	Homo sapiens	IC50	nM	24.4
	22479111	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)OCc2ccccc2)n1		CHEMBL4762235	=	IC50	nM	1523.0	CHEMBL5285	Homo sapiens	IC50	nM	1523.0
	22479112	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)OC(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4744430	=	IC50	nM	473.1	CHEMBL5285	Homo sapiens	IC50	nM	473.1
	22479113	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Oc2ccccc2)n1		CHEMBL4751836	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	22479114	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)NCc2ccccc2)n1		CHEMBL4741998	=	IC50	nM	7018.0	CHEMBL5285	Homo sapiens	IC50	nM	7018.0
	22479115	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccccc2)n1		CHEMBL4750505	=	IC50	nM	2838.0	CHEMBL5285	Homo sapiens	IC50	nM	2838.0
	22479116	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cccc(-c3cnn(C)c3)c2)n1		CHEMBL4753726	=	IC50	nM	2120.0	CHEMBL5285	Homo sapiens	IC50	nM	2120.0
	22479117	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccc(-c3cnn(C)c3)cc2)n1		CHEMBL4753801	=	IC50	nM	245.4	CHEMBL5285	Homo sapiens	IC50	nM	245.4
	22479118	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccccn2)n1		CHEMBL4776637	=	IC50	nM	43.4	CHEMBL5285	Homo sapiens	IC50	nM	43.4
	22479119	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cccnc2)n1		CHEMBL4748086	=	IC50	nM	1208.0	CHEMBL5285	Homo sapiens	IC50	nM	1208.0
	22479120	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccncc2)n1		CHEMBL4745716	=	IC50	nM	337.2	CHEMBL5285	Homo sapiens	IC50	nM	337.2
	22479121	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cnccn2)n1		CHEMBL4754232	=	IC50	nM	90.3	CHEMBL5285	Homo sapiens	IC50	nM	90.3
	22479122	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccc(-c3cnn(C)c3)cn2)n1		CHEMBL4753312	=	IC50	nM	64.2	CHEMBL5285	Homo sapiens	IC50	nM	64.2
	22479123	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccc(-c3ccn(C)n3)cn2)n1		CHEMBL4744931	=	IC50	nM	64.2	CHEMBL5285	Homo sapiens	IC50	nM	64.2
	22479124	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccn[nH]2)n1		CHEMBL4796219	=	IC50	nM	66.7	CHEMBL5285	Homo sapiens	IC50	nM	66.7
	22479125	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	Cc1cc(NC(=O)Nc2cccc(-c3nncn3C(C)C)n2)nn1C		CHEMBL4799364	=	IC50	nM	142.7	CHEMBL5285	Homo sapiens	IC50	nM	142.7
	22479126	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	Cc1cc(NC(=O)Nc2cccc(-c3nncn3C(C)C)n2)[nH]n1		CHEMBL4795694	=	IC50	nM	141.9	CHEMBL5285	Homo sapiens	IC50	nM	141.9
	22479127	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CCc1cc(NC(=O)Nc2cccc(-c3nncn3C(C)C)n2)[nH]n1		CHEMBL4753690	=	IC50	nM	152.7	CHEMBL5285	Homo sapiens	IC50	nM	152.7
	22479128	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)c1cc(NC(=O)Nc2cccc(-c3nncn3C(C)C)n2)[nH]n1		CHEMBL4788912	=	IC50	nM	393.0	CHEMBL5285	Homo sapiens	IC50	nM	393.0
	22479129	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cc(C3CC3)n[nH]2)n1		CHEMBL4753192	=	IC50	nM	123.7	CHEMBL5285	Homo sapiens	IC50	nM	123.7
	22479130	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	Cc1cc(NC(=O)Nc2cccc(-c3nncn3C(C)C)n2)n(C)n1		CHEMBL4799783	=	IC50	nM	4143.0	CHEMBL5285	Homo sapiens	IC50	nM	4143.0
	22479131	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cc(C3CC3)nn2C)n1		CHEMBL4792461	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	22479132	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cnn(C)c2)n1		CHEMBL4753270	=	IC50	nM	1859.0	CHEMBL5285	Homo sapiens	IC50	nM	1859.0
	22479133	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2nccc3ccccc23)n1		CHEMBL4763562	=	IC50	nM	48.5	CHEMBL5285	Homo sapiens	IC50	nM	48.5
	22479134	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccc3cn2)n1		CHEMBL4749551	=	IC50	nM	50.6	CHEMBL5285	Homo sapiens	IC50	nM	50.6
	22479135	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccc3ccccc3n2)n1		CHEMBL4795965	=	IC50	nM	69.1	CHEMBL5285	Homo sapiens	IC50	nM	69.1
	22479136	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cncc3ccccc23)n1		CHEMBL4759766	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	22479137	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccnc3ccccc23)n1		CHEMBL4747851	=	IC50	nM	3258.0	CHEMBL5285	Homo sapiens	IC50	nM	3258.0
	22479138	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ncnc3ccccc23)n1		CHEMBL4751918	=	IC50	nM	71.0	CHEMBL5285	Homo sapiens	IC50	nM	71.0
	22479139	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cnc3ccccc3n2)n1		CHEMBL4778358	=	IC50	nM	58.0	CHEMBL5285	Homo sapiens	IC50	nM	58.0
	22479140	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ncc3ccccc3n2)n1		CHEMBL4750857	=	IC50	nM	65.7	CHEMBL5285	Homo sapiens	IC50	nM	65.7
	22479141	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ncc3[nH]cnc3n2)n1		CHEMBL4759182	=	IC50	nM	32.6	CHEMBL5285	Homo sapiens	IC50	nM	32.6
	22479142	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2nn(C)c3ccccc23)n1		CHEMBL4787238	=	IC50	nM	259.3	CHEMBL5285	Homo sapiens	IC50	nM	259.3
	22479143	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2nc3ccccc3[nH]2)n1		CHEMBL4758606	=	IC50	nM	110.8	CHEMBL5285	Homo sapiens	IC50	nM	110.8
	22479144	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4740051	=	IC50	nM	85.3	CHEMBL5285	Homo sapiens	IC50	nM	85.3
	22479145	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cnn3ccccc23)n1		CHEMBL4754359	=	IC50	nM	3646.0	CHEMBL5285	Homo sapiens	IC50	nM	3646.0
	22479146	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cnc3ccccn23)n1		CHEMBL4780607	>	IC50	nM	10000.0	CHEMBL5285	Homo sapiens	IC50	uM	10.0
	22479147	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(N(C)C(=O)N(C)c2cc3ccccn3n2)n1		CHEMBL4792109	=	IC50	nM	6641.0	CHEMBL5285	Homo sapiens	IC50	nM	6641.0
	22479148	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)N(C)c2ccc3ccccc3n2)n1		CHEMBL4785979	=	IC50	nM	318.6	CHEMBL5285	Homo sapiens	IC50	nM	318.6
	22479149	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2nccc3ccccc23)n1		CHEMBL4764071	=	IC50	nM	37.9	CHEMBL5285	Homo sapiens	IC50	nM	37.9
	22479150	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2ccc3ccccc3n2)n1		CHEMBL4753203	=	IC50	nM	47.4	CHEMBL5285	Homo sapiens	IC50	nM	47.4
	22479151	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cnc3ccccc3n2)n1		CHEMBL4761865	=	IC50	nM	113.9	CHEMBL5285	Homo sapiens	IC50	nM	113.9
	22479152	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2ncc3ccccc3n2)n1		CHEMBL4752034	=	IC50	nM	81.0	CHEMBL5285	Homo sapiens	IC50	nM	81.0
	22479153	CHEMBL4686914	Inhibition of ASK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925	=	IC50	nM	33.8	CHEMBL5285	Homo sapiens	IC50	nM	33.8
	22479230	CHEMBL4686921	Inhibition of human recombinant ASK1 (649 to 946 residues) assessed as residual activity using myelin as substrate at 1 uM incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925	<	Activity	%	10.0	CHEMBL5285	Homo sapiens	Activity	%	10.0
Not Active	22479276	CHEMBL4686961	Inhibition of ASK1 phosphorylation in human HepG2 cells	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
Not Active	22479277	CHEMBL4686962	Inhibition of ASK1-mediated p38 phosphorylation in human HepG2 cells	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925		Inhibition	%		CHEMBL5285	Homo sapiens	INH		
	22479278	CHEMBL4686963	Inhibition of ASK1 (unknown origin) by competitive TR-FRET assay	B	O=C(Nc1cccc(-c2nncn2C2CC2)c1)c1cc(-n2cnc(C3CC3)c2)ccn1		CHEMBL4783726	=	IC50	nM	2.87	CHEMBL5285	Homo sapiens	IC50	nM	2.87
	22479279	CHEMBL4686963	Inhibition of ASK1 (unknown origin) by competitive TR-FRET assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	5.0	CHEMBL5285	Homo sapiens	IC50	nM	5.0
	22809799	CHEMBL4713334	Inhibition of recombinant human ASK1 (649 to 946 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	39.0	CHEMBL5285	Homo sapiens	Activity	%	39.0
	22818092	CHEMBL4715315	Inhibition of recombinant N-terminal GST-tagged/C-terminal His6-tagged human ASK1 (649 to 946 residues) expressed in Escherichia coli at 2 uM using MBP as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL5285	Homo sapiens	INH	%	50.0
	22820426	CHEMBL4716215	Inhibition of human recombinant ASK1 assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	104.0	CHEMBL5285	Homo sapiens	Activity	%	104.0
	22820427	CHEMBL4716215	Inhibition of human recombinant ASK1 assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	99.0	CHEMBL5285	Homo sapiens	Activity	%	99.0
	22843496	CHEMBL4720493	Inhibition of human ASK1 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	130.16	CHEMBL5285	Homo sapiens	Activity	%	130.16
	22843846	CHEMBL4720832	Inhibition of human ASK1 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	17.6	CHEMBL5285	Homo sapiens	IC50	10^-8M	1.76
	22844622	CHEMBL4721297	Inhibition of wild-type human partial length ASK1 (E648 to S964 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	92.15	CHEMBL5285	Homo sapiens	Activity	%	92.15
	22845468	CHEMBL4721749	Binding affinity to Nluc-tagged MAP3K5 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	2.9	CHEMBL5285	Homo sapiens	deltaTm	degrees C	2.9
	22883436	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3952214	=	IC50	nM	14.0	CHEMBL5285	Homo sapiens	IC50	nM	14.0
	22883437	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3952214	=	IC50	nM	12.59	CHEMBL5285	Homo sapiens	pIC50		7.9
	22883438	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	Cc1ccc(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)c(F)c1		CHEMBL3891901	=	IC50	nM	55.0	CHEMBL5285	Homo sapiens	IC50	nM	55.0
	22883439	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	22883440	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	Cc1cc(F)c(C(=O)Nc2ccccn2)cc1-n1cnc(C2CC2)c1		CHEMBL3981026	=	IC50	nM	6000.0	CHEMBL5285	Homo sapiens	IC50	uM	6.0
	22883441	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2ccccc2F)n1		CHEMBL4451125	=	IC50	nM	100.0	CHEMBL5285	Homo sapiens	IC50	nM	100.0
	22883442	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1		CHEMBL4759397	=	IC50	nM	270.0	CHEMBL5285	Homo sapiens	IC50	nM	270.0
	22883443	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1		CHEMBL4759397	=	IC50	nM	251.19	CHEMBL5285	Homo sapiens	pIC50		6.6
	22883444	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CN(C)CCO2)n1		CHEMBL4743649	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
	22883445	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CN(c3ccccc3)CCO2)n1		CHEMBL4748155	=	IC50	nM	130.0	CHEMBL5285	Homo sapiens	IC50	nM	130.0
	22883446	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CN(c3cccnc3)CCO2)n1		CHEMBL4753983	=	IC50	nM	31.0	CHEMBL5285	Homo sapiens	IC50	nM	31.0
	22883447	CHEMBL4727543	Inhibition of ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	=	IC50	nM	17.0	CHEMBL5285	Homo sapiens	IC50	nM	17.0
	22883486	CHEMBL4727570	Inhibition of ASK1 (unknown origin) by cell based assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	EC50	nM	2.0	CHEMBL5285	Homo sapiens	EC50	nM	2.0
	22883487	CHEMBL4727570	Inhibition of ASK1 (unknown origin) by cell based assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	=	EC50	nM	24.0	CHEMBL5285	Homo sapiens	EC50	nM	24.0
	22883488	CHEMBL4727571	Binding affinity to ASK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	<	Kd	nM	1.0	CHEMBL5285	Homo sapiens	Kd	nM	1.0
	22952756	CHEMBL4766693	Inhibition of recombinant human ASK1 (649 to 946 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	99.0	CHEMBL5285	Homo sapiens	Activity	%	99.0
	23120632	CHEMBL4804422	Inhibition of MAP3K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	25600.0	CHEMBL5285	Homo sapiens	IC50	uM	25.6
	23120633	CHEMBL4804422	Inhibition of MAP3K5 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-6200.0	CHEMBL5285	Homo sapiens	IC50	uM	-6.2
	23120634	CHEMBL4804422	Inhibition of MAP3K5 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-34300.0	CHEMBL5285	Homo sapiens	IC50	uM	-34.3
	23120635	CHEMBL4804422	Inhibition of MAP3K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	16300.0	CHEMBL5285	Homo sapiens	IC50	uM	16.3
	23120636	CHEMBL4804422	Inhibition of MAP3K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-12400.0	CHEMBL5285	Homo sapiens	IC50	uM	-12.4
	23120637	CHEMBL4804422	Inhibition of MAP3K5 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	30600.0	CHEMBL5285	Homo sapiens	IC50	uM	30.6
	23121671	CHEMBL4804604	Inhibition of MAP3K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	23121672	CHEMBL4804604	Inhibition of MAP3K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	23121673	CHEMBL4804604	Inhibition of MAP3K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	23121674	CHEMBL4804604	Inhibition of MAP3K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	23121675	CHEMBL4804604	Inhibition of MAP3K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	23121676	CHEMBL4804604	Inhibition of MAP3K5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL5285	Homo sapiens	INH	%	0.0
	23122448	CHEMBL4804799	Inhibition of human ASK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	91.0	CHEMBL5285	Homo sapiens	Activity	%	91.0
	23123143	CHEMBL4805387	Inhibition of human ASK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	75.0	CHEMBL5285	Homo sapiens	Activity	%	75.0
	23123744	CHEMBL4805988	Inhibition of DNA-tagged human ASK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	23124376	CHEMBL4806404	Inhibition of human ASK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	23124377	CHEMBL4806404	Inhibition of human ASK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5285	Homo sapiens	Activity	%	100.0
	23127819	CHEMBL4807748	Inhibition of ASK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5285	Homo sapiens	Activity	%	75.0
	23127820	CHEMBL4807748	Inhibition of ASK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5285	Homo sapiens	Activity	%	75.0
	23127821	CHEMBL4807748	Inhibition of ASK1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5285	Homo sapiens	Activity	%	75.0
	23197491	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccccc3o2)n1		CHEMBL4846965	=	IC50	nM	151.6	CHEMBL5285	Homo sapiens	IC50	nM	151.6
	23197492	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	Cc1c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)oc2ccccc12		CHEMBL4876111	=	IC50	nM	1106.0	CHEMBL5285	Homo sapiens	IC50	nM	1106.0
	23197493	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	Cc1c(C(=O)Nc2cccc(-n3cnnn3)c2)oc2ccccc12		CHEMBL4874376	=	IC50	nM	16700.0	CHEMBL5285	Homo sapiens	IC50	nM	16700.0
	23197494	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2nc3ccccc3s2)n1		CHEMBL4851548	=	IC50	nM	506.0	CHEMBL5285	Homo sapiens	IC50	nM	506.0
	23197495	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccccc3[nH]2)n1		CHEMBL4853834	=	IC50	nM	41.4	CHEMBL5285	Homo sapiens	IC50	nM	41.4
	23197496	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccnc3[nH]2)n1		CHEMBL4868746	=	IC50	nM	125.1	CHEMBL5285	Homo sapiens	IC50	nM	125.1
	23197497	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccccc3n2C)n1		CHEMBL4878207	=	IC50	nM	743.0	CHEMBL5285	Homo sapiens	IC50	nM	743.0
	23197498	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	Cc1c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)[nH]c2ccccc12		CHEMBL4848718	=	IC50	nM	88.2	CHEMBL5285	Homo sapiens	IC50	nM	88.2
	23197499	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2[nH]c3ccccc3c2-c2ccoc2)n1		CHEMBL4846465	=	IC50	nM	142.8	CHEMBL5285	Homo sapiens	IC50	nM	142.8
	23197500	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	Cc1ccc2cc(C(=O)Nc3cccc(-c4nncn4C(C)C)n3)[nH]c2c1		CHEMBL4855351	=	IC50	nM	32.8	CHEMBL5285	Homo sapiens	IC50	nM	32.8
	23197501	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	COc1ccc2cc(C(=O)Nc3cccc(-c4nncn4C(C)C)n3)[nH]c2c1		CHEMBL4870487	=	IC50	nM	54.3	CHEMBL5285	Homo sapiens	IC50	nM	54.3
	23197502	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccc(-c4cn[nH]c4)cc3[nH]2)n1		CHEMBL4879378	=	IC50	nM	37.5	CHEMBL5285	Homo sapiens	IC50	nM	37.5
	23197503	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CCOC(C)n1cc(-c2ccc3cc(C(=O)Nc4cccc(-c5nncn5C(C)C)n4)[nH]c3c2)cn1		CHEMBL4866091	=	IC50	nM	91.1	CHEMBL5285	Homo sapiens	IC50	nM	91.1
	23197504	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccc(-c4cnn(C5CCOCC5)c4)cc3[nH]2)n1		CHEMBL4847905	=	IC50	nM	73.7	CHEMBL5285	Homo sapiens	IC50	nM	73.7
	23197505	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccc(-c4cccnc4)cc3[nH]2)n1		CHEMBL4873038	=	IC50	nM	68.5	CHEMBL5285	Homo sapiens	IC50	nM	68.5
	23197506	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(=O)Nc1cccc2cc(C(=O)Nc3cccc(-c4nncn4C(C)C)n3)[nH]c12		CHEMBL4846645	=	IC50	nM	240.1	CHEMBL5285	Homo sapiens	IC50	nM	240.1
	23197507	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccc(Cl)c3[nH]2)n1		CHEMBL4854772	=	IC50	nM	89.6	CHEMBL5285	Homo sapiens	IC50	nM	89.6
	23197508	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccc(-c4cn[nH]c4)c3[nH]2)n1		CHEMBL4878410	=	IC50	nM	38.9	CHEMBL5285	Homo sapiens	IC50	nM	38.9
	23197509	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccc(-c4ccncc4)c3[nH]2)n1		CHEMBL4845717	=	IC50	nM	23.1	CHEMBL5285	Homo sapiens	IC50	nM	23.1
	23197510	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccc(-c4ccsc4)c3[nH]2)n1		CHEMBL4852337	=	IC50	nM	153.3	CHEMBL5285	Homo sapiens	IC50	nM	153.3
	23197511	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3c(-c4cnn(C)c4)cccc3[nH]2)n1		CHEMBL4870142	=	IC50	nM	19.6	CHEMBL5285	Homo sapiens	IC50	nM	19.6
	23197512	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cc(-c4cn[nH]c4)ccc3[nH]2)n1		CHEMBL4861744	=	IC50	nM	31.6	CHEMBL5285	Homo sapiens	IC50	nM	31.6
	23197513	CHEMBL4820058	Inhibition of N-terminal GST-tagged recombinant human full length ASK1 expressed in baculovirus-infected Sf21 cells using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRF assay	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)c2cc3ccccc3[nH]2)n1		CHEMBL4850703	=	IC50	nM	65.5	CHEMBL5285	Homo sapiens	IC50	nM	65.5
	23197514	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	Inhibition	%	76.67	CHEMBL5285	Homo sapiens	INH	%	76.67
	23197515	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccccc3o2)n1		CHEMBL4846965	=	Inhibition	%	25.33	CHEMBL5285	Homo sapiens	INH	%	25.33
	23197516	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccccc3[nH]2)n1		CHEMBL4853834	=	Inhibition	%	56.46	CHEMBL5285	Homo sapiens	INH	%	56.46
	23197517	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccnc3[nH]2)n1		CHEMBL4868746	=	Inhibition	%	32.54	CHEMBL5285	Homo sapiens	INH	%	32.54
	23197518	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	Cc1c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)[nH]c2ccccc12		CHEMBL4848718	=	Inhibition	%	92.48	CHEMBL5285	Homo sapiens	INH	%	92.48
	23197519	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	Cc1ccc2cc(C(=O)Nc3cccc(-c4nncn4C(C)C)n3)[nH]c2c1		CHEMBL4855351	=	Inhibition	%	95.59	CHEMBL5285	Homo sapiens	INH	%	95.59
	23197520	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	COc1ccc2cc(C(=O)Nc3cccc(-c4nncn4C(C)C)n3)[nH]c2c1		CHEMBL4870487	=	Inhibition	%	95.93	CHEMBL5285	Homo sapiens	INH	%	95.93
	23197521	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccc(-c4cn[nH]c4)cc3[nH]2)n1		CHEMBL4879378	=	Inhibition	%	94.39	CHEMBL5285	Homo sapiens	INH	%	94.39
	23197522	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CCOC(C)n1cc(-c2ccc3cc(C(=O)Nc4cccc(-c5nncn5C(C)C)n4)[nH]c3c2)cn1		CHEMBL4866091	=	Inhibition	%	94.04	CHEMBL5285	Homo sapiens	INH	%	94.04
	23197523	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccc(-c4cnn(C5CCOCC5)c4)cc3[nH]2)n1		CHEMBL4847905	=	Inhibition	%	64.63	CHEMBL5285	Homo sapiens	INH	%	64.63
	23197524	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3ccc(-c4cccnc4)cc3[nH]2)n1		CHEMBL4873038	=	Inhibition	%	95.66	CHEMBL5285	Homo sapiens	INH	%	95.66
	23197525	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccc(Cl)c3[nH]2)n1		CHEMBL4854772	=	Inhibition	%	90.84	CHEMBL5285	Homo sapiens	INH	%	90.84
	23197526	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cccc(-c4cn[nH]c4)c3[nH]2)n1		CHEMBL4878410	=	Inhibition	%	59.86	CHEMBL5285	Homo sapiens	INH	%	59.86
	23197527	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3c(-c4cnn(C)c4)cccc3[nH]2)n1		CHEMBL4870142	=	Inhibition	%	72.88	CHEMBL5285	Homo sapiens	INH	%	72.88
	23197528	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1cccc(NC(=O)c2cc3cc(-c4cn[nH]c4)ccc3[nH]2)n1		CHEMBL4861744	=	Inhibition	%	89.55	CHEMBL5285	Homo sapiens	INH	%	89.55
	23197529	CHEMBL4820059	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)c2cc3ccccc3[nH]2)n1		CHEMBL4850703	=	Inhibition	%	61.26	CHEMBL5285	Homo sapiens	INH	%	61.26
	23197538	CHEMBL4820064	Inhibition of ASK1 (unknown origin)	B	O=C(Nc1cccc(-c2nncn2C2CC2)c1)c1cc(-n2cnc(C3CC3)c2)ccn1		CHEMBL4783726	=	IC50	nM	2.87	CHEMBL5285	Homo sapiens	IC50	nM	2.87
	23197539	CHEMBL4820064	Inhibition of ASK1 (unknown origin)	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3[C@@H](C)C(F)(F)F)n2)cc1-n1cnc(C2CC2)c1		CHEMBL4855907	=	IC50	nM	4.3	CHEMBL5285	Homo sapiens	IC50	nM	4.3
	23197540	CHEMBL4820064	Inhibition of ASK1 (unknown origin)	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	5.9	CHEMBL5285	Homo sapiens	IC50	nM	5.9
	23197586	CHEMBL4820093	Inhibition of human recombinant ASK1 (654 to 971 residues) expressed in baculovirus-infected Sf21 cells using GST-fused MAP2K7 as substrate in presence of ATP by ELISA	B	COc1cc2nncc(Oc3ccc(NC(=O)c4cn(C(C)C)c5ccccc5c4=O)cc3)c2cc1OC		CHEMBL4466569	=	IC50	nM	6.0	CHEMBL5285	Homo sapiens	IC50	nM	6.0
	23283915	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	12.9	CHEMBL5285	Homo sapiens	IC50	nM	12.9
	23283916	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	O=C(Nc1cccc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1)c1ccc(C(F)(F)F)cc1		CHEMBL4869354	=	IC50	nM	532.0	CHEMBL5285	Homo sapiens	IC50	nM	532.0
	23283917	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(NC(=O)c4ccc(C(F)(F)F)cc4)c3)c2c1		CHEMBL4851372	=	IC50	nM	197.0	CHEMBL5285	Homo sapiens	IC50	nM	197.0
	23283918	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-n4cnc(C5CC5)c4)c3)c2c1		CHEMBL4856712	=	IC50	nM	62.2	CHEMBL5285	Homo sapiens	IC50	nM	62.2
	23283919	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(C(N)=O)c3)c2c1		CHEMBL4855684	=	IC50	nM	74.2	CHEMBL5285	Homo sapiens	IC50	nM	74.2
	23283920	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(C(=O)NC4CC4)c3)c2c1		CHEMBL4878217	=	IC50	nM	271.0	CHEMBL5285	Homo sapiens	IC50	nM	271.0
	23283921	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	COCCNC(=O)c1cccc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)c1		CHEMBL4871624	=	IC50	nM	245.0	CHEMBL5285	Homo sapiens	IC50	nM	245.0
	23283922	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(C(=O)Nc4cnn(C)c4)c3)c2c1		CHEMBL4860121	=	IC50	nM	144.0	CHEMBL5285	Homo sapiens	IC50	nM	144.0
	23283923	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(S(C)(=O)=O)c3)c2c1		CHEMBL4865938	=	IC50	nM	733.0	CHEMBL5285	Homo sapiens	IC50	nM	733.0
	23283924	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CCS(=O)(=O)Nc1cccc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)c1		CHEMBL4860629	=	IC50	nM	19.8	CHEMBL5285	Homo sapiens	IC50	nM	19.8
	23283925	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	COCn1cc(-c2cccc(-c3n[nH]c4ccc(-c5nncn5C(C)C)cc34)c2)cn1		CHEMBL4866123	=	IC50	nM	26.9	CHEMBL5285	Homo sapiens	IC50	nM	26.9
	23283926	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CCOC(C)n1cc(-c2cccc(-c3n[nH]c4ccc(-c5nncn5C(C)C)cc34)c2)cn1		CHEMBL4855899	=	IC50	nM	29.9	CHEMBL5285	Homo sapiens	IC50	nM	29.9
	23283927	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4cnn(C)c4)c3)c2c1		CHEMBL4861117	=	IC50	nM	63.6	CHEMBL5285	Homo sapiens	IC50	nM	63.6
	23283928	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4cnn(C5CCOCC5)c4)c3)c2c1		CHEMBL4861821	=	IC50	nM	50.1	CHEMBL5285	Homo sapiens	IC50	nM	50.1
	23283929	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4ccnn4C)c3)c2c1		CHEMBL4856252	=	IC50	nM	855.0	CHEMBL5285	Homo sapiens	IC50	nM	855.0
	23283930	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-n4cnc(C5CC5)n4)c3)c2c1		CHEMBL4846492	=	IC50	nM	37.0	CHEMBL5285	Homo sapiens	IC50	nM	37.0
	23283931	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4cccnc4)c3)c2c1		CHEMBL4851116	=	IC50	nM	283.0	CHEMBL5285	Homo sapiens	IC50	nM	283.0
	23283932	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4869497	=	IC50	nM	50.0	CHEMBL5285	Homo sapiens	IC50	nM	50.0
	23283933	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CCC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4862079	=	IC50	nM	70.0	CHEMBL5285	Homo sapiens	IC50	nM	70.0
	23283934	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CCCC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4864119	=	IC50	nM	54.1	CHEMBL5285	Homo sapiens	IC50	nM	54.1
	23283935	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CCCCC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4878127	=	IC50	nM	243.0	CHEMBL5285	Homo sapiens	IC50	nM	243.0
	23283936	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	c1cc(-c2n[nH]c3ccc(-c4cn[nH]c4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4851478	=	IC50	nM	274.6	CHEMBL5285	Homo sapiens	IC50	nM	274.6
	23283937	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3ccc(N4CCOCC4)c(-n4cnc(C5CC5)c4)c3)c2c1		CHEMBL4859892	=	IC50	nM	31.8	CHEMBL5285	Homo sapiens	IC50	nM	31.8
	23283938	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cc(N4CCOCC4)cc(-n4cnc(C5CC5)c4)c3)c2c1		CHEMBL4865331	=	IC50	nM	75.1	CHEMBL5285	Homo sapiens	IC50	nM	75.1
	23283939	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	Cc1ccc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)cc1-n1cnc(C2CC2)c1		CHEMBL4861520	=	IC50	nM	56.9	CHEMBL5285	Homo sapiens	IC50	nM	56.9
	23283940	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	COc1cc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4878227	=	IC50	nM	48.6	CHEMBL5285	Homo sapiens	IC50	nM	48.6
	23283941	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	COc1ccc(-n2cnc(C3CC3)c2)cc1-c1n[nH]c2ccc(-c3nncn3C(C)C)cc12		CHEMBL4873179	=	IC50	nM	270.0	CHEMBL5285	Homo sapiens	IC50	nM	270.0
	23283942	CHEMBL4837908	Inhibition of human full length recombinant ASK1 using STK-Substrate-3 biotin as substrate in presence of ATP measured after 2 hrs by HTRP kinase assay	B	CCOC(C)n1cc(-c2cncc(-c3n[nH]c4ccc(-c5nncn5C(C)C)cc34)c2)cn1		CHEMBL4852798	=	IC50	nM	277.0	CHEMBL5285	Homo sapiens	IC50	nM	277.0
	23283943	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	Inhibition	%	76.7	CHEMBL5285	Homo sapiens	INH	%	76.7
	23283944	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-n4cnc(C5CC5)c4)c3)c2c1		CHEMBL4856712	=	Inhibition	%	52.1	CHEMBL5285	Homo sapiens	INH	%	52.1
	23283945	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(C(N)=O)c3)c2c1		CHEMBL4855684	=	Inhibition	%	2.7	CHEMBL5285	Homo sapiens	INH	%	2.7
	23283946	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(C(=O)Nc4cnn(C)c4)c3)c2c1		CHEMBL4860121	=	Inhibition	%	7.9	CHEMBL5285	Homo sapiens	INH	%	7.9
	23283947	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CCS(=O)(=O)Nc1cccc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)c1		CHEMBL4860629	=	Inhibition	%	4.5	CHEMBL5285	Homo sapiens	INH	%	4.5
	23283948	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	COCn1cc(-c2cccc(-c3n[nH]c4ccc(-c5nncn5C(C)C)cc34)c2)cn1		CHEMBL4866123	=	Inhibition	%	63.6	CHEMBL5285	Homo sapiens	INH	%	63.6
	23283949	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CCOC(C)n1cc(-c2cccc(-c3n[nH]c4ccc(-c5nncn5C(C)C)cc34)c2)cn1		CHEMBL4855899	=	Inhibition	%	78.6	CHEMBL5285	Homo sapiens	INH	%	78.6
	23283950	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4cnn(C)c4)c3)c2c1		CHEMBL4861117	=	Inhibition	%	67.4	CHEMBL5285	Homo sapiens	INH	%	67.4
	23283951	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4cnn(C5CCOCC5)c4)c3)c2c1		CHEMBL4861821	=	Inhibition	%	69.4	CHEMBL5285	Homo sapiens	INH	%	69.4
	23283952	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-n4cnc(C5CC5)n4)c3)c2c1		CHEMBL4846492	=	Inhibition	%	84.9	CHEMBL5285	Homo sapiens	INH	%	84.9
	23283953	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4869497	=	Inhibition	%	96.28	CHEMBL5285	Homo sapiens	INH	%	96.28
	23283954	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CCC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4862079	=	Inhibition	%	93.84	CHEMBL5285	Homo sapiens	INH	%	93.84
	23283955	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CCCC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4864119	=	Inhibition	%	93.4	CHEMBL5285	Homo sapiens	INH	%	93.4
	23283956	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3ccc(N4CCOCC4)c(-n4cnc(C5CC5)c4)c3)c2c1		CHEMBL4859892	=	Inhibition	%	89.41	CHEMBL5285	Homo sapiens	INH	%	89.41
	23283957	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	Cc1ccc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)cc1-n1cnc(C2CC2)c1		CHEMBL4861520	=	Inhibition	%	89.98	CHEMBL5285	Homo sapiens	INH	%	89.98
	23283958	CHEMBL4837909	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity at 10 uM preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay relative to control	B	COc1cc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4878227	=	Inhibition	%	96.12	CHEMBL5285	Homo sapiens	INH	%	96.12
	23283959	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	=	IC50	nM	7501.0	CHEMBL5285	Homo sapiens	IC50	nM	7501.0
Not Determined	23283960	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-n4cnc(C5CC5)c4)c3)c2c1		CHEMBL4856712		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Determined	23283961	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(C(N)=O)c3)c2c1		CHEMBL4855684		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Determined	23283962	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(C(=O)Nc4cnn(C)c4)c3)c2c1		CHEMBL4860121		IC50			CHEMBL5285	Homo sapiens	IC50		
Not Determined	23283963	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CCS(=O)(=O)Nc1cccc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)c1		CHEMBL4860629		IC50			CHEMBL5285	Homo sapiens	IC50		
	23283964	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	COCn1cc(-c2cccc(-c3n[nH]c4ccc(-c5nncn5C(C)C)cc34)c2)cn1		CHEMBL4866123	=	IC50	nM	9808.0	CHEMBL5285	Homo sapiens	IC50	nM	9808.0
	23283965	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CCOC(C)n1cc(-c2cccc(-c3n[nH]c4ccc(-c5nncn5C(C)C)cc34)c2)cn1		CHEMBL4855899	=	IC50	nM	4462.0	CHEMBL5285	Homo sapiens	IC50	nM	4462.0
	23283966	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4cnn(C)c4)c3)c2c1		CHEMBL4861117	=	IC50	nM	8333.0	CHEMBL5285	Homo sapiens	IC50	nM	8333.0
	23283967	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-c4cnn(C5CCOCC5)c4)c3)c2c1		CHEMBL4861821	=	IC50	nM	12064.0	CHEMBL5285	Homo sapiens	IC50	nM	12064.0
	23283968	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3cccc(-n4cnc(C5CC5)n4)c3)c2c1		CHEMBL4846492	=	IC50	nM	8877.0	CHEMBL5285	Homo sapiens	IC50	nM	8877.0
	23283969	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4869497	=	IC50	nM	7045.0	CHEMBL5285	Homo sapiens	IC50	nM	7045.0
	23283970	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CCC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4862079	=	IC50	nM	7276.0	CHEMBL5285	Homo sapiens	IC50	nM	7276.0
	23283971	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	c1cc(-c2n[nH]c3ccc(-c4nncn4C4CCCC4)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4864119	=	IC50	nM	5502.0	CHEMBL5285	Homo sapiens	IC50	nM	5502.0
	23283972	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	CC(C)n1cnnc1-c1ccc2[nH]nc(-c3ccc(N4CCOCC4)c(-n4cnc(C5CC5)c4)c3)c2c1		CHEMBL4859892	=	IC50	nM	11633.0	CHEMBL5285	Homo sapiens	IC50	nM	11633.0
	23283973	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	Cc1ccc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)cc1-n1cnc(C2CC2)c1		CHEMBL4861520	=	IC50	nM	8729.0	CHEMBL5285	Homo sapiens	IC50	nM	8729.0
	23283974	CHEMBL4837910	Inhibition of ASK1 in human HEK293 cells transfected with AP1 assessed as inhibition of AP1-induced firefly luciferase activity preincubated for 1 hr followed by PMA stimulation and measured after 6 hrs by luciferase reporter assay	B	COc1cc(-c2n[nH]c3ccc(-c4nncn4C(C)C)cc23)cc(-n2cnc(C3CC3)c2)c1		CHEMBL4878227	=	IC50	nM	11294.0	CHEMBL5285	Homo sapiens	IC50	nM	11294.0
	23316554	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4643577	=	IC50	nM	6.0	CHEMBL5285	Homo sapiens	IC50	nM	6.0
	23316555	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)CO)n1		CHEMBL4865259	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
	23316556	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COC[C@@H](C)n1cnnc1-c1cccc(NC(=O)c2cn(C)nc2OC)n1		CHEMBL4867144	=	IC50	nM	31.0	CHEMBL5285	Homo sapiens	IC50	nM	31.0
	23316557	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COC[C@H](C)n1cnnc1-c1cccc(NC(=O)c2cn(C)nc2OC)n1		CHEMBL4867281	=	IC50	nM	44.0	CHEMBL5285	Homo sapiens	IC50	nM	44.0
	23316558	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@H]2CCOC2)n1		CHEMBL4848618	=	IC50	nM	8.0	CHEMBL5285	Homo sapiens	IC50	nM	8.0
	23316559	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H]2CCOC2)n1		CHEMBL4860731	=	IC50	nM	5.0	CHEMBL5285	Homo sapiens	IC50	nM	5.0
	23316560	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C(F)(F)F)n1		CHEMBL4857053	=	IC50	nM	9.0	CHEMBL5285	Homo sapiens	IC50	nM	9.0
	23316561	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4860819	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	23316562	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@H](C)C(F)(F)F)n1		CHEMBL4863056	=	IC50	nM	94.0	CHEMBL5285	Homo sapiens	IC50	nM	94.0
	23316563	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@H](C)C(F)F)n1		CHEMBL4864439	=	IC50	nM	37.0	CHEMBL5285	Homo sapiens	IC50	nM	37.0
	23316564	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)F)n1		CHEMBL4878163	=	IC50	nM	6.0	CHEMBL5285	Homo sapiens	IC50	nM	6.0
	23316565	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C2(C(F)(F)F)CC2)n1		CHEMBL4868362	=	IC50	nM	1.0	CHEMBL5285	Homo sapiens	IC50	nM	1.0
	23316566	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C2CC(F)(F)C2)n1		CHEMBL4860716	=	IC50	nM	20.0	CHEMBL5285	Homo sapiens	IC50	nM	20.0
	23316567	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C2CCC2(F)F)n1		CHEMBL4876558	=	IC50	nM	5.0	CHEMBL5285	Homo sapiens	IC50	nM	5.0
	23316568	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	CCn1cc(C(=O)Nc2cccc(-c3nncn3[C@@H](C)C(F)(F)F)n2)c(OC)n1		CHEMBL4857751	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
	23316569	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(CC2CC2)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4871543	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
	23316570	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(CC(F)(F)F)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4862258	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	23316571	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COCCn1cc(C(=O)Nc2cccc(-c3nncn3[C@@H](C)C(F)(F)F)n2)c(OC)n1		CHEMBL4850048	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
	23316572	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(-c2cnccn2)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4866921	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	23316573	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1nn(-c2cccnn2)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4862847	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	23316574	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1ccccc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4861953	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	23316575	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccc3c2OCCN3C)n1)C(F)(F)F		CHEMBL4874460	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
	23316576	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccc3cccnc23)n1)C(F)(F)F		CHEMBL4875364	=	IC50	nM	2.0	CHEMBL5285	Homo sapiens	IC50	nM	2.0
	23316577	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccc3nccnc23)n1)C(F)(F)F		CHEMBL4877113	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	23316578	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1ncccc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4852061	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
	23316579	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccn(C)c2=O)n1)C(F)(F)F		CHEMBL4873779	=	IC50	nM	18.0	CHEMBL5285	Homo sapiens	IC50	nM	18.0
	23316580	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1ncncc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4862220	=	IC50	nM	17.0	CHEMBL5285	Homo sapiens	IC50	nM	17.0
	23316581	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1ncc(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4853505	=	IC50	nM	3.0	CHEMBL5285	Homo sapiens	IC50	nM	3.0
	23316582	CHEMBL4845477	Inhibition of ASK1 (unknown origin) using myelin basic protein as substrate preincubated for 20 mins followed by 33P-ATP addition and measured after 2 hrs	B	COc1ncc(F)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4849014	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
	23316583	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4643577	=	IC50	nM	90.0	CHEMBL5285	Homo sapiens	IC50	nM	90.0
	23316584	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)CO)n1		CHEMBL4865259	=	IC50	nM	2895.0	CHEMBL5285	Homo sapiens	IC50	nM	2895.0
	23316585	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COC[C@@H](C)n1cnnc1-c1cccc(NC(=O)c2cn(C)nc2OC)n1		CHEMBL4867144	=	IC50	nM	403.0	CHEMBL5285	Homo sapiens	IC50	nM	403.0
	23316586	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COC[C@H](C)n1cnnc1-c1cccc(NC(=O)c2cn(C)nc2OC)n1		CHEMBL4867281	=	IC50	nM	793.0	CHEMBL5285	Homo sapiens	IC50	nM	793.0
	23316587	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@H]2CCOC2)n1		CHEMBL4848618	=	IC50	nM	144.0	CHEMBL5285	Homo sapiens	IC50	nM	144.0
	23316588	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H]2CCOC2)n1		CHEMBL4860731	=	IC50	nM	129.0	CHEMBL5285	Homo sapiens	IC50	nM	129.0
	23316589	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C(C)C(F)(F)F)n1		CHEMBL4857053	=	IC50	nM	40.0	CHEMBL5285	Homo sapiens	IC50	nM	40.0
	23316590	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4860819	=	IC50	nM	17.0	CHEMBL5285	Homo sapiens	IC50	nM	17.0
	23316591	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@H](C)C(F)(F)F)n1		CHEMBL4863056	=	IC50	nM	350.0	CHEMBL5285	Homo sapiens	IC50	nM	350.0
	23316592	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@H](C)C(F)F)n1		CHEMBL4864439	=	IC50	nM	143.0	CHEMBL5285	Homo sapiens	IC50	nM	143.0
	23316593	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)F)n1		CHEMBL4878163	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
	23316594	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C2(C(F)(F)F)CC2)n1		CHEMBL4868362	=	IC50	nM	31.0	CHEMBL5285	Homo sapiens	IC50	nM	31.0
	23316595	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C2CC(F)(F)C2)n1		CHEMBL4860716	=	IC50	nM	316.0	CHEMBL5285	Homo sapiens	IC50	nM	316.0
	23316596	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(C)cc1C(=O)Nc1cccc(-c2nncn2C2CCC2(F)F)n1		CHEMBL4876558	=	IC50	nM	7.0	CHEMBL5285	Homo sapiens	IC50	nM	7.0
	23316597	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	CCn1cc(C(=O)Nc2cccc(-c3nncn3[C@@H](C)C(F)(F)F)n2)c(OC)n1		CHEMBL4857751	=	IC50	nM	13.0	CHEMBL5285	Homo sapiens	IC50	nM	13.0
	23316598	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(CC2CC2)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4871543	=	IC50	nM	9.0	CHEMBL5285	Homo sapiens	IC50	nM	9.0
	23316599	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(CC(F)(F)F)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4862258	=	IC50	nM	36.0	CHEMBL5285	Homo sapiens	IC50	nM	36.0
	23316600	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COCCn1cc(C(=O)Nc2cccc(-c3nncn3[C@@H](C)C(F)(F)F)n2)c(OC)n1		CHEMBL4850048	=	IC50	nM	15.0	CHEMBL5285	Homo sapiens	IC50	nM	15.0
	23316601	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(-c2cnccn2)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4866921	=	IC50	nM	58.0	CHEMBL5285	Homo sapiens	IC50	nM	58.0
	23316602	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1nn(-c2cccnn2)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4862847	=	IC50	nM	50.0	CHEMBL5285	Homo sapiens	IC50	nM	50.0
	23316603	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1ccccc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4861953	=	IC50	nM	53.0	CHEMBL5285	Homo sapiens	IC50	nM	53.0
	23316604	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccc3c2OCCN3C)n1)C(F)(F)F		CHEMBL4874460	=	IC50	nM	187.0	CHEMBL5285	Homo sapiens	IC50	nM	187.0
	23316605	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccc3cccnc23)n1)C(F)(F)F		CHEMBL4875364	=	IC50	nM	72.0	CHEMBL5285	Homo sapiens	IC50	nM	72.0
	23316606	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccc3nccnc23)n1)C(F)(F)F		CHEMBL4877113	=	IC50	nM	50.0	CHEMBL5285	Homo sapiens	IC50	nM	50.0
	23316607	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1ncccc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4852061	=	IC50	nM	27.0	CHEMBL5285	Homo sapiens	IC50	nM	27.0
	23316608	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	C[C@H](n1cnnc1-c1cccc(NC(=O)c2cccn(C)c2=O)n1)C(F)(F)F		CHEMBL4873779	=	IC50	nM	363.0	CHEMBL5285	Homo sapiens	IC50	nM	363.0
	23316609	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1ncncc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4862220	=	IC50	nM	302.0	CHEMBL5285	Homo sapiens	IC50	nM	302.0
	23316610	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1ncc(C)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4853505	=	IC50	nM	51.0	CHEMBL5285	Homo sapiens	IC50	nM	51.0
	23316611	CHEMBL4845478	Inhibition of full-length human ASK1 expressed in HEK293T cells assessed as reduction in autophosphorylation of ASK1 at T383 residue incubated for 1 hr	B	COc1ncc(F)cc1C(=O)Nc1cccc(-c2nncn2[C@@H](C)C(F)(F)F)n1		CHEMBL4849014	=	IC50	nM	25.0	CHEMBL5285	Homo sapiens	IC50	nM	25.0
Not Active	23317283	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	93.0	CHEMBL5285	Homo sapiens	% Control	%	93.0
Not Active	23317751	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23318425	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	77.0	CHEMBL5285	Homo sapiens	% Control	%	77.0
Not Active	23318901	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23319541	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23320013	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23320691	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	93.0	CHEMBL5285	Homo sapiens	% Control	%	93.0
Not Active	23321159	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	98.0	CHEMBL5285	Homo sapiens	% Control	%	98.0
Not Active	23321789	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23322257	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL5285	Homo sapiens	% Control	%	97.0
Not Active	23322946	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	94.0	CHEMBL5285	Homo sapiens	% Control	%	94.0
Not Active	23323414	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23323952	CHEMBL4880571	ASK1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-6.0	CHEMBL5285	Homo sapiens	% inhibition	%	-6.0
Not Active	23324268	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23324903	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	95.0	CHEMBL5285	Homo sapiens	% Control	%	95.0
Not Active	23325371	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	94.0	CHEMBL5285	Homo sapiens	% Control	%	94.0
Not Active	23326018	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23326486	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	88.0	CHEMBL5285	Homo sapiens	% Control	%	88.0
Not Active	23327186	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23327654	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23328241	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23328709	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23329250	CHEMBL4880957	ASK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	99.0	CHEMBL5285	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23329655	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	92.0	CHEMBL5285	Homo sapiens	% Control	%	92.0
Not Active	23330123	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	99.0	CHEMBL5285	Homo sapiens	% Control	%	99.0
Not Active	23330879	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23331347	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23331934	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23332402	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23333118	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	94.8	CHEMBL5285	Homo sapiens	% Control	%	94.8
Not Active	23333757	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23334225	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23335204	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	98.0	CHEMBL5285	Homo sapiens	% Control	%	98.0
Not Active	23335672	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	97.0	CHEMBL5285	Homo sapiens	% Control	%	97.0
Active	23336299	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	13.0	CHEMBL5285	Homo sapiens	% Control	%	13.0
Not Active	23336767	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	95.0	CHEMBL5285	Homo sapiens	% Control	%	95.0
Not Active	23337655	CHEMBL4882026	MAP3K5 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.0	CHEMBL5285	Homo sapiens	% Ctrl	%	99.0
Not Active	23337848	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	99.0	CHEMBL5285	Homo sapiens	% Control	%	99.0
Not Active	23338316	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23338928	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23339396	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23340033	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	97.0	CHEMBL5285	Homo sapiens	% Control	%	97.0
Not Active	23340501	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	96.0	CHEMBL5285	Homo sapiens	% Control	%	96.0
Not Active	23341158	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23341626	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23342242	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23342710	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23343340	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	98.0	CHEMBL5285	Homo sapiens	% Control	%	98.0
Not Active	23343808	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	86.0	CHEMBL5285	Homo sapiens	% Control	%	86.0
Not Active	23344446	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23345019	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	93.0	CHEMBL5285	Homo sapiens	% Control	%	93.0
Not Active	23345487	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23346064	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	83.3	CHEMBL5285	Homo sapiens	% Control	%	83.3
Not Active	23346533	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23347143	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23347624	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23348203	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23348671	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	85.0	CHEMBL5285	Homo sapiens	% Control	%	85.0
Not Active	23349258	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	80.0	CHEMBL5285	Homo sapiens	% Control	%	80.0
Not Active	23349876	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23350344	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23350949	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23351417	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL5285	Homo sapiens	% Control	%	90.0
Not Active	23352106	CHEMBL4882796	MAP3K5 (ASK1) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	71.9	CHEMBL5285	Homo sapiens	% Inhibition	%	71.904
	23352107	CHEMBL4882796	MAP3K5 (ASK1) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		IC50	nM	428.0	CHEMBL5285	Homo sapiens	IC50	nM	428.0
Not Active	23352441	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	88.0	CHEMBL5285	Homo sapiens	% Control	%	88.0
Not Active	23352909	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23353791	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23354259	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23354991	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	84.0	CHEMBL5285	Homo sapiens	% Control	%	84.0
Not Active	23355459	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23356095	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23356563	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	96.0	CHEMBL5285	Homo sapiens	% Control	%	96.0
Not Active	23357172	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23357819	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23358287	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	98.0	CHEMBL5285	Homo sapiens	% Control	%	98.0
Not Active	23358873	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	97.8	CHEMBL5285	Homo sapiens	% Control	%	97.8
Not Active	23359471	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	85.0	CHEMBL5285	Homo sapiens	% Control	%	85.0
Not Active	23359939	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23360524	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23360992	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	83.0	CHEMBL5285	Homo sapiens	% Control	%	83.0
Not Active	23361565	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23362101	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23362569	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23364211	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	78.0	CHEMBL5285	Homo sapiens	% Control	%	78.0
Not Active	23364679	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	82.0	CHEMBL5285	Homo sapiens	% Control	%	82.0
Not Active	23365418	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	94.0	CHEMBL5285	Homo sapiens	% Control	%	94.0
Not Active	23365961	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	94.0	CHEMBL5285	Homo sapiens	% Control	%	94.0
Not Active	23366551	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	81.0	CHEMBL5285	Homo sapiens	% Control	%	81.0
Not Active	23367019	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	91.0	CHEMBL5285	Homo sapiens	% Control	%	91.0
Not Active	23367473	CHEMBL4883826	ASK1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	103.0	CHEMBL5285	Homo sapiens	% Residual activity with Skepinone-L	%	103.0
Not Active	23367897	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	84.0	CHEMBL5285	Homo sapiens	% Control	%	84.0
Not Active	23368365	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	87.0	CHEMBL5285	Homo sapiens	% Control	%	87.0
Not Active	23368964	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23369432	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23369977	CHEMBL4884222	ASK1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	99.0	CHEMBL5285	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23370400	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23370868	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	89.0	CHEMBL5285	Homo sapiens	% Control	%	89.0
Not Active	23371677	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23372145	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
	23372787	CHEMBL4884752	ASK [MAP3K5(M3K5LGA1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5285	Homo sapiens	pIC50		6.0
	23373196	CHEMBL4885043	ASK [MAP3K5(M3K5LGA1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5285	Homo sapiens	pIC50		6.0
	23373556	CHEMBL4885333	ASK [MAP3K5(M3K5LGA1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5285	Homo sapiens	pIC50		6.0
Not Active	23374916	CHEMBL4885910	ASK1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	3.5	CHEMBL5285	Homo sapiens	% Inhibition	%	3.5
Not Active	23375308	CHEMBL4886290	mitogen-activated protein kinase kinase kinase 5 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-2.0	CHEMBL5285	Homo sapiens	% inhibition	%	-2.0
Not Active	23375572	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	84.0	CHEMBL5285	Homo sapiens	% Control	%	84.0
Not Active	23376040	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	90.0	CHEMBL5285	Homo sapiens	% Control	%	90.0
Not Active	23376618	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	75.0	CHEMBL5285	Homo sapiens	% Control	%	75.0
Not Active	23377087	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	72.0	CHEMBL5285	Homo sapiens	% Control	%	72.0
Not Active	23377945	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	94.0	CHEMBL5285	Homo sapiens	% Control	%	94.0
Not Active	23378413	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23379580	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	75.0	CHEMBL5285	Homo sapiens	% Control	%	75.0
Not Active	23380048	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	80.0	CHEMBL5285	Homo sapiens	% Control	%	80.0
Not Active	23380742	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	98.0	CHEMBL5285	Homo sapiens	% Control	%	98.0
Not Active	23381390	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	92.0	CHEMBL5285	Homo sapiens	% Control	%	92.0
Not Active	23381858	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23382482	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23382950	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL5285	Homo sapiens	% Control	%	100.0
Not Active	23383856	CHEMBL4887480	MAP3K5 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL5285	Homo sapiens	% Ctrl	%	99.0
Not Active	23384182	CHEMBL4887777	ASK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-9.98	CHEMBL5285	Homo sapiens	% inhibition	%	-9.98
Not Active	23384865	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	84.0	CHEMBL5285	Homo sapiens	% Control	%	84.0
Not Active	23385332	CHEMBL4879589	KinomeScan assay: inhibition of ASK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	81.0	CHEMBL5285	Homo sapiens	% Control	%	81.0
